BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1135575 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135576 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2FNO4/c1-27(2,36)20-13-23-25(24(32)14-20)29(19-5-9-22(31)10-6-19,37-17-28(16-34)11-12-28)33(26(23)35)15-18-3-7-21(30)8-4-18/h3-10,13-14,34,36H,11-12,15-17H2,1-2H3/t29-/m1/s1 QUBUREFIXVDKEB-GDLZYMKVSA-N 427047 US10544132, Example 2::US10981898, Example 2::US11236047, Example 2 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427047&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281669 434321364 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135577 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCO)c1ccc(Cl)cc1 InChI=1S/C26H25Cl2NO4/c1-25(2,32)19-7-12-23-22(15-19)24(31)29(16-17-3-8-20(27)9-4-17)26(23,33-14-13-30)18-5-10-21(28)11-6-18/h3-12,15,30,32H,13-14,16H2,1-2H3/t26-/m1/s1 BDOTXISZENQYGP-AREMUKBSSA-N 427048 US10544132, Example 3::US10981898, Example 3::US11236047, Example 3 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 93.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427048&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281430 434321365 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135578 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(2,35)21-7-12-25-24(13-21)26(34)32(14-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)37-18-28(15-33)16-36-17-28/h3-13,33,35H,14-18H2,1-2H3/t29-/m1/s1 GDUHFOYTYPKEOT-GDLZYMKVSA-N 427049 US10544132, Example 4::US10981898, Example 4::US11236047, Example 4 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 43.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427049&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281482 434321366 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135579 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C(O)=O)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2NO5/c1-27(2,36)20-7-12-24-23(15-20)25(33)32(16-18-3-8-21(30)9-4-18)29(24,19-5-10-22(31)11-6-19)37-17-28(13-14-28)26(34)35/h3-12,15,36H,13-14,16-17H2,1-2H3,(H,34,35)/t29-/m1/s1 IAJLMKLNFWIPMA-GDLZYMKVSA-N 427050 US10544132, Example 5::US10981898, Example 5::US11236047, Example 5 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427050&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281515 434321367 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135580 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC(C)(O)CO)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO5/c1-18(19-5-10-22(30)11-6-19)32-26(34)24-15-21(27(2,3)35)9-14-25(24)29(32,37-17-28(4,36)16-33)20-7-12-23(31)13-8-20/h5-15,18,33,35-36H,16-17H2,1-4H3/t18-,28?,29+/m0/s1 UUZINBSIYDKSFT-PDIMESBLSA-N 427051 US10544132, Example 6::US10981898, Example 6::US11236047, Example 6 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427051&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281509 434321368 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135581 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-19(20-4-9-23(31)10-5-20)33-27(35)25-16-22(28(2,3)36)8-13-26(25)30(33,21-6-11-24(32)12-7-21)37-18-29(17-34)14-15-29/h4-13,16,19,34,36H,14-15,17-18H2,1-3H3/t19-,30+/m0/s1 OBIKGGOHRXESCS-WWOZWPLTSA-N 427053 US10544132, Example 7::US10981898, Example 7::US11236047, Example 7 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427053&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281662 434321370 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135582 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27?,29-/m1/s1 NVLQHQFGNPTQCC-ZBAATNBSSA-N 535132 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 8::US11236047, Example 9 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281498 464920407 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135583 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27?,29-/m1/s1 NVLQHQFGNPTQCC-ZBAATNBSSA-N 535132 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 8::US11236047, Example 9 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281498 464920407 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135584 COCC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29?,31+/m0/s1 UIFBZUZURMPJLE-VMDBBOCCSA-N 535135 (3R)-2-[(5-Chloro-1-oxo-1lambda5-pyridin-2- yl)methyl]-3-(4-chlorophenyl)-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 10::US11236047, Example 11 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281724 464920409 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135585 COCC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29?,31+/m0/s1 UIFBZUZURMPJLE-VMDBBOCCSA-N 535135 (3R)-2-[(5-Chloro-1-oxo-1lambda5-pyridin-2- yl)methyl]-3-(4-chlorophenyl)-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 10::US11236047, Example 11 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 33.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281724 464920409 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135586 CN(C)CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29?,31-/m1/s1 FLSKRFKVCWLISS-ZGVDRVBQSA-N 535138 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methylpyridazin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 12::US11236047, Example 13 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535138&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281744 464920411 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135587 CN(C)CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29?,31-/m1/s1 FLSKRFKVCWLISS-ZGVDRVBQSA-N 535138 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methylpyridazin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 12::US11236047, Example 13 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535138&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281744 464920411 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135588 CC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](CC(O)=O)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2NO6/c1-29(2,39)21-7-12-25-24(15-21)28(38)34(26(16-27(36)37)19-3-8-22(32)9-4-19)31(25,20-5-10-23(33)11-6-20)40-18-30(17-35)13-14-30/h3-12,15,26,35,39H,13-14,16-18H2,1-2H3,(H,36,37)/t26-,31+/m0/s1 ZJSPHSZNTWLUQB-SUYBVONHSA-N 427061 US10544132, Example 14::US10981898, Example 14::US11236047, Example 14 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427061&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405302 434321378 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135589 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(O)CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO5/c1-19(20-3-8-23(31)9-4-20)33-27(36)25-15-22(28(2,37)16-34)7-12-26(25)30(33,21-5-10-24(32)11-6-21)38-18-29(17-35)13-14-29/h3-12,15,19,34-35,37H,13-14,16-18H2,1-2H3/t19-,28?,30+/m0/s1 HLYNUXSLMMUNHC-WDWHWGHSSA-N 427062 US10544132, Example 15::US10981898, Example 15::US11236047, Example 15 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 19.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427062&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281406 434321379 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135590 CC(C)(O)CCO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO4/c1-27(2,34)15-16-36-29(20-7-12-23(31)13-8-20)25-14-9-21(28(3,4)35)17-24(25)26(33)32(29)18-19-5-10-22(30)11-6-19/h5-14,17,34-35H,15-16,18H2,1-4H3/t29-/m1/s1 QFAIKCYCAGIEDP-GDLZYMKVSA-N 427063 US10544132, Example 16::US10981898, Example 16::US11236047, Example 16 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427063&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281465 434321380 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135591 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCc1cn[nH]c1)c1ccc(Cl)cc1 492921 US10981898, Example 17::US11236047, Example 17 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 63.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492921&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281433 447119610 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135592 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C#N)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2N2O3/c1-27(2,35)21-7-12-25-24(15-21)26(34)33(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-32)13-14-28/h3-12,15,35H,13-14,16,18H2,1-2H3/t29-/m1/s1 CHHGWWCMCGHFMJ-GDLZYMKVSA-N 427065 US10544132, Example 18::US10981898, Example 18::US11236047, Example 18 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 45.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427065&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281503 434321382 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135593 CCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO3/c1-4-29(15-16-29)19-36-30(21-7-12-24(32)13-8-21)26-14-9-22(28(2,3)35)17-25(26)27(34)33(30)18-20-5-10-23(31)11-6-20/h5-14,17,35H,4,15-16,18-19H2,1-3H3/t30-/m1/s1 ONXUOCISKNKLEO-SSEXGKCCSA-N 535154 N-{[1-({[(1R)-1-(4-chlorophenyl)-2- [(4-chlorophenyl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropyl]methyl} methanesulfonamide::US11236047, Example 19 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 22.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535154&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765556 464920424 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135594 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#C)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H30ClNO4/c1-4-21-5-7-22(8-6-21)18-33-28(35)26-17-24(29(2,3)36)11-14-27(26)31(33,23-9-12-25(32)13-10-23)37-20-30(19-34)15-16-30/h1,5-14,17,34,36H,15-16,18-20H2,2-3H3/t31-/m1/s1 LTEBUYNLVXWZOS-WJOKGBTCSA-N 427067 US10544132, Example 20::US11236047, Example 20 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427067&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search U3Z 7BMG 135281739 434321384 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135595 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO4/c1-4-20-5-7-21(8-6-20)17-34-28(36)25-15-23(29(2,3)37)16-26(33)27(25)31(34,22-9-11-24(32)12-10-22)38-19-30(18-35)13-14-30/h1,5-12,15-16,35,37H,13-14,17-19H2,2-3H3/t31-/m1/s1 NBPAQCMFLGCFBK-WJOKGBTCSA-N 427068 US10544132, Example 21::US10544132, Example 24::US11236047, Example 21 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427068&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281734 434321385 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135596 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO5/c1-3-20-4-6-21(7-5-20)16-34-28(37)25-14-23(29(2,38)17-35)15-26(33)27(25)31(34,22-8-10-24(32)11-9-22)39-19-30(18-36)12-13-30/h1,4-11,14-15,35-36,38H,12-13,16-19H2,2H3/t29?,31-/m1/s1 LDOCNQIRVXHZQU-ZGVDRVBQSA-N 535162 US11236047, Example 22::US11236047, Example 23 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535162&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281420 464920431 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135597 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28ClFN2O4/c1-28(2,37)22-13-24-26(25(32)14-22)30(21-7-9-23(31)10-8-21,38-18-29(17-35)11-12-29)34(27(24)36)16-20-5-3-19(15-33)4-6-20/h3-10,13-14,35,37H,11-12,16-18H2,1-2H3/t30-/m1/s1 DIVMTXBUDOMYFO-SSEXGKCCSA-N 535163 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-5-(2-hydroxypropan-2- yl)-3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}benzonitrile::US11236047, Example 24 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535163&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407600 464920432 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135598 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O4/c1-28(2,36)23-9-12-26-25(15-23)27(35)33(17-21-5-3-20(16-32)4-6-21)30(26,22-7-10-24(31)11-8-22)37-19-29(18-34)13-14-29/h3-12,15,34,36H,13-14,17-19H2,1-2H3/t30-/m1/s1 KUYDFZZMIJDWQY-SSEXGKCCSA-N 427071 US10544132, Example 25::US10981898, Example 25::US11236047, Example 25 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427071&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281419 434321387 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135599 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(C)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,34)21-8-13-25-24(14-21)26(33)32(15-19-4-9-22(30)10-5-19)29(25,20-6-11-23(31)12-7-20)36-18-28(3)16-35-17-28/h4-14,34H,15-18H2,1-3H3/t29-/m1/s1 JPJMGSQFTCZFQV-GDLZYMKVSA-N 427072 US10544132, Example 26::US10981898, Example 26::US11236047, Example 26 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 32.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427072&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281408 434321388 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135600 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O5/c1-28(37,17-34)23-8-11-26-25(14-23)27(36)33(16-21-4-2-20(15-32)3-5-21)30(26,22-6-9-24(31)10-7-22)38-19-29(18-35)12-13-29/h2-11,14,34-35,37H,12-13,16-19H2,1H3/t28?,30-/m1/s1 WAODAYOZKYTGDR-FUJFQHJFSA-N 492934 US10981898, Example 28::US11236047, Example 28 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 65.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492934&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281411 447119623 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135601 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O5/c1-28(37,17-34)23-8-11-26-25(14-23)27(36)33(16-21-4-2-20(15-32)3-5-21)30(26,22-6-9-24(31)10-7-22)38-19-29(18-35)12-13-29/h2-11,14,34-35,37H,12-13,16-19H2,1H3/t28?,30-/m1/s1 WAODAYOZKYTGDR-FUJFQHJFSA-N 492934 US10981898, Example 28::US11236047, Example 28 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492934&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281411 447119623 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135602 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(O)CC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-26(2,33)20-7-12-24-23(15-20)25(32)31(16-18-3-8-21(29)9-4-18)28(24,35-17-27(34)13-14-27)19-5-10-22(30)11-6-19/h3-12,15,33-34H,13-14,16-17H2,1-2H3/t28-/m1/s1 RCIVCEHJWTYZDO-MUUNZHRXSA-N 427075 US10544132, Example 29::US11236047, Example 29 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427075&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281489 434321391 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135603 CN(C)C(=O)CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C28H28Cl2N2O4/c1-27(2,35)20-9-14-24-23(15-20)26(34)32(16-18-5-10-21(29)11-6-18)28(24,36-17-25(33)31(3)4)19-7-12-22(30)13-8-19/h5-15,35H,16-17H2,1-4H3/t28-/m1/s1 RRQCJUUJERJVBP-MUUNZHRXSA-N 427076 US10544132, Example 30::US11236047, Example 30 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 86.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427076&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281547 434321392 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135604 COCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO4/c1-28(2,35)22-8-13-26-25(16-22)27(34)33(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)37-19-29(14-15-29)18-36-3/h4-13,16,35H,14-15,17-19H2,1-3H3/t30-/m1/s1 RARQEPSEJKMFPX-SSEXGKCCSA-N 427077 US10544132, Example 31::US10981898, Example 31::US11236047, Example 31 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 38.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427077&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281414 434321393 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135605 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1C(O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2NO6/c1-28(2,38)20-6-10-25-24(13-20)26(35)33(15-18-3-7-22(32)14-23(18)27(36)37)30(25,19-4-8-21(31)9-5-19)39-17-29(16-34)11-12-29/h3-10,13-14,34,38H,11-12,15-17H2,1-2H3,(H,36,37)/t30-/m1/s1 NQWVLAWWWVVUAN-SSEXGKCCSA-N 427078 US10544132, Example 33::US11236047, Example 33 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427078&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281410 434321394 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135606 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(=O)(=O)N1CCOCC1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H36Cl2N2O7S/c1-31(2,40)24-6-10-28-27(17-24)30(39)37(33(28,23-4-8-25(34)9-5-23)44-21-32(20-38)11-12-32)19-22-3-7-26(35)18-29(22)45(41,42)36-13-15-43-16-14-36/h3-10,17-18,38,40H,11-16,19-21H2,1-2H3/t33-/m1/s1 JFAQMYZAZWRRKT-MGBGTMOVSA-N 427079 US10544132, Example 34::US11236047, Example 34 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427079&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281697 434321395 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135607 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN2O6S/c1-28(2,38)19-12-22-25(23(33)13-19)30(18-5-8-20(31)9-6-18,41-16-29(10-11-29)27(34)37)35(26(22)36)15-17-4-7-21(32)14-24(17)42(3,39)40/h4-9,12-14,38H,10-11,15-16H2,1-3H3,(H2,34,37)/t30-/m1/s1 QXTIAAQSOXPAAN-SSEXGKCCSA-N 492940 US10981898, Example 35::US11236047, Example 35 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492940&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281548 447119629 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135608 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(C)(=O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO6S/c1-28(2,36)21-7-11-25-24(14-21)27(35)33(16-19-4-8-23(32)15-26(19)40(3,37)38)30(25,20-5-9-22(31)10-6-20)39-18-29(17-34)12-13-29/h4-11,14-15,34,36H,12-13,16-18H2,1-3H3/t30-/m1/s1 RXUWUIRMPWZSAR-SSEXGKCCSA-N 427081 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-3-({1-[hydroxy(2H2)methyl]cyclopropyl}(2H2)methoxy)-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 36::US10981898, Example 36::US11236047, Example 36 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427081&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732958 434321397 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135609 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23?,28-/m1/s1 ITVICYXWRBVNRA-GBAZGAGXSA-N 535193 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methoxypyridin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 37::US11236047, Example 38 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 41.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281490 464920462 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135610 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23?,28-/m1/s1 ITVICYXWRBVNRA-GBAZGAGXSA-N 535193 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methoxypyridin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 37::US11236047, Example 38 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281490 464920462 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135611 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20?,29-/m1/s1 OTIYWWDOPCSJHZ-NORZDRCHSA-N 535196 US11236047, Example 39::US11236047, Example 40 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 68.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535196&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281448 464920464 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135612 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20?,29-/m1/s1 OTIYWWDOPCSJHZ-NORZDRCHSA-N 535196 US11236047, Example 39::US11236047, Example 40 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 63.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535196&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281448 464920464 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135613 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32?,34-/m1/s1 JFGISRYCIHBUCK-SZFCLFMZSA-N 535204 US11236047, Example 41::US11236047, Example 42 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535204&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281670 464920471 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135614 CC(O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32?,34-/m1/s1 NTYHQRPYZXGTGT-SZFCLFMZSA-N 535205 US11236047, Example 43::US11236047, Example 44 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535205&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281538 464920472 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135615 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25+,26?,29+/m0/s1 JLJRDOGQKDSPHW-BKVJDPFESA-N 427090 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 45::US10981898, Example 45::US11236047, Example 45 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 230 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427090&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765588 434321406 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135616 C[C@H](N1C(=O)c2cc(ccc2[C@]1(O[C@@H]1COC[C@@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25-,26+,29+/m0/s1 JLJRDOGQKDSPHW-OPLXESSESA-N 535207 (3R)-3-(4-chlorophenyl)-2-[(1S)-1- (4-chlorophenyl)ethyl]-3-{[(3R,4S)-4- hydroxyoxolan-3-yl]oxy}-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 46 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10780 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535207&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281435 464920474 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135617 CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2NO3/c1-24(2,30)18-8-13-22-21(14-18)23(29)28(15-16-4-9-19(26)10-5-16)25(22,31-3)17-6-11-20(27)12-7-17/h4-14,30H,15H2,1-3H3/t25-/m1/s1 GBBKEWOTKMXEJW-RUZDIDTESA-N 427092 US10544132, Example 47::US10981898, Example 47::US11236047, Example 47 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 430 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427092&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281412 434321408 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135618 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135619 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCCO)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2NO4/c1-26(2,33)20-8-13-24-23(16-20)25(32)30(17-18-4-9-21(28)10-5-18)27(24,34-15-3-14-31)19-6-11-22(29)12-7-19/h4-13,16,31,33H,3,14-15,17H2,1-2H3/t27-/m1/s1 OAZOTQYKBROZDC-HHHXNRCGSA-N 427095 US10544132, Example 49::US10981898, Example 49::US11236047, Example 49 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 82.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427095&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281478 434321410 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135620 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.800 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135621 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC(F)(F)CO)c1ccc(Cl)cc1 InChI=1S/C27H25Cl2F2NO4/c1-25(2,35)19-7-12-23-22(13-19)24(34)32(14-17-3-8-20(28)9-4-17)27(23,36-16-26(30,31)15-33)18-5-10-21(29)11-6-18/h3-13,33,35H,14-16H2,1-2H3/t27-/m1/s1 DKLIPENWHNVPEY-HHHXNRCGSA-N 427099 US10544132, Example 51::US10981898, Example 51::US11236047, Example 51 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 130 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427099&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281507 434321414 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135622 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135623 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135624 CC(O)(C(=O)N1CCCC1)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2N2O5/c1-31(41,30(40)36-16-2-3-17-36)24-8-13-28-27(18-24)29(39)37(19-22-4-9-25(34)10-5-22)33(28,23-6-11-26(35)12-7-23)42-21-32(20-38)14-15-32/h4-13,18,38,41H,2-3,14-17,19-21H2,1H3/t31?,33-/m1/s1 AVCINXLMIYQZIG-NFCCVXSLSA-N 427103 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[2-hydroxy-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 54::US11236047, Example 55 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427103&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281508 434321418 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135625 CN(C)C(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29?,31-/m1/s1 QSQWTXWPCPYZCQ-ZGVDRVBQSA-N 535226 US11236047, Example 56::US11236047, Example 57 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535226&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281506 464920493 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135626 CN(C)C(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29?,31-/m1/s1 QSQWTXWPCPYZCQ-ZGVDRVBQSA-N 535226 US11236047, Example 56::US11236047, Example 57 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 61.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535226&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281506 464920493 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135627 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28?,30-/m1/s1 FLAAYSHQWIAMDD-FUJFQHJFSA-N 535228 US11236047, Example 58::US11236047, Example 59 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535228&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281484 464920494 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135628 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28?,30-/m1/s1 FLAAYSHQWIAMDD-FUJFQHJFSA-N 535228 US11236047, Example 58::US11236047, Example 59 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535228&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281484 464920494 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135629 CSc1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO4S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,38-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)39-3/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 OAWFYJRYUZCBKK-SSEXGKCCSA-N 427111 US10544132, Example 60::US10981898, Example 60::US11236047, Example 60 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 14.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427111&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281694 434321425 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135630 CS(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40?/m1/s1 PVRYETGYPNIACM-OKVUXXRHSA-N 535231 3-{[(1R)-1-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-1lambda6- thiolane-1,1-dione-Isomer 1::US11236047, Example 61::US11236047, Example 62 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535231&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405340 464920496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135631 CS(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40?/m1/s1 PVRYETGYPNIACM-OKVUXXRHSA-N 535231 3-{[(1R)-1-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-1lambda6- thiolane-1,1-dione-Isomer 1::US11236047, Example 61::US11236047, Example 62 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535231&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405340 464920496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135632 COCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29?,31-/m1/s1 XPPOSVDBYKUPEU-ZGVDRVBQSA-N 535234 (3R)-3-[(1-acetylazetidin-3- yl)methoxy]-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 63::US11236047, Example 64 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535234&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281521 464920498 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135633 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28?,30-/m1/s1 HJVLHGXGDKFDKJ-FUJFQHJFSA-N 535235 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-[3- (hydroxymethyl)cyclobutoxy]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 65::US11236047, Example 66 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535235&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281693 464920499 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135634 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28?,30-/m1/s1 HJVLHGXGDKFDKJ-FUJFQHJFSA-N 535235 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-[3- (hydroxymethyl)cyclobutoxy]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 65::US11236047, Example 66 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535235&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281693 464920499 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135635 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OC4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27?,33?,34-/m1/s1 GEZPZMXREXHEJZ-WRPALDRWSA-N 535237 US11236047, Example 67::US11236047, Example 68 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535237&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154587067 464920500 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135636 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33?,34+/m0/s1 GEZPZMXREXHEJZ-FNHRJEOVSA-N 535238 US11236047, Example 69::US11236047, Example 70 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.700 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535238&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281717 464920501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135637 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33?,34+/m0/s1 GEZPZMXREXHEJZ-FNHRJEOVSA-N 535238 US11236047, Example 69::US11236047, Example 70 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535238&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281717 464920501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135638 CC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO6/c1-29(2,38)19-13-23-27(24(33)14-19)30(40-22-11-12-39-16-22,18-5-9-21(32)10-6-18)34(28(23)37)25(15-26(35)36)17-3-7-20(31)8-4-17/h3-10,13-14,22,25,38H,11-12,15-16H2,1-2H3,(H,35,36)/t22-,25-,30+/m0/s1 PMXGSEVMEXTCLI-SGOMLOLCSA-N 427124 US10544132, Example 71::US10981898, Example 71::US11236047, Example 71 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427124&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281459 434321438 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135639 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3CO)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN2O4/c1-28(2,38)21-12-24-26(25(33)13-21)30(20-4-7-22(31)8-5-20,39-17-29(16-34)9-10-29)35(27(24)37)14-18-3-6-23(32)11-19(18)15-36/h3-8,11-13,36,38H,9-10,14-15,17H2,1-2H3/t30-/m1/s1 FZOWPLQXTSEWMX-SSEXGKCCSA-N 427125 US10544132, Example 72::US10981898, Example 72::US11236047, Example 72 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427125&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281421 434321439 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135640 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31?,33-/m1/s1 YLXVSCUQMYZKFT-NFCCVXSLSA-N 535242 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[2- (hydroxymethyl)cyclopentyl]oxy}-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 73::US11236047, Example 74 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535242&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281413 464920504 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135641 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31?,33-/m1/s1 YLXVSCUQMYZKFT-NFCCVXSLSA-N 535242 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[2- (hydroxymethyl)cyclopentyl]oxy}-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 73::US11236047, Example 74 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.500 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535242&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281413 464920504 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135642 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30?,32-/m1/s1 FATKFLNSLQQUOY-BDJZEIKTSA-N 492975 US10981898, Example 76::US11236047, Example 76 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492975&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281442 447119664 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135643 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33?,35-/m1/s1 UAASDXMLTUDYGD-PWXSHKNQSA-N 492976 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10981898, Example 78::US11236047, Example 78 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492976&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281423 447119665 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135644 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25Cl2FN2O5/c1-28(2,39)19-11-23-25(24(33)12-19)30(18-4-7-20(31)8-5-18,40-16-29(15-34)9-10-29)35(26(23)36)14-17-3-6-21(32)13-22(17)27(37)38/h3-8,11-13,39H,9-10,14,16H2,1-2H3,(H,37,38)/t30-/m1/s1 DEAVUDZEMMDBRA-SSEXGKCCSA-N 427132 US10544132, Example 79::US11236047, Example 79 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281403 434321446 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135645 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H39Cl2FN2O6S/c1-33(43,23-10-14-39(2)15-11-23)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,46-21-34(20-41)12-13-34)40(32(28)42)19-22-4-7-27(37)18-30(22)47(3,44)45/h4-9,16-18,23,41,43H,10-15,19-21H2,1-3H3/t33?,35-/m1/s1 MNUHQOFWGYDTKI-PWXSHKNQSA-N 535247 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-[(cis-3-hydroxycyclobutyl)methoxy]- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 81 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535247&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281599 464920508 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135646 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3P(C)(C)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FNO5P/c1-29(2,38)21-13-24-27(25(34)14-21)31(20-6-9-22(32)10-7-20,40-18-30(17-36)11-12-30)35(28(24)37)16-19-5-8-23(33)15-26(19)41(3,4)39/h5-10,13-15,36,38H,11-12,16-18H2,1-4H3/t31-/m1/s1 IARKWVZHJYWTDX-WJOKGBTCSA-N 427135 US10544132, Example 82::US10981898, Example 82::US11236047, Example 82 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405337 434321449 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135647 CS(=O)(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(O)C1CCOCC1 InChI=1S/C33H34Cl2FNO7S/c1-45(41,42)28-16-25(35)5-2-21(28)17-37-31(40)26-14-22(30(39)20-8-12-43-13-9-20)15-27(36)29(26)33(37,23-3-6-24(34)7-4-23)44-19-32(18-38)10-11-32/h2-7,14-16,20,30,38-39H,8-13,17-19H2,1H3/t30?,33-/m1/s1 IRIZYNABKNVLML-FULUQAKVSA-N 535249 US11236047, Example 83::US11236047, Example 84 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.000 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535249&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281613 464920510 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135648 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32?,34-/m1/s1 WPEIHYLRRFWOGP-SZFCLFMZSA-N 535250 US11236047, Example 85::US11236047, Example 86 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.490 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535250&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281494 464920511 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135649 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30?,31+/m0/s1 AVDHVIXZENQIRS-JCHZNZEOSA-N 535251 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[1- hydroxy-1-(1-oxo-1lambda5-pyridin-3- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 88::US11236047, Example 89 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.790 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535251&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281674 464920512 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135650 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30?,31+/m0/s1 AVDHVIXZENQIRS-JCHZNZEOSA-N 535251 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[1- hydroxy-1-(1-oxo-1lambda5-pyridin-3- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 88::US11236047, Example 89 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535251&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281674 464920512 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135651 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32?,33+/m0/s1 CDUKUNZREUVQKN-UBORAUAPSA-N 535254 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-(2- hydroxy-2-methylpropoxy)-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 96::US11236047, Example 97 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.640 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535254&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281536 464920514 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135652 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 HZTQINJSGAPBLS-SBYPTKLRSA-N 535255 US11236047, Example 98::US11236047, Example 99 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.800 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535255&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281416 464920515 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135653 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 HZTQINJSGAPBLS-SBYPTKLRSA-N 535255 US11236047, Example 98::US11236047, Example 99 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535255&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281416 464920515 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135654 CCC(O)(c1ccn(C)n1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O5/c1-4-31(42,27-15-16-37(2)36-27)21-17-24-29(25(35)18-21)32(43-3,20-7-11-23(34)12-8-20)38(30(24)41)26(13-14-28(39)40)19-5-9-22(33)10-6-19/h5-12,15-18,26,42H,4,13-14H2,1-3H3,(H,39,40)/t26-,31?,32+/m0/s1 ACCSRYKZIIOHIZ-LTZUXFEUSA-N 427160 US10544132, Example 100::US10981898, Example 100::US11236047, Example 100 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427160&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281496 434321474 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135655 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31?,32+/m0/s1 HXHSKGLWTNIZIS-LTZUXFEUSA-N 535258 US11236047, Example 101::US11236047, Example 102 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535258&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281540 464920517 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135656 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32+,33+/m0/s1 YDGNPXHTWKENIC-XEUSQTKLSA-N 427168 US10544132, Example 108::US10981898, Example 108::US11236047, Example 108 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427168&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281545 434321482 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135657 CCC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 NAMQEWAUDBCILZ-SBYPTKLRSA-N 535261 US11236047, Example 125::US11236047, Example 126 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535261&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281454 464920520 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135658 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C32H27Cl2FN2O5/c1-3-31(41,27-6-4-5-15-36-27)21-16-24-29(25(35)17-21)32(42-2,20-9-13-23(34)14-10-20)37(30(24)40)26(18-28(38)39)19-7-11-22(33)12-8-19/h4-17,26,41H,3,18H2,1-2H3,(H,38,39)/t26-,31?,32+/m0/s1 KHSRSNYUTBONQS-LTZUXFEUSA-N 535262 1-({[(1R)-5-[1-(4-Acetylpiperazin-1- yl)-2-hydroxypropan-2-yl]-1-(4- chlorophenyl)-2-[(5-chloropyridin-2- yl)methyl]-7-fluoro-3-oxo-2,3-dihydro- 1H-isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 127::US11236047, Example 128 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535262&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281621 464920521 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135659 CC[C@](O)(C1CCN(CC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN2O5/c1-3-31(41,21-12-14-36(15-13-21)19-28(38)39)23-16-26-29(27(35)17-23)32(42-2,22-6-10-25(34)11-7-22)37(30(26)40)18-20-4-8-24(33)9-5-20/h4-11,16-17,21,41H,3,12-15,18-19H2,1-2H3,(H,38,39)/t31-,32+/m0/s1 MFPOPVHVIGVWNK-AJQTZOPKSA-N 427194 US10544132, Example 135::US10981898, Example 134::US11236047, Example 134 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427194&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281570 434321507 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135660 CC[C@](O)(C1CCN(CCC(=O)OC)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H37Cl2FN2O5/c1-4-33(42,23-13-16-38(17-14-23)18-15-30(40)43-2)25-19-28-31(29(37)20-25)34(44-3,24-7-11-27(36)12-8-24)39(32(28)41)21-22-5-9-26(35)10-6-22/h5-12,19-20,23,42H,4,13-18,21H2,1-3H3/t33-,34+/m0/s1 ATEBGPCVCPBSLM-SZAHLOSFSA-N 427195 US10544132, Example 136::US10981898, Example 137::US11236047, Example 136 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427195&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281761 434321508 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135661 CC[C@](O)(C1CCN(CCC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H35Cl2FN2O5/c1-3-32(42,22-12-15-37(16-13-22)17-14-29(39)40)24-18-27-30(28(36)19-24)33(43-2,23-6-10-26(35)11-7-23)38(31(27)41)20-21-4-8-25(34)9-5-21/h4-11,18-19,22,42H,3,12-17,20H2,1-2H3,(H,39,40)/t32-,33+/m0/s1 ZKUGFHUACFYRES-JHOUSYSJSA-N 535265 3-{4-[(1S)-1-[(1R)-1-(4- chlorophenyl)-2-[(4- chlorophenyl)methyl]-7-fluoro-1- methoxy-3-oxo-2,3-dihydro-1H- isoindol-5-yl]-1- hydroxypropyl]piperidin-1- yl}propanoic acid::US11236047, Example 137 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.570 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535265&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281444 464920524 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135662 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-19(20-4-9-23(31)10-5-20)33-27(35)25-16-22(28(2,3)36)8-13-26(25)30(33,21-6-11-24(32)12-7-21)37-18-29(17-34)14-15-29/h4-13,16,19,34,36H,14-15,17-18H2,1-3H3/t19-,30+/m0/s1 OBIKGGOHRXESCS-WWOZWPLTSA-N 427053 US10544132, Example 7::US10981898, Example 7::US11236047, Example 7 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427053&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281662 434321370 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135663 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27?,29-/m1/s1 NVLQHQFGNPTQCC-ZBAATNBSSA-N 535132 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 8::US11236047, Example 9 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 53.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281498 464920407 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135664 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC(C)(O)CO)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO5/c1-18(19-5-10-22(30)11-6-19)32-26(34)24-15-21(27(2,3)35)9-14-25(24)29(32,37-17-28(4,36)16-33)20-7-12-23(31)13-8-20/h5-15,18,33,35-36H,16-17H2,1-4H3/t18-,28?,29+/m0/s1 UUZINBSIYDKSFT-PDIMESBLSA-N 427051 US10544132, Example 6::US10981898, Example 6::US11236047, Example 6 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 23.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427051&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281509 434321368 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135665 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27?,29-/m1/s1 NVLQHQFGNPTQCC-ZBAATNBSSA-N 535132 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 8::US11236047, Example 9 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281498 464920407 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135666 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3CO)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)25-13-28-31(29(36)14-25)34(45-27-10-11-44-19-27,24-6-8-26(35)9-7-24)40(32(28)42)16-22-5-4-21(15-37)12-23(22)18-41/h4-9,12-14,17,20,27,41,43H,3,10-11,16,18-19H2,1-2H3/t27-,33?,34+/m0/s1 LQLKHTDURGSYEY-FNHRJEOVSA-N 535266 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-(3- hydroxy-3-methylbutoxy)-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 92::US11236047, Example 93 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 30.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535266&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281612 464920525 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135667 COCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO4/c1-28(2,35)22-8-13-26-25(16-22)27(34)33(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)37-19-29(14-15-29)18-36-3/h4-13,16,35H,14-15,17-19H2,1-3H3/t30-/m1/s1 RARQEPSEJKMFPX-SSEXGKCCSA-N 427077 US10544132, Example 31::US10981898, Example 31::US11236047, Example 31 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427077&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281414 434321393 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135668 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135669 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O4/c1-3-33(43,29-18-39(2)21-38-29)25-14-27-30(28(36)15-25)34(24-8-10-26(35)11-9-24,44-20-32(19-41)12-13-32)40(31(27)42)17-23-6-4-22(16-37)5-7-23/h4-11,14-15,18,21,41,43H,3,12-13,17,19-20H2,1-2H3/t33?,34-/m1/s1 ZOWAIYZZMIRJLG-MUADHRSZSA-N 535267 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-(2- methanesulfonylethoxy)-2,3-dihydro- 1H-isoindol-1-one::US11236047, Example 94::US11236047, Example 95 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 100.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535267&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281488 464920526 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135670 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2FNO4/c1-27(2,36)20-13-23-25(24(32)14-20)29(19-5-9-22(31)10-6-19,37-17-28(16-34)11-12-28)33(26(23)35)15-18-3-7-21(30)8-4-18/h3-10,13-14,34,36H,11-12,15-17H2,1-2H3/t29-/m1/s1 QUBUREFIXVDKEB-GDLZYMKVSA-N 427047 US10544132, Example 2::US10981898, Example 2::US11236047, Example 2 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427047&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281669 434321364 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135671 CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2NO3/c1-24(2,30)18-8-13-22-21(14-18)23(29)28(15-16-4-9-19(26)10-5-16)25(22,31-3)17-6-11-20(27)12-7-17/h4-14,30H,15H2,1-3H3/t25-/m1/s1 GBBKEWOTKMXEJW-RUZDIDTESA-N 427092 US10544132, Example 47::US10981898, Example 47::US11236047, Example 47 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427092&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281412 434321408 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135672 C[C@H](N1C(=O)c2cc(ccc2[C@]1(O[C@@H]1COC[C@@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25-,26+,29+/m0/s1 JLJRDOGQKDSPHW-OPLXESSESA-N 535207 (3R)-3-(4-chlorophenyl)-2-[(1S)-1- (4-chlorophenyl)ethyl]-3-{[(3R,4S)-4- hydroxyoxolan-3-yl]oxy}-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 46 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535207&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281435 464920474 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135673 COCC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29?,31+/m0/s1 UIFBZUZURMPJLE-VMDBBOCCSA-N 535135 (3R)-2-[(5-Chloro-1-oxo-1lambda5-pyridin-2- yl)methyl]-3-(4-chlorophenyl)-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 10::US11236047, Example 11 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281724 464920409 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135674 CC(O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32?,34-/m1/s1 NTYHQRPYZXGTGT-SZFCLFMZSA-N 535205 US11236047, Example 43::US11236047, Example 44 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535205&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281538 464920472 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135675 CS(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40?/m1/s1 PVRYETGYPNIACM-OKVUXXRHSA-N 535231 3-{[(1R)-1-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-1lambda6- thiolane-1,1-dione-Isomer 1::US11236047, Example 61::US11236047, Example 62 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535231&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405340 464920496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135676 CS(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40?/m1/s1 PVRYETGYPNIACM-OKVUXXRHSA-N 535231 3-{[(1R)-1-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-1lambda6- thiolane-1,1-dione-Isomer 1::US11236047, Example 61::US11236047, Example 62 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 41.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535231&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405340 464920496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135677 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C(O)=O)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2NO5/c1-27(2,36)20-7-12-24-23(15-20)25(33)32(16-18-3-8-21(30)9-4-18)29(24,19-5-10-22(31)11-6-19)37-17-28(13-14-28)26(34)35/h3-12,15,36H,13-14,16-17H2,1-2H3,(H,34,35)/t29-/m1/s1 IAJLMKLNFWIPMA-GDLZYMKVSA-N 427050 US10544132, Example 5::US10981898, Example 5::US11236047, Example 5 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427050&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281515 434321367 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135678 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23?,28-/m1/s1 ITVICYXWRBVNRA-GBAZGAGXSA-N 535193 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methoxypyridin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 37::US11236047, Example 38 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281490 464920462 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135679 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20?,29-/m1/s1 OTIYWWDOPCSJHZ-NORZDRCHSA-N 535196 US11236047, Example 39::US11236047, Example 40 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535196&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281448 464920464 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135680 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25+,26?,29+/m0/s1 JLJRDOGQKDSPHW-BKVJDPFESA-N 427090 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 45::US10981898, Example 45::US11236047, Example 45 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427090&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765588 434321406 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135681 COCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29?,31-/m1/s1 XPPOSVDBYKUPEU-ZGVDRVBQSA-N 535234 (3R)-3-[(1-acetylazetidin-3- yl)methoxy]-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 63::US11236047, Example 64 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 32.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535234&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281521 464920498 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135682 COCC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29?,31+/m0/s1 UIFBZUZURMPJLE-VMDBBOCCSA-N 535135 (3R)-2-[(5-Chloro-1-oxo-1lambda5-pyridin-2- yl)methyl]-3-(4-chlorophenyl)-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 10::US11236047, Example 11 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281724 464920409 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135683 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CCC1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-28(2,36)22-8-13-26-25(16-22)27(35)33(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)37-19-29(18-34)14-3-15-29/h4-13,16,34,36H,3,14-15,17-19H2,1-2H3/t30-/m1/s1 OYVZDYIWPZZTME-SSEXGKCCSA-N 535269 (3R)-3-(4-Chlorophenyl)-2-[(4- chlorophenyl)methyl]-3-{[1- (hydroxymethyl)cyclobutyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 32 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535269&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281405 464920527 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135684 CN(C)CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29?,31-/m1/s1 FLSKRFKVCWLISS-ZGVDRVBQSA-N 535138 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methylpyridazin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 12::US11236047, Example 13 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 46.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535138&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281744 464920411 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135685 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1C(O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2NO6/c1-28(2,38)20-6-10-25-24(13-20)26(35)33(15-18-3-7-22(32)14-23(18)27(36)37)30(25,19-4-8-21(31)9-5-19)39-17-29(16-34)11-12-29/h3-10,13-14,34,38H,11-12,15-17H2,1-2H3,(H,36,37)/t30-/m1/s1 NQWVLAWWWVVUAN-SSEXGKCCSA-N 427078 US10544132, Example 33::US11236047, Example 33 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427078&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281410 434321394 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135686 CN(C)CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29?,31-/m1/s1 FLSKRFKVCWLISS-ZGVDRVBQSA-N 535138 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methylpyridazin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 12::US11236047, Example 13 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535138&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281744 464920411 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135687 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135688 COCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29?,31-/m1/s1 XPPOSVDBYKUPEU-ZGVDRVBQSA-N 535234 (3R)-3-[(1-acetylazetidin-3- yl)methoxy]-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 63::US11236047, Example 64 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 40.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535234&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281521 464920498 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135689 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O4/c1-3-33(43,29-18-39(2)21-38-29)25-14-27-30(28(36)15-25)34(24-8-10-26(35)11-9-24,44-20-32(19-41)12-13-32)40(31(27)42)17-23-6-4-22(16-37)5-7-23/h4-11,14-15,18,21,41,43H,3,12-13,17,19-20H2,1-2H3/t33?,34-/m1/s1 ZOWAIYZZMIRJLG-MUADHRSZSA-N 535267 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxypropan-2-yl)-3-(2- methanesulfonylethoxy)-2,3-dihydro- 1H-isoindol-1-one::US11236047, Example 94::US11236047, Example 95 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 60.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535267&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281488 464920526 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135690 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(=O)(=O)N1CCOCC1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H36Cl2N2O7S/c1-31(2,40)24-6-10-28-27(17-24)30(39)37(33(28,23-4-8-25(34)9-5-23)44-21-32(20-38)11-12-32)19-22-3-7-26(35)18-29(22)45(41,42)36-13-15-43-16-14-36/h3-10,17-18,38,40H,11-16,19-21H2,1-2H3/t33-/m1/s1 JFAQMYZAZWRRKT-MGBGTMOVSA-N 427079 US10544132, Example 34::US11236047, Example 34 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 85.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427079&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281697 434321395 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135691 CC(C)(O)CCO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO4/c1-27(2,34)15-16-36-29(20-7-12-23(31)13-8-20)25-14-9-21(28(3,4)35)17-24(25)26(33)32(29)18-19-5-10-22(30)11-6-19/h5-14,17,34-35H,15-16,18H2,1-4H3/t29-/m1/s1 QFAIKCYCAGIEDP-GDLZYMKVSA-N 427063 US10544132, Example 16::US10981898, Example 16::US11236047, Example 16 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 30.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427063&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281465 434321380 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135692 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCc1cn[nH]c1)c1ccc(Cl)cc1 492921 US10981898, Example 17::US11236047, Example 17 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492921&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281433 447119610 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135693 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCO)c1ccc(Cl)cc1 InChI=1S/C26H25Cl2NO4/c1-25(2,32)19-7-12-23-22(15-19)24(31)29(16-17-3-8-20(27)9-4-17)26(23,33-14-13-30)18-5-10-21(28)11-6-18/h3-12,15,30,32H,13-14,16H2,1-2H3/t26-/m1/s1 BDOTXISZENQYGP-AREMUKBSSA-N 427048 US10544132, Example 3::US10981898, Example 3::US11236047, Example 3 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427048&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281430 434321365 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135694 CC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](CC(O)=O)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2NO6/c1-29(2,39)21-7-12-25-24(15-21)28(38)34(26(16-27(36)37)19-3-8-22(32)9-4-19)31(25,20-5-10-23(33)11-6-20)40-18-30(17-35)13-14-30/h3-12,15,26,35,39H,13-14,16-18H2,1-2H3,(H,36,37)/t26-,31+/m0/s1 ZJSPHSZNTWLUQB-SUYBVONHSA-N 427061 US10544132, Example 14::US10981898, Example 14::US11236047, Example 14 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 29.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427061&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405302 434321378 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135695 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(O)CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO5/c1-19(20-3-8-23(31)9-4-20)33-27(36)25-15-22(28(2,37)16-34)7-12-26(25)30(33,21-5-10-24(32)11-6-21)38-18-29(17-35)13-14-29/h3-12,15,19,34-35,37H,13-14,16-18H2,1-2H3/t19-,28?,30+/m0/s1 HLYNUXSLMMUNHC-WDWHWGHSSA-N 427062 US10544132, Example 15::US10981898, Example 15::US11236047, Example 15 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427062&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281406 434321379 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135696 CC(O)(C(=O)N1CCCC1)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2N2O5/c1-31(41,30(40)36-16-2-3-17-36)24-8-13-28-27(18-24)29(39)37(19-22-4-9-25(34)10-5-22)33(28,23-6-11-26(35)12-7-23)42-21-32(20-38)14-15-32/h4-13,18,38,41H,2-3,14-17,19-21H2,1H3/t31?,33-/m1/s1 AVCINXLMIYQZIG-NFCCVXSLSA-N 427103 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[2-hydroxy-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 54::US11236047, Example 55 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 100.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427103&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281508 434321418 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135697 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28?,30-/m1/s1 FLAAYSHQWIAMDD-FUJFQHJFSA-N 535228 US11236047, Example 58::US11236047, Example 59 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 34.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535228&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281484 464920494 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135698 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(2,35)21-7-12-25-24(13-21)26(34)32(14-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)37-18-28(15-33)16-36-17-28/h3-13,33,35H,14-18H2,1-2H3/t29-/m1/s1 GDUHFOYTYPKEOT-GDLZYMKVSA-N 427049 US10544132, Example 4::US10981898, Example 4::US11236047, Example 4 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427049&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281482 434321366 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135699 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCCO)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2NO4/c1-26(2,33)20-8-13-24-23(16-20)25(32)30(17-18-4-9-21(28)10-5-18)27(24,34-15-3-14-31)19-6-11-22(29)12-7-19/h4-13,16,31,33H,3,14-15,17H2,1-2H3/t27-/m1/s1 OAZOTQYKBROZDC-HHHXNRCGSA-N 427095 US10544132, Example 49::US10981898, Example 49::US11236047, Example 49 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 40.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427095&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281478 434321410 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135700 CSc1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO4S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,38-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)39-3/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 OAWFYJRYUZCBKK-SSEXGKCCSA-N 427111 US10544132, Example 60::US10981898, Example 60::US11236047, Example 60 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 20.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427111&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281694 434321425 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135701 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C#N)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2N2O3/c1-27(2,35)21-7-12-25-24(15-21)26(34)33(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-32)13-14-28/h3-12,15,35H,13-14,16,18H2,1-2H3/t29-/m1/s1 CHHGWWCMCGHFMJ-GDLZYMKVSA-N 427065 US10544132, Example 18::US10981898, Example 18::US11236047, Example 18 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 20.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427065&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281503 434321382 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135702 CCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO3/c1-4-29(15-16-29)19-36-30(21-7-12-24(32)13-8-21)26-14-9-22(28(2,3)35)17-25(26)27(34)33(30)18-20-5-10-23(31)11-6-20/h5-14,17,35H,4,15-16,18-19H2,1-3H3/t30-/m1/s1 ONXUOCISKNKLEO-SSEXGKCCSA-N 535154 N-{[1-({[(1R)-1-(4-chlorophenyl)-2- [(4-chlorophenyl)methyl]-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropyl]methyl} methanesulfonamide::US11236047, Example 19 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535154&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765556 464920424 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135703 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28?,30-/m1/s1 HJVLHGXGDKFDKJ-FUJFQHJFSA-N 535235 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-[3- (hydroxymethyl)cyclobutoxy]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 65::US11236047, Example 66 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 21.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535235&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281693 464920499 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135704 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN2O6S/c1-28(2,38)19-12-22-25(23(33)13-19)30(18-5-8-20(31)9-6-18,41-16-29(10-11-29)27(34)37)35(26(22)36)15-17-4-7-21(32)14-24(17)42(3,39)40/h4-9,12-14,38H,10-11,15-16H2,1-3H3,(H2,34,37)/t30-/m1/s1 QXTIAAQSOXPAAN-SSEXGKCCSA-N 492940 US10981898, Example 35::US11236047, Example 35 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492940&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281548 447119629 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135705 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32?,34-/m1/s1 JFGISRYCIHBUCK-SZFCLFMZSA-N 535204 US11236047, Example 41::US11236047, Example 42 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535204&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281670 464920471 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135706 CC(O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32?,34-/m1/s1 NTYHQRPYZXGTGT-SZFCLFMZSA-N 535205 US11236047, Example 43::US11236047, Example 44 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535205&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281538 464920472 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135707 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20?,29-/m1/s1 OTIYWWDOPCSJHZ-NORZDRCHSA-N 535196 US11236047, Example 39::US11236047, Example 40 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 46.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535196&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281448 464920464 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135708 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32?,34-/m1/s1 JFGISRYCIHBUCK-SZFCLFMZSA-N 535204 US11236047, Example 41::US11236047, Example 42 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535204&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281670 464920471 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135709 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23?,28-/m1/s1 ITVICYXWRBVNRA-GBAZGAGXSA-N 535193 (3R)-3-(4-Chlorophenyl)-4-fluoro-3- ({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-6-(2-hydroxypropan-2-yl)-2- [(6-methoxypyridin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 37::US11236047, Example 38 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 35.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281490 464920462 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135710 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135711 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32?,33+/m0/s1 CDUKUNZREUVQKN-UBORAUAPSA-N 535254 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-(2- hydroxy-2-methylpropoxy)-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 96::US11236047, Example 97 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535254&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281536 464920514 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135712 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC(F)(F)CO)c1ccc(Cl)cc1 InChI=1S/C27H25Cl2F2NO4/c1-25(2,35)19-7-12-23-22(13-19)24(34)32(14-17-3-8-20(28)9-4-17)27(23,36-16-26(30,31)15-33)18-5-10-21(29)11-6-18/h3-13,33,35H,14-16H2,1-2H3/t27-/m1/s1 DKLIPENWHNVPEY-HHHXNRCGSA-N 427099 US10544132, Example 51::US10981898, Example 51::US11236047, Example 51 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 690 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427099&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281507 434321414 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135713 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO5/c1-3-20-4-6-21(7-5-20)16-34-28(37)25-14-23(29(2,38)17-35)15-26(33)27(25)31(34,22-8-10-24(32)11-9-22)39-19-30(18-36)12-13-30/h1,4-11,14-15,35-36,38H,12-13,16-19H2,2H3/t29?,31-/m1/s1 LDOCNQIRVXHZQU-ZGVDRVBQSA-N 535162 US11236047, Example 22::US11236047, Example 23 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535162&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281420 464920431 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135714 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO5/c1-3-20-4-6-21(7-5-20)16-34-28(37)25-14-23(29(2,38)17-35)15-26(33)27(25)31(34,22-8-10-24(32)11-9-22)39-19-30(18-36)12-13-30/h1,4-11,14-15,35-36,38H,12-13,16-19H2,2H3/t29?,31-/m1/s1 LDOCNQIRVXHZQU-ZGVDRVBQSA-N 535162 US11236047, Example 22::US11236047, Example 23 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535162&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281420 464920431 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135715 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(C)(=O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO6S/c1-28(2,36)21-7-11-25-24(14-21)27(35)33(16-19-4-8-23(32)15-26(19)40(3,37)38)30(25,20-5-9-22(31)10-6-20)39-18-29(17-34)12-13-29/h4-11,14-15,34,36H,12-13,16-18H2,1-3H3/t30-/m1/s1 RXUWUIRMPWZSAR-SSEXGKCCSA-N 427081 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-3-({1-[hydroxy(2H2)methyl]cyclopropyl}(2H2)methoxy)-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 36::US10981898, Example 36::US11236047, Example 36 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427081&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732958 434321397 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135716 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31?,33-/m1/s1 YLXVSCUQMYZKFT-NFCCVXSLSA-N 535242 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[2- (hydroxymethyl)cyclopentyl]oxy}-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 73::US11236047, Example 74 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535242&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281413 464920504 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135717 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O5/c1-28(37,17-34)23-8-11-26-25(14-23)27(36)33(16-21-4-2-20(15-32)3-5-21)30(26,22-6-9-24(31)10-7-22)38-19-29(18-35)12-13-29/h2-11,14,34-35,37H,12-13,16-19H2,1H3/t28?,30-/m1/s1 WAODAYOZKYTGDR-FUJFQHJFSA-N 492934 US10981898, Example 28::US11236047, Example 28 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 14.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492934&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281411 447119623 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135718 CC(O)(C(=O)N1CCCC1)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2N2O5/c1-31(41,30(40)36-16-2-3-17-36)24-8-13-28-27(18-24)29(39)37(19-22-4-9-25(34)10-5-22)33(28,23-6-11-26(35)12-7-23)42-21-32(20-38)14-15-32/h4-13,18,38,41H,2-3,14-17,19-21H2,1H3/t31?,33-/m1/s1 AVCINXLMIYQZIG-NFCCVXSLSA-N 427103 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[2-hydroxy-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 54::US11236047, Example 55 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 490 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427103&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281508 434321418 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135719 CN(C)C(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29?,31-/m1/s1 QSQWTXWPCPYZCQ-ZGVDRVBQSA-N 535226 US11236047, Example 56::US11236047, Example 57 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 21.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535226&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281506 464920493 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135720 CN(C)C(=O)CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C28H28Cl2N2O4/c1-27(2,35)20-9-14-24-23(15-20)26(34)32(16-18-5-10-21(29)11-6-18)28(24,36-17-25(33)31(3)4)19-7-12-22(30)13-8-19/h5-15,35H,16-17H2,1-4H3/t28-/m1/s1 RRQCJUUJERJVBP-MUUNZHRXSA-N 427076 US10544132, Example 30::US11236047, Example 30 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427076&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281547 434321392 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135721 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28ClFN2O4/c1-28(2,37)22-13-24-26(25(32)14-22)30(21-7-9-23(31)10-8-21,38-18-29(17-35)11-12-29)34(27(24)36)16-20-5-3-19(15-33)4-6-20/h3-10,13-14,35,37H,11-12,16-18H2,1-2H3/t30-/m1/s1 DIVMTXBUDOMYFO-SSEXGKCCSA-N 535163 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-5-(2-hydroxypropan-2- yl)-3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}benzonitrile::US11236047, Example 24 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535163&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407600 464920432 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135722 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O4/c1-28(2,36)23-9-12-26-25(15-23)27(35)33(17-21-5-3-20(16-32)4-6-21)30(26,22-7-10-24(31)11-8-22)37-19-29(18-34)13-14-29/h3-12,15,34,36H,13-14,17-19H2,1-2H3/t30-/m1/s1 KUYDFZZMIJDWQY-SSEXGKCCSA-N 427071 US10544132, Example 25::US10981898, Example 25::US11236047, Example 25 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427071&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281419 434321387 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135723 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(C)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,34)21-8-13-25-24(14-21)26(33)32(15-19-4-9-22(30)10-5-19)29(25,20-6-11-23(31)12-7-20)36-18-28(3)16-35-17-28/h4-14,34H,15-18H2,1-3H3/t29-/m1/s1 JPJMGSQFTCZFQV-GDLZYMKVSA-N 427072 US10544132, Example 26::US10981898, Example 26::US11236047, Example 26 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 27.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427072&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281408 434321388 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135724 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 31.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135725 CO[C@]1(N(Cc2ccc(Cl)cc2C(O)=O)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2FN2O5/c1-30(40,19-10-12-35(2)13-11-19)21-14-25-27(26(34)15-21)31(41-3,20-5-8-22(32)9-6-20)36(28(25)37)17-18-4-7-23(33)16-24(18)29(38)39/h4-9,14-16,19,40H,10-13,17H2,1-3H3,(H,38,39)/t30?,31-/m1/s1 PGUDRRCAMVOBPY-NLIBRCFJSA-N 427146 US10544132, Example 87::US11236047, Example 87 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 31.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427146&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281456 434321460 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135726 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33?,35-/m1/s1 UAASDXMLTUDYGD-PWXSHKNQSA-N 492976 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10981898, Example 78::US11236047, Example 78 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 76.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492976&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281423 447119665 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135727 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33?,35-/m1/s1 UAASDXMLTUDYGD-PWXSHKNQSA-N 492976 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10981898, Example 78::US11236047, Example 78 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492976&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281423 447119665 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135728 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135729 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(O)CC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-26(2,33)20-7-12-24-23(15-20)25(32)31(16-18-3-8-21(29)9-4-18)28(24,35-17-27(34)13-14-27)19-5-10-22(30)11-6-19/h3-12,15,33-34H,13-14,16-17H2,1-2H3/t28-/m1/s1 RCIVCEHJWTYZDO-MUUNZHRXSA-N 427075 US10544132, Example 29::US11236047, Example 29 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427075&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281489 434321391 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135730 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#C)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H30ClNO4/c1-4-21-5-7-22(8-6-21)18-33-28(35)26-17-24(29(2,3)36)11-14-27(26)31(33,23-9-12-25(32)13-10-23)37-20-30(19-34)15-16-30/h1,5-14,17,34,36H,15-16,18-20H2,2-3H3/t31-/m1/s1 LTEBUYNLVXWZOS-WJOKGBTCSA-N 427067 US10544132, Example 20::US11236047, Example 20 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427067&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search U3Z 7BMG 135281739 434321384 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135731 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO4/c1-4-20-5-7-21(8-6-20)17-34-28(36)25-15-23(29(2,3)37)16-26(33)27(25)31(34,22-9-11-24(32)12-10-22)38-19-30(18-35)13-14-30/h1,5-12,15-16,35,37H,13-14,17-19H2,2-3H3/t31-/m1/s1 NBPAQCMFLGCFBK-WJOKGBTCSA-N 427068 US10544132, Example 21::US10544132, Example 24::US11236047, Example 21 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427068&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281734 434321385 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135732 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(C)cc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H32ClF2NO6/c1-4-31(40,30(35)11-13-42-14-12-30)22-16-25-27(26(34)17-22)32(41-3,21-7-9-23(33)10-8-21)36(28(25)37)18-20-6-5-19(2)15-24(20)29(38)39/h5-10,15-17,40H,4,11-14,18H2,1-3H3,(H,38,39)/t31-,32-/m1/s1 XFQWQHWLXCPJND-ROJLCIKYSA-N 427178 US10544132, Example 119::US11236047, Example 119 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427178&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281401 434321491 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135733 CCO[C@]1(N(Cc2ccc(Cl)cc2C([O-])=O)C(=O)c2cc(cc(F)c12)[C@](O)(CC)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-11-13-41-14-12-20)22-15-26-28(27(35)16-22)32(42-4-2,21-6-9-23(33)10-7-21)36(29(26)37)18-19-5-8-24(34)17-25(19)30(38)39/h5-10,15-17,20,40H,3-4,11-14,18H2,1-2H3,(H,38,39)/p-1/t31-,32+/m0/s1 DLUFTCNJNCOQGS-AJQTZOPKSA-M 535278 5-chloro-2-{[(1R)-1-(4-chlorophenyl)- 1-ethoxy-7-fluoro-5-[(1S)-1-hydroxy- 1-(oxan-4-yl)propyl]-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}benzoic acid- (tris(hydroxymethyl)aminomethane salt)::US11236047, Example 118 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 34.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535278&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154587066 464920532 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135734 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25Cl2FN2O5/c1-28(2,39)19-11-23-25(24(33)12-19)30(18-4-7-20(31)8-5-18,40-16-29(15-34)9-10-29)35(26(23)36)14-17-3-6-21(32)13-22(17)27(37)38/h3-8,11-13,39H,9-10,14,16H2,1-2H3,(H,37,38)/t30-/m1/s1 DEAVUDZEMMDBRA-SSEXGKCCSA-N 427132 US10544132, Example 79::US11236047, Example 79 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281403 434321446 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135735 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32?,33+/m0/s1 CDUKUNZREUVQKN-UBORAUAPSA-N 535254 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-(2- hydroxy-2-methylpropoxy)-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 96::US11236047, Example 97 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535254&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281536 464920514 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135736 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 HZTQINJSGAPBLS-SBYPTKLRSA-N 535255 US11236047, Example 98::US11236047, Example 99 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535255&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281416 464920515 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135737 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31?,33-/m1/s1 YLXVSCUQMYZKFT-NFCCVXSLSA-N 535242 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[2- (hydroxymethyl)cyclopentyl]oxy}-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 73::US11236047, Example 74 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 82.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535242&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281413 464920504 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135738 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30?,32-/m1/s1 FATKFLNSLQQUOY-BDJZEIKTSA-N 492975 US10981898, Example 76::US11236047, Example 76 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492975&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281442 447119664 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135739 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33?,34+/m0/s1 GEZPZMXREXHEJZ-FNHRJEOVSA-N 535238 US11236047, Example 69::US11236047, Example 70 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535238&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281717 464920501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135740 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30?,32-/m1/s1 FATKFLNSLQQUOY-BDJZEIKTSA-N 492975 US10981898, Example 76::US11236047, Example 76 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=492975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=492975&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281442 447119664 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135741 CC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO6/c1-29(2,38)19-13-23-27(24(33)14-19)30(40-22-11-12-39-16-22,18-5-9-21(32)10-6-18)34(28(23)37)25(15-26(35)36)17-3-7-20(31)8-4-17/h3-10,13-14,22,25,38H,11-12,15-16H2,1-2H3,(H,35,36)/t22-,25-,30+/m0/s1 PMXGSEVMEXTCLI-SGOMLOLCSA-N 427124 US10544132, Example 71::US10981898, Example 71::US11236047, Example 71 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 82.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427124&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281459 434321438 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135742 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H]([C@H](C)C(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-4-32(41,21-13-15-43-16-14-21)23-17-26-28(27(36)18-23)33(42-3,22-7-11-25(35)12-8-22)37(30(26)38)29(19(2)31(39)40)20-5-9-24(34)10-6-20/h5-12,17-19,21,29,41H,4,13-16H2,1-3H3,(H,39,40)/t19-,29-,32-,33+/m0/s1 JDCHPEZNOKLHPK-KJEAJVGRSA-N 427183 US10544132, Example 124::US11236047, Example 124 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 93.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427183&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281467 434321496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135743 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3CC([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,21-10-12-42-13-11-21)23-16-26-29(27(35)17-23)32(41-2,22-5-8-24(33)9-6-22)36(30(26)39)18-19-4-7-25(34)14-20(19)15-28(37)38/h4-9,14,16-17,21,40H,3,10-13,15,18H2,1-2H3,(H,37,38)/p-1/t31-,32+/m0/s1 KSQHEVCOEVTEOI-AJQTZOPKSA-M 535282 2-(5-chloro-2-{[(1R)-1-(4- chlorophenyl)-7-fluoro-5-[(1S)-1- hydroxy-1-(oxan-4-yl)propyl]-1- methoxy-3-oxo-2,3-dihydro-1H- isoindol-2-yl]methyl}phenyl)acetic acid (tris(hydroxymethyl)aminomethane salt)::US11236047, Example 122 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 33.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535282&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765561 464920535 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135744 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3CC(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,21-10-12-42-13-11-21)23-16-26-29(27(35)17-23)32(41-2,22-5-8-24(33)9-6-22)36(30(26)39)18-19-4-7-25(34)14-20(19)15-28(37)38/h4-9,14,16-17,21,40H,3,10-13,15,18H2,1-2H3,(H,37,38)/t31-,32-/m1/s1 KSQHEVCOEVTEOI-ROJLCIKYSA-N 427182 US10544132, Example 123::US11236047, Example 123 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427182&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281591 434321495 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135745 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(OC)cc3C([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H32ClF2NO7/c1-4-31(40,30(35)11-13-43-14-12-30)21-15-25-27(26(34)16-21)32(42-3,20-6-8-22(33)9-7-20)36(28(25)37)18-19-5-10-23(41-2)17-24(19)29(38)39/h5-10,15-17,40H,4,11-14,18H2,1-3H3,(H,38,39)/p-1/t31-,32-/m1/s1 AMRXPNINJISJEN-ROJLCIKYSA-M 427179 US10544132, Example 120::US11236047, Example 120 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 85.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427179&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765586 434321492 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135746 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(C)(C)C([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO6/c1-5-33(42,21-12-14-44-15-13-21)23-16-26-29(28(37)17-23)34(43-4,22-7-10-24(35)11-8-22)38(30(26)39)19-20-6-9-25(36)18-27(20)32(2,3)31(40)41/h6-11,16-18,21,42H,5,12-15,19H2,1-4H3,(H,40,41)/p-1/t33-,34+/m0/s1 DMHHJJRAOBKLND-SZAHLOSFSA-M 427180 US10544132, Example 121::US11236047, Example 121 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 23.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427180&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765546 434321493 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135747 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-12-14-42-15-13-20)22-16-25-29(26(35)17-22)32(41-2,21-6-10-24(34)11-7-21)36(30(25)39)27(18-28(37)38)19-4-8-23(33)9-5-19/h4-11,16-17,20,27,40H,3,12-15,18H2,1-2H3,(H,37,38)/t27-,31-,32+/m0/s1 TXTARTLLGHDDSD-SUXPEFEVSA-N 535286 (3S)-3-(4-chlorophenyl)-3-[(1R)-1- (4-chlorophenyl)-7-fluoro-5-[(1S)-1- hydroxy-1-(oxan-4-yl)propyl]-1- methoxy-3-oxo-2,3-dihydro-1H- isoindol-2-yl]propanoic acid::US11236047, Example 105 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535286&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281588 464920539 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135748 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OC4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27?,33?,34-/m1/s1 GEZPZMXREXHEJZ-WRPALDRWSA-N 535237 US11236047, Example 67::US11236047, Example 68 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 29.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535237&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154587067 464920500 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135749 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32?,34-/m1/s1 WPEIHYLRRFWOGP-SZFCLFMZSA-N 535250 US11236047, Example 85::US11236047, Example 86 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535250&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281494 464920511 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135750 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32?,34-/m1/s1 WPEIHYLRRFWOGP-SZFCLFMZSA-N 535250 US11236047, Example 85::US11236047, Example 86 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535250&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281494 464920511 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135751 CCO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](O)(CC)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C33H33Cl2F2NO6/c1-3-32(42,31(37)13-15-43-16-14-31)22-17-25-29(26(36)18-22)33(44-4-2,21-7-11-24(35)12-8-21)38(30(25)41)27(19-28(39)40)20-5-9-23(34)10-6-20/h5-12,17-18,27,42H,3-4,13-16,19H2,1-2H3,(H,39,40)/t27-,32+,33+/m0/s1 JMXJOWWAIDYRLU-SKTNCWGXSA-N 427171 US10544132, Example 111::US11236047, Example 111 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 59.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427171&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281526 434321484 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135752 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-12-14-42-15-13-20)22-16-25-29(26(35)17-22)32(41-2,21-6-10-24(34)11-7-21)36(30(25)39)27(18-28(37)38)19-4-8-23(33)9-5-19/h4-11,16-17,20,27,40H,3,12-15,18H2,1-2H3,(H,37,38)/t27-,31+,32+/m0/s1 TXTARTLLGHDDSD-QUBLIXHFSA-N 427166 US10544132, Example 106::US11236047, Example 106 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 520 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427166&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281471 434321480 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135753 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32-,33+/m0/s1 YDGNPXHTWKENIC-KXLBIAJQSA-N 427167 US10544132, Example 107::US11236047, Example 107 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427167&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281641 434321481 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135754 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32+,33+/m0/s1 YDGNPXHTWKENIC-XEUSQTKLSA-N 427168 US10544132, Example 108::US10981898, Example 108::US11236047, Example 108 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 790 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427168&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281545 434321482 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135755 CC[C@@](O)(c1cc2C(=O)N([C@@H](CCC([O-])=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C33H33Cl2F2NO6/c1-3-32(42,31(37)14-16-44-17-15-31)22-18-25-29(26(36)19-22)33(43-2,21-6-10-24(35)11-7-21)38(30(25)41)27(12-13-28(39)40)20-4-8-23(34)9-5-20/h4-11,18-19,27,42H,3,12-17H2,1-2H3,(H,39,40)/p-1/t27-,32+,33+/m0/s1 KQTPBMJSGVVRKO-SKTNCWGXSA-M 427169 US10544132, Example 109::US11236047, Example 109 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427169&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765594 434321483 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135756 CCC(O)([C@H]1CC[C@H](O)CC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO6/c1-3-33(43,21-8-14-26(39)15-9-21)23-18-27-31(28(37)19-23)34(44-2,22-6-12-25(36)13-7-22)38(32(27)42)29(16-17-30(40)41)20-4-10-24(35)11-5-20/h4-7,10-13,18-19,21,26,29,39,43H,3,8-9,14-17H2,1-2H3,(H,40,41)/t21-,26-,29-,33?,34+/m0/s1 QJTCYWYDSIOJFY-OYLRFEPJSA-N 427173 US10544132, Example 114::US11236047, Example 114 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427173&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405365 434321486 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135757 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3P(C)(C)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FNO5P/c1-29(2,38)21-13-24-27(25(34)14-21)31(20-6-9-22(32)10-7-20,40-18-30(17-36)11-12-30)35(28(24)37)16-19-5-8-23(33)15-26(19)41(3,4)39/h5-10,13-15,36,38H,11-12,16-18H2,1-4H3/t31-/m1/s1 IARKWVZHJYWTDX-WJOKGBTCSA-N 427135 US10544132, Example 82::US10981898, Example 82::US11236047, Example 82 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 27.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405337 434321449 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135758 CC(O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28?,30-/m1/s1 HJVLHGXGDKFDKJ-FUJFQHJFSA-N 535235 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-[3- (hydroxymethyl)cyclobutoxy]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 65::US11236047, Example 66 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535235&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281693 464920499 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135759 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30?,31+/m0/s1 AVDHVIXZENQIRS-JCHZNZEOSA-N 535251 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[1- hydroxy-1-(1-oxo-1lambda5-pyridin-3- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 88::US11236047, Example 89 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535251&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281674 464920512 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135760 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N([C@@H](CO)c3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)24-14-27-31(28(36)15-24)34(45-26-12-13-44-19-26,23-8-10-25(35)11-9-23)40(32(27)42)29(18-41)22-6-4-21(16-37)5-7-22/h4-11,14-15,17,20,26,29,41,43H,3,12-13,18-19H2,1-2H3/t26-,29-,33?,34+/m0/s1 DLDOXTZEZBHSKM-OJHXNHCWSA-N 535294 US11236047, Example 90 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.640 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535294&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281652 464920545 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135761 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(C)C(=O)C1)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2N4O4/c1-28(38,18-34-13-12-33(2)26(36)17-34)20-6-11-25-24(14-20)27(37)35(16-23-10-9-22(31)15-32-23)29(25,39-3)19-4-7-21(30)8-5-19/h4-11,14-15,38H,12-13,16-18H2,1-3H3/t28?,29-/m1/s1 DZIHXZOXUTVDGM-YPJJGMIRSA-N 535295 US11236047, Example 112 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 180 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535295&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283185 464920546 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135762 CC[C@@](O)(c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(OC)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C34H36ClF2NO7/c1-4-33(42,32(37)15-17-45-18-16-32)23-19-26-30(27(36)20-23)34(44-3,22-7-9-24(35)10-8-22)38(31(26)41)28(13-14-29(39)40)21-5-11-25(43-2)12-6-21/h5-12,19-20,28,42H,4,13-18H2,1-3H3,(H,39,40)/t28-,33+,34+/m0/s1 NOKLTVPSPDXSBE-HUTUBIKLSA-N 427172 US10544132, Example 113::US11236047, Example 113 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427172&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281626 434321485 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135763 CS(=O)(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(O)C1CCOCC1 InChI=1S/C33H34Cl2FNO7S/c1-45(41,42)28-16-25(35)5-2-21(28)17-37-31(40)26-14-22(30(39)20-8-12-43-13-9-20)15-27(36)29(26)33(37,23-3-6-24(34)7-4-23)44-19-32(18-38)10-11-32/h2-7,14-16,20,30,38-39H,8-13,17-19H2,1H3/t30?,33-/m1/s1 IRIZYNABKNVLML-FULUQAKVSA-N 535249 US11236047, Example 83::US11236047, Example 84 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 22.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535249&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281613 464920510 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135764 CCC(O)(c1ccn(C)n1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O5/c1-4-31(42,27-15-16-37(2)36-27)21-17-24-29(25(35)18-21)32(43-3,20-7-11-23(34)12-8-20)38(30(24)41)26(13-14-28(39)40)19-5-9-22(33)10-6-19/h5-12,15-18,26,42H,4,13-14H2,1-3H3,(H,39,40)/t26-,31?,32+/m0/s1 ACCSRYKZIIOHIZ-LTZUXFEUSA-N 427160 US10544132, Example 100::US10981898, Example 100::US11236047, Example 100 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427160&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281496 434321474 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135765 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31?,32+/m0/s1 HXHSKGLWTNIZIS-LTZUXFEUSA-N 535258 US11236047, Example 101::US11236047, Example 102 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535258&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281540 464920517 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135766 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3CO)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN2O4/c1-28(2,38)21-12-24-26(25(33)13-21)30(20-4-7-22(31)8-5-20,39-17-29(16-34)9-10-29)35(27(24)37)14-18-3-6-23(32)11-19(18)15-36/h3-8,11-13,36,38H,9-10,14-15,17H2,1-2H3/t30-/m1/s1 FZOWPLQXTSEWMX-SSEXGKCCSA-N 427125 US10544132, Example 72::US10981898, Example 72::US11236047, Example 72 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427125&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281421 434321439 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135767 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H39Cl2FN2O6S/c1-33(43,23-10-14-39(2)15-11-23)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,46-21-34(20-41)12-13-34)40(32(28)42)19-22-4-7-27(37)18-30(22)47(3,44)45/h4-9,16-18,23,41,43H,10-15,19-21H2,1-3H3/t33?,35-/m1/s1 MNUHQOFWGYDTKI-PWXSHKNQSA-N 535247 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-[(cis-3-hydroxycyclobutyl)methoxy]- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 81 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535247&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281599 464920508 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135768 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3CO)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)25-13-28-31(29(36)14-25)34(45-27-10-11-44-19-27,24-6-8-26(35)9-7-24)40(32(28)42)16-22-5-4-21(15-37)12-23(22)18-41/h4-9,12-14,17,20,27,41,43H,3,10-11,16,18-19H2,1-2H3/t27-,33?,34+/m0/s1 LQLKHTDURGSYEY-FNHRJEOVSA-N 535266 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-3-(3- hydroxy-3-methylbutoxy)-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 92::US11236047, Example 93 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535266&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281612 464920525 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135769 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCC1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO5/c1-29(38,18-4-3-5-18)20-14-23-27(24(33)15-20)30(39-2,19-8-12-22(32)13-9-19)34(28(23)37)25(16-26(35)36)17-6-10-21(31)11-7-17/h6-15,18,25,38H,3-5,16H2,1-2H3,(H,35,36)/t25-,29?,30+/m0/s1 BVCCIEZECAVANS-NIJCYXJWSA-N 535301 US11236047, Example 103 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 22.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535301&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281441 464920549 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135770 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OC4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27?,33?,34-/m1/s1 GEZPZMXREXHEJZ-WRPALDRWSA-N 535237 US11236047, Example 67::US11236047, Example 68 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535237&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154587067 464920500 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135771 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33?,34+/m0/s1 GEZPZMXREXHEJZ-FNHRJEOVSA-N 535238 US11236047, Example 69::US11236047, Example 70 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535238&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281717 464920501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135772 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28?,30-/m1/s1 FLAAYSHQWIAMDD-FUJFQHJFSA-N 535228 US11236047, Example 58::US11236047, Example 59 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535228&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281484 464920494 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135773 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30?,31+/m0/s1 AVDHVIXZENQIRS-JCHZNZEOSA-N 535251 (3R)-3-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[1- hydroxy-1-(1-oxo-1lambda5-pyridin-3- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 88::US11236047, Example 89 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 28.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535251&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281674 464920512 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135774 CCC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 NAMQEWAUDBCILZ-SBYPTKLRSA-N 535261 US11236047, Example 125::US11236047, Example 126 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 100.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535261&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281454 464920520 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135775 CCC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29?,31+/m0/s1 NAMQEWAUDBCILZ-SBYPTKLRSA-N 535261 US11236047, Example 125::US11236047, Example 126 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535261&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281454 464920520 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135776 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-3-30(39,19-10-12-41-13-11-19)21-14-25-27(26(34)15-21)31(40-2,20-5-8-22(32)9-6-20)35(28(25)36)17-18-4-7-23(33)16-24(18)29(37)38/h4-9,14-16,19,39H,3,10-13,17H2,1-2H3,(H,37,38)/t30-,31-/m1/s1 NOIABBKIABICFM-FIRIVFDPSA-N 427176 US10544132, Example 117::US11236047, Example 117 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427176&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281388 434321489 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135777 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OC[C@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H27ClFN3O4/c1-28(2,37)20-11-24-26(25(31)12-20)29(19-4-6-21(30)7-5-19,38-16-18-9-23(35)10-18)34(27(24)36)15-22-8-3-17(13-32)14-33-22/h3-8,11-12,14,18,23,35,37H,9-10,15-16H2,1-2H3/t18-,23-,29-/m1/s1 BMTZOKAZWFZZTA-WPGLZZBSSA-N 535305 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-(2-hydroxypropan-2-yl)-3-oxo-1- {[(trans-3- hydroxycyclobutyl]methoxy}-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 419 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535305&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282816 464920552 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135778 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O3/c1-28(36,19-12-14-33(2)15-13-19)21-6-11-26-25(16-21)27(35)34(18-24-10-9-23(31)17-32-24)29(26,37-3)20-4-7-22(30)8-5-20/h4-11,16-17,19,36H,12-15,18H2,1-3H3/t28?,29-/m1/s1 XDRDDFDNMPCGJS-YPJJGMIRSA-N 535306 US11236047, Example 319 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535306&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282540 464920553 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135779 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CC[C@H](O)C1)c1ccc(Cl)cc1 InChI=1S/C28H29Cl2N3O4/c1-27(36,17-32-12-11-23(34)16-32)19-5-10-25-24(13-19)26(35)33(15-22-9-8-21(30)14-31-22)28(25,37-2)18-3-6-20(29)7-4-18/h3-10,13-14,23,34,36H,11-12,15-17H2,1-2H3/t23-,27?,28+/m0/s1 HRIJPCHUKWYMAZ-FNPAGISBSA-N 535307 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[(3S)-3-hydroxypyrrolidin- 1-yl]propan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 382 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 36.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535307&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282701 464920554 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135780 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCCNCC1)c1ccc(Cl)cc1 InChI=1S/C29H32Cl2N4O3/c1-28(37,19-34-14-3-12-32-13-15-34)21-6-11-26-25(16-21)27(36)35(18-24-10-9-23(31)17-33-24)29(26,38-2)20-4-7-22(30)8-5-20/h4-11,16-17,32,37H,3,12-15,18-19H2,1-2H3/t28?,29-/m1/s1 PQOGDMMHRYSZLL-YPJJGMIRSA-N 535308 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[1-(1,4- diazepan-1-yl)-2-hydroxypropan-2-yl]- 3-methoxy-2,3-dihydro-1H-isoindol-1- one::US11236047, Example 243 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535308&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282570 464920555 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135781 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCNC(=O)C1)c1ccc(Cl)cc1 InChI=1S/C28H28Cl2N4O4/c1-27(37,17-33-12-11-31-25(35)16-33)19-5-10-24-23(13-19)26(36)34(15-22-9-8-21(30)14-32-22)28(24,38-2)18-3-6-20(29)7-4-18/h3-10,13-14,37H,11-12,15-17H2,1-2H3,(H,31,35)/t27?,28-/m1/s1 VPGDQGXCZJKOKB-PLYLYKGUSA-N 535309 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(3-oxopiperazin-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 241 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535309&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282586 464920556 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135782 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN(C)C1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C31H36Cl2N4O3/c1-30(39,20-36(3)26-13-15-35(2)16-14-26)22-7-12-28-27(17-22)29(38)37(19-25-11-10-24(33)18-34-25)31(28,40-4)21-5-8-23(32)9-6-21/h5-12,17-18,26,39H,13-16,19-20H2,1-4H3/t30?,31-/m1/s1 NIQLOSGJNQWVPZ-NLIBRCFJSA-N 535310 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[methyl(1-methylpiperidin- 4-yl)amino]propan-2-yl}-3-methoxy- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 239 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535310&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282584 464920557 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135783 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCC(O)CC1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O4/c1-28(37,18-33-13-11-24(35)12-14-33)20-5-10-26-25(15-20)27(36)34(17-23-9-8-22(31)16-32-23)29(26,38-2)19-3-6-21(30)7-4-19/h3-10,15-16,24,35,37H,11-14,17-18H2,1-2H3/t28?,29-/m1/s1 KKZFHPXILKNMKT-YPJJGMIRSA-N 535311 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(4-hydroxypiperidin-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 247 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 22.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535311&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282781 464920558 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135784 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(CCO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2N4O4/c1-29(39,20-35-13-11-34(12-14-35)15-16-37)22-5-10-27-26(17-22)28(38)36(19-25-9-8-24(32)18-33-25)30(27,40-2)21-3-6-23(31)7-4-21/h3-10,17-18,37,39H,11-16,19-20H2,1-2H3/t29?,30-/m1/s1 DPPXNNDVKLQDMN-BDCODIICSA-N 535312 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[4-(2- hydroxyethyl)piperazin-1-yl]propan-2- yl}-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 237 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535312&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282491 464920559 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135785 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CNC1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O4/c1-28(36,18-33-23-11-13-38-14-12-23)20-5-10-26-25(15-20)27(35)34(17-24-9-8-22(31)16-32-24)29(26,37-2)19-3-6-21(30)7-4-19/h3-10,15-16,23,33,36H,11-14,17-18H2,1-2H3/t28?,29-/m1/s1 NNFNCIHBRADXMA-YPJJGMIRSA-N 535313 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[(oxan-4-yl)amino]propan- 2-yl}-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 240 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 32.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535313&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282709 464920560 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135786 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)Cn1ccnc1)c1ccc(Cl)cc1 InChI=1S/C27H24Cl2N4O3/c1-26(35,16-32-12-11-30-17-32)19-5-10-24-23(13-19)25(34)33(15-22-9-8-21(29)14-31-22)27(24,36-2)18-3-6-20(28)7-4-18/h3-14,17,35H,15-16H2,1-2H3/t26?,27-/m1/s1 YGKSMVLPXSQVDL-SSYAZFEXSA-N 535314 US11236047, Example 159 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 31.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535314&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282840 464920561 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135787 C[C@@H](CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(C)O)c1ccc(Cl)cc1)C(N)=O InChI=1S/C27H26Cl2FN3O4/c1-15(24(31)34)14-37-27(16-4-6-18(28)7-5-16)23-21(10-17(11-22(23)30)26(2,3)36)25(35)33(27)13-20-9-8-19(29)12-32-20/h4-12,15,36H,13-14H2,1-3H3,(H2,31,34)/t15-,27+/m0/s1 BQIHMGXSJXBAHX-KUNJGFBQSA-N 535315 (2S)-3-{[(1R)-1-(4-Chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-7-fluoro- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-2- methylpropanamide::US11236047, Example 167 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535315&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282097 464920562 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135788 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN(C)C1CCN(CC1)C(C)=O)c1ccc(Cl)cc1 InChI=1S/C32H36Cl2N4O4/c1-21(39)37-15-13-27(14-16-37)36(3)20-31(2,41)23-7-12-29-28(17-23)30(40)38(19-26-11-10-25(34)18-35-26)32(29,42-4)22-5-8-24(33)9-6-22/h5-12,17-18,27,41H,13-16,19-20H2,1-4H3/t31?,32-/m1/s1 WILRRCSJAZCUSZ-IADGFXSZSA-N 535316 US11236047, Example 253a E3 ubiquitin-protein ligase Mdm2 Homo sapiens 35.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535316&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282547 464920563 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135789 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCS(=O)(=O)CC1)c1ccc(Cl)cc1 InChI=1S/C28H29Cl2N3O5S/c1-27(35,18-32-11-13-39(36,37)14-12-32)20-5-10-25-24(15-20)26(34)33(17-23-9-8-22(30)16-31-23)28(25,38-2)19-3-6-21(29)7-4-19/h3-10,15-16,35H,11-14,17-18H2,1-2H3/t27?,28-/m1/s1 KREFOPSIIIDQPU-PLYLYKGUSA-N 535317 4-{2-[(1R)-1-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-1-methoxy- 3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2- hydroxypropyl}-1lambda6-thiomorpholine- 1,1-dione::US11236047, Example 249 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535317&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498041 464920564 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135790 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O4/c1-28(37,18-33-13-3-4-24(33)17-35)20-7-12-26-25(14-20)27(36)34(16-23-11-10-22(31)15-32-23)29(26,38-2)19-5-8-21(30)9-6-19/h5-12,14-15,24,35,37H,3-4,13,16-18H2,1-2H3/t24-,28?,29+/m0/s1 JFFLEFUMQHMYIZ-QLMXRQDHSA-N 535318 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[(2S)-2- (hydroxymethyl)pyrrolidin-1- yl]propan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 250 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535318&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282683 464920565 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135791 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)c1ccccn1)c1ccc(Cl)cc1 InChI=1S/C28H23Cl2N3O3/c1-27(35,25-5-3-4-14-31-25)19-8-13-24-23(15-19)26(34)33(17-22-12-11-21(30)16-32-22)28(24,36-2)18-6-9-20(29)10-7-18/h3-16,35H,17H2,1-2H3/t27?,28-/m1/s1 AEIKRFTUDLNFOQ-PLYLYKGUSA-N 535319 US11236047, Example 320::US11236047, Example 321 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535319&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282337 464920566 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135792 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)c1ccccn1)c1ccc(Cl)cc1 InChI=1S/C28H23Cl2N3O3/c1-27(35,25-5-3-4-14-31-25)19-8-13-24-23(15-19)26(34)33(17-22-12-11-21(30)16-32-22)28(24,36-2)18-6-9-20(29)10-7-18/h3-16,35H,17H2,1-2H3/t27?,28-/m1/s1 AEIKRFTUDLNFOQ-PLYLYKGUSA-N 535319 US11236047, Example 320::US11236047, Example 321 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535319&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282337 464920566 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135793 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCCC1=O)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2N3O4/c1-27(36,17-32-13-3-4-25(32)34)19-7-12-24-23(14-19)26(35)33(16-22-11-10-21(30)15-31-22)28(24,37-2)18-5-8-20(29)9-6-18/h5-12,14-15,36H,3-4,13,16-17H2,1-2H3/t27?,28-/m1/s1 LEGWQUAVGNVBCC-PLYLYKGUSA-N 535321 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(2-oxopyrrolidin-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 257 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535321&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282785 464920567 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135794 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C29H32Cl2N4O3/c1-28(37,19-34-14-12-33(2)13-15-34)21-6-11-26-25(16-21)27(36)35(18-24-10-9-23(31)17-32-24)29(26,38-3)20-4-7-22(30)8-5-20/h4-11,16-17,37H,12-15,18-19H2,1-3H3/t28?,29-/m1/s1 ZGKBSBXWXVIPTA-YPJJGMIRSA-N 535322 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(4-methylpiperazin-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 255 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535322&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282565 464920568 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135795 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCC(N)CC1)c1ccc(Cl)cc1 InChI=1S/C29H32Cl2N4O3/c1-28(37,18-34-13-11-23(32)12-14-34)20-5-10-26-25(15-20)27(36)35(17-24-9-8-22(31)16-33-24)29(26,38-2)19-3-6-21(30)7-4-19/h3-10,15-16,23,37H,11-14,17-18,32H2,1-2H3/t28?,29-/m1/s1 YWQGLDHZKOMWAR-YPJJGMIRSA-N 535323 (3R)-6-[1-(4-aminopiperidin-1-yl)-2- hydroxypropan-2-yl]-3-(4- chlorophenyl)-2-[(5-chloropyridin-2- yl)methyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 259 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535323&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282311 464920569 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135796 CC[C@@](O)(C1CCN(CC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN2O5/c1-3-31(41,21-12-14-36(15-13-21)19-28(38)39)23-16-26-29(27(35)17-23)32(42-2,22-6-10-25(34)11-7-22)37(30(26)40)18-20-4-8-24(33)9-5-20/h4-11,16-17,21,41H,3,12-15,18-19H2,1-2H3,(H,38,39)/t31-,32-/m1/s1 MFPOPVHVIGVWNK-ROJLCIKYSA-N 427193 US10544132, Example 134::US11236047, Example 135 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 49.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281491 434321506 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135797 Cc1nc(cn1C)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-18-36-26(16-37(18)3)29(2,40)20-12-24-27(25(34)13-20)31(42-17-30(41)10-11-30,19-4-6-21(32)7-5-19)38(28(24)39)15-23-9-8-22(33)14-35-23/h4-9,12-14,16,40-41H,10-11,15,17H2,1-3H3/t29?,31-/m1/s1 VZJXEPGTXSZTFT-ZGVDRVBQSA-N 535325 US11236047, Example 324::US11236047, Example 325 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 28.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535325&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283141 464920571 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135798 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCNC(=O)CC1)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2N4O4/c1-28(38,18-34-13-11-26(36)32-12-14-34)20-5-10-25-24(15-20)27(37)35(17-23-9-8-22(31)16-33-23)29(25,39-2)19-3-6-21(30)7-4-19/h3-10,15-16,38H,11-14,17-18H2,1-2H3,(H,32,36)/t28?,29-/m1/s1 VTTCUOOPEDMGDZ-YPJJGMIRSA-N 535326 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(5-oxo-1,4-diazepan-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 261 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 48.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535326&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282751 464920572 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135799 C[C@H](N1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(cn1)C#N InChI=1S/C30H29ClFN3O4/c1-18(25-9-4-19(14-33)15-34-25)35-27(37)23-12-21(28(2,3)38)13-24(32)26(23)30(35,20-5-7-22(31)8-6-20)39-17-29(16-36)10-11-29/h4-9,12-13,15,18,36,38H,10-11,16-17H2,1-3H3/t18-,30+/m0/s1 ZTHJYOMAEPHLCZ-YVGXBJCXSA-N 535327 6-[(1S)-1-[(1R)-1-(4-Chlorophenyl)-7- fluoro-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]ethyl]pyridine-3-carbonitrile::US11236047, Example 169 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535327&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282773 464920573 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135800 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCn2nncc2C1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2N6O3/c1-28(39,18-35-11-12-37-24(17-35)15-33-34-37)20-5-10-26-25(13-20)27(38)36(16-23-9-8-22(31)14-32-23)29(26,40-2)19-3-6-21(30)7-4-19/h3-10,13-15,39H,11-12,16-18H2,1-2H3/t28?,29-/m1/s1 VHIUFRHFXUUDAW-YPJJGMIRSA-N 535328 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(2- hydroxy-1-{4H,5H,6H,7H- [1,2,3]triazolo[1,5-a]pyrazin-5- yl}propan-2-yl)-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 262 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 33.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535328&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282942 464920574 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135801 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)COc1cccnc1)c1ccc(Cl)cc1 InChI=1S/C29H25Cl2N3O4/c1-28(36,18-38-24-4-3-13-32-16-24)20-7-12-26-25(14-20)27(35)34(17-23-11-10-22(31)15-33-23)29(26,37-2)19-5-8-21(30)9-6-19/h3-16,36H,17-18H2,1-2H3/t28?,29-/m1/s1 OSFLWVFFCXOKFW-YPJJGMIRSA-N 535329 US11236047, Example 234 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535329&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282449 464920575 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135802 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C32H27Cl2FN2O5/c1-3-31(41,27-6-4-5-15-36-27)21-16-24-29(25(35)17-21)32(42-2,20-9-13-23(34)14-10-20)37(30(24)40)26(18-28(38)39)19-7-11-22(33)12-8-19/h4-17,26,41H,3,18H2,1-2H3,(H,38,39)/t26-,31?,32+/m0/s1 KHSRSNYUTBONQS-LTZUXFEUSA-N 535262 1-({[(1R)-5-[1-(4-Acetylpiperazin-1- yl)-2-hydroxypropan-2-yl]-1-(4- chlorophenyl)-2-[(5-chloropyridin-2- yl)methyl]-7-fluoro-3-oxo-2,3-dihydro- 1H-isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 127::US11236047, Example 128 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535262&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281621 464920521 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135803 CCC(O)(c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCNCC1 InChI=1S/C31H32Cl2F2N2O5S/c1-4-30(39,29(35)11-13-36-14-12-29)21-15-24-27(25(34)16-21)31(42-2,20-6-9-22(32)10-7-20)37(28(24)38)18-19-5-8-23(33)17-26(19)43(3,40)41/h5-10,15-17,36,39H,4,11-14,18H2,1-3H3/t30?,31-/m1/s1 YMXGZYIWCPLVGI-NLIBRCFJSA-N 427188 US10544132, Example 129::US11236047, Example 129 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427188&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281595 434321501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135804 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1C[C@H]2C[C@@H]1CN2C)c1ccc(Cl)cc1 InChI=1S/C30H32Cl2N4O3/c1-29(38,18-35-17-24-13-25(35)16-34(24)2)20-6-11-27-26(12-20)28(37)36(15-23-10-9-22(32)14-33-23)30(27,39-3)19-4-7-21(31)8-5-19/h4-12,14,24-25,38H,13,15-18H2,1-3H3/t24-,25-,29?,30-/m1/s1 PBBNOTCNGPJVQE-ILVBBMGSSA-N 535332 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[(1S,4S)-5-methyl-2,5- diazabicyclo[2.2.1]heptan-2- yl]propan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 264 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 43.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535332&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137513243 464920577 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135805 CCOCC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cn1)[C@@]2(OC)c1ccc(Cl)cc1 InChI=1S/C26H26Cl2N2O4/c1-4-34-16-25(2,32)18-7-12-23-22(13-18)24(31)30(15-21-11-10-20(28)14-29-21)26(23,33-3)17-5-8-19(27)9-6-17/h5-14,32H,4,15-16H2,1-3H3/t25?,26-/m1/s1 WQLWSRLBJFQPMN-FXDYGKIASA-N 535333 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-(1- ethoxy-2-hydroxypropan-2-yl)-3- methoxy-2,3-dihydro-1H-isoindol-1- one::US11236047, Example 236 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 41.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535333&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282505 464920578 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135806 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-30(42,23-15-37-38(2)16-23)22-11-26-28(27(34)12-22)32(21-4-6-24(33)7-5-21,43-19-31(18-40)9-10-31)39(29(26)41)17-25-8-3-20(13-35)14-36-25/h3-8,11-12,14-16,40,42H,9-10,17-19H2,1-2H3/t30?,32-/m1/s1 GCKLTVVEUHWDDO-BDJZEIKTSA-N 535334 US11236047, Example 316::US11236047, Example 317 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535334&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282782 464920579 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135807 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-30(42,23-15-37-38(2)16-23)22-11-26-28(27(34)12-22)32(21-4-6-24(33)7-5-21,43-19-31(18-40)9-10-31)39(29(26)41)17-25-8-3-20(13-35)14-36-25/h3-8,11-12,14-16,40,42H,9-10,17-19H2,1-2H3/t30?,32-/m1/s1 GCKLTVVEUHWDDO-BDJZEIKTSA-N 535334 US11236047, Example 316::US11236047, Example 317 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535334&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282782 464920579 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135808 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)COC1CCNCC1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O4/c1-28(36,18-38-24-11-13-32-14-12-24)20-5-10-26-25(15-20)27(35)34(17-23-9-8-22(31)16-33-23)29(26,37-2)19-3-6-21(30)7-4-19/h3-10,15-16,24,32,36H,11-14,17-18H2,1-2H3/t28?,29-/m1/s1 OEHYQQAEGJJOGR-YPJJGMIRSA-N 535336 US11236047, Example 377 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535336&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282350 464920580 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135809 CC(=O)N1CCC(CC1)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cn1)C2(O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2N3O4/c1-18(35)33-13-11-19(12-14-33)28(2,37)21-5-10-26-25(15-21)27(36)34(17-24-9-8-23(31)16-32-24)29(26,38)20-3-6-22(30)7-4-20/h3-10,15-16,19,37-38H,11-14,17H2,1-2H3 YZQDUBHOKBMFJN-UHFFFAOYSA-N 535337 6-[1-(1-Acetylpiperidin-4-yl)-1- hydroxyethyl]-3-(4-chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-4-fluoro- 3-hydroxy-2,3-dihydro-1H-isoindol-1- one::US11236047, Example 376 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535337&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 140963863 464920581 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135810 CC(=O)N1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN4O5/c1-20(42)40-13-9-21(10-14-40)32(2,45)23-15-27-29(28(37)16-23)34(22-3-5-24(35)6-4-22,46-19-33(11-12-33)31(38)44)41(30(27)43)18-26-8-7-25(36)17-39-26/h3-8,15-17,21,45H,9-14,18-19H2,1-2H3,(H2,38,44)/t32?,34-/m1/s1 JNWIBTVWXFDIHN-SZFCLFMZSA-N 535338 US11236047, Example 303 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535338&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282309 464920582 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135811 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2N4O3/c1-29(38,20-35-14-4-13-34(2)15-16-35)22-7-12-27-26(17-22)28(37)36(19-25-11-10-24(32)18-33-25)30(27,39-3)21-5-8-23(31)9-6-21/h5-12,17-18,38H,4,13-16,19-20H2,1-3H3/t29?,30-/m1/s1 UYAUDKAFRBHDQL-BDCODIICSA-N 535339 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-[2- hydroxy-1-(4-methyl-1,4-diazepan-1- yl)propan-2-yl]-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 266 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535339&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282525 464920583 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135812 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCC[C@@H]1CO)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2N3O4/c1-28(37,18-33-13-3-4-24(33)17-35)20-7-12-26-25(14-20)27(36)34(16-23-11-10-22(31)15-32-23)29(26,38-2)19-5-8-21(30)9-6-19/h5-12,14-15,24,35,37H,3-4,13,16-18H2,1-2H3/t24-,28?,29-/m1/s1 JFFLEFUMQHMYIZ-ZOPIJBJZSA-N 535340 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{2- hydroxy-1-[(2R)-2- (hydroxymethyl)pyrrolidin-1- yl]propan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 265 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 44.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535340&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282677 464920584 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135813 CC(O)(C1CCNCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34ClFN4O4/c1-31(42,22-8-12-37-13-9-22)24-14-27-29(28(35)15-24)33(23-3-5-25(34)6-4-23,43-20-32(19-40)10-11-32)39(30(27)41)18-26-7-2-21(16-36)17-38-26/h2-7,14-15,17,22,37,40,42H,8-13,18-20H2,1H3/t31?,33-/m1/s1 NFSWATKGUGXRKR-NFCCVXSLSA-N 535341 US11236047, Example 289::US11236047, Example 290 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535341&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282279 464920585 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135814 CC(=O)N1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H36ClFN4O5/c1-22(43)40-13-9-24(10-14-40)33(2,45)26-15-29-31(30(37)16-26)35(25-4-6-27(36)7-5-25,46-21-34(20-42)11-12-34)41(32(29)44)19-28-8-3-23(17-38)18-39-28/h3-8,15-16,18,24,42,45H,9-14,19-21H2,1-2H3/t33?,35-/m1/s1 ILWWWJCABRTVHO-PWXSHKNQSA-N 535342 US11236047, Example 292 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 21.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535342&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282777 464920586 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135815 C[S+]([O-])C1(CO[C@]2(N(Cc3ccc(Cl)cn3)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C28H27Cl2FN2O4S/c1-26(2,35)18-12-22-24(23(31)13-18)28(17-4-6-19(29)7-5-17,37-16-27(10-11-27)38(3)36)33(25(22)34)15-21-9-8-20(30)14-32-21/h4-9,12-14,35H,10-11,15-16H2,1-3H3/t28-,38?/m1/s1 BMDCWINLUAOPGG-GOGSRFGOSA-N 535343 US11236047, Example 171::US11236047, Example 172 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 130 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535343&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282711 464920587 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135816 C[S+]([O-])C1(CO[C@]2(N(Cc3ccc(Cl)cn3)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C28H27Cl2FN2O4S/c1-26(2,35)18-12-22-24(23(31)13-18)28(17-4-6-19(29)7-5-17,37-16-27(10-11-27)38(3)36)33(25(22)34)15-21-9-8-20(30)14-32-21/h4-9,12-14,35H,10-11,15-16H2,1-3H3/t28-,38?/m1/s1 BMDCWINLUAOPGG-GOGSRFGOSA-N 535343 US11236047, Example 171::US11236047, Example 172 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535343&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282711 464920587 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135817 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCC1)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2N3O3/c1-26(34,17-31-12-3-13-31)19-6-11-24-23(14-19)25(33)32(16-22-10-9-21(29)15-30-22)27(24,35-2)18-4-7-20(28)8-5-18/h4-11,14-15,34H,3,12-13,16-17H2,1-2H3/t26?,27-/m1/s1 OZCYVNAYNKYZPN-SSYAZFEXSA-N 535345 (3R)-6-[1-(azetidin-1-yl)-2- hydroxypropan-2-yl]-3-(4- chlorophenyl)-2-[(5-chloropyridin-2- yl)methyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 269 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 160 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535345&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282142 464920588 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135818 CC(O)(C1CCNCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34ClFN4O4/c1-31(42,22-8-12-37-13-9-22)24-14-27-29(28(35)15-24)33(23-3-5-25(34)6-4-23,43-20-32(19-40)10-11-32)39(30(27)41)18-26-7-2-21(16-36)17-38-26/h2-7,14-15,17,22,37,40,42H,8-13,18-20H2,1H3/t31?,33-/m1/s1 NFSWATKGUGXRKR-NFCCVXSLSA-N 535341 US11236047, Example 289::US11236047, Example 290 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535341&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282279 464920585 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135819 C[C@H](CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(C)O)c1ccc(Cl)cc1)C(N)=O InChI=1S/C27H26Cl2FN3O4/c1-15(24(31)34)14-37-27(16-4-6-18(28)7-5-16)23-21(10-17(11-22(23)30)26(2,3)36)25(35)33(27)13-20-9-8-19(29)12-32-20/h4-12,15,36H,13-14H2,1-3H3,(H2,31,34)/t15-,27-/m1/s1 BQIHMGXSJXBAHX-YVORESIASA-N 535347 (2R)-3-{[(1R)-1-(4-Chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-7-fluoro- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1-yl]oxy}-2- methylpropanamide::US11236047, Example 168 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 39.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535347&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282694 464920589 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135820 Cn1cc(cn1)C(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H26Cl2FN5O4/c1-37-14-18(12-36-37)26(39)17-10-23-25(24(33)11-17)30(19-2-4-20(31)5-3-19,42-16-29(8-9-29)28(34)41)38(27(23)40)15-22-7-6-21(32)13-35-22/h2-7,10-14,26,39H,8-9,15-16H2,1H3,(H2,34,41)/t26?,30-/m1/s1 PHAFDTKHQROBDP-NPRFROTHSA-N 535348 US11236047, Example 175::US11236047, Example 176 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535348&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282380 464920590 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135821 Cn1cc(cn1)C(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H26Cl2FN5O4/c1-37-14-18(12-36-37)26(39)17-10-23-25(24(33)11-17)30(19-2-4-20(31)5-3-19,42-16-29(8-9-29)28(34)41)38(27(23)40)15-22-7-6-21(32)13-35-22/h2-7,10-14,26,39H,8-9,15-16H2,1H3,(H2,34,41)/t26?,30-/m1/s1 PHAFDTKHQROBDP-NPRFROTHSA-N 535348 US11236047, Example 175::US11236047, Example 176 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.000 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535348&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282380 464920590 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135822 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(C)[C@@H](C)C1)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2N4O3/c1-20-17-35(14-13-34(20)3)19-29(2,38)22-7-12-27-26(15-22)28(37)36(18-25-11-10-24(32)16-33-25)30(27,39-4)21-5-8-23(31)9-6-21/h5-12,15-16,20,38H,13-14,17-19H2,1-4H3/t20-,29?,30+/m0/s1 XDGXLCFSFAEFAF-BUVZGADESA-N 535350 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{1-[(3S)- 3,4-dimethylpiperazin-1-yl]-2- hydroxypropan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 271 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 14.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535350&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282731 464920591 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135823 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(C)C[C@@H]1C)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2N4O3/c1-20-17-34(3)13-14-35(20)19-29(2,38)22-7-12-27-26(15-22)28(37)36(18-25-11-10-24(32)16-33-25)30(27,39-4)21-5-8-23(31)9-6-21/h5-12,15-16,20,38H,13-14,17-19H2,1-4H3/t20-,29?,30+/m0/s1 OAXQKVNYPRRULT-BUVZGADESA-N 535351 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{1-[(2S)- 2,4-dimethylpiperazin-1-yl]-2- hydroxypropan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 274 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535351&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282887 464920592 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135824 CC(O)(c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C33H28ClFN4O4/c1-31(42,28-4-2-3-13-37-28)23-14-26-29(27(35)15-23)33(22-6-8-24(34)9-7-22,43-20-32(19-40)11-12-32)39(30(26)41)18-25-10-5-21(16-36)17-38-25/h2-10,13-15,17,40,42H,11-12,18-20H2,1H3/t31?,33-/m1/s1 GBXYQVTUXFUTDE-NFCCVXSLSA-N 535352 US11236047, Example 309 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535352&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282651 464920593 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135825 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)CN1CCN(C)[C@H](C)C1)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2N4O3/c1-20-17-35(14-13-34(20)3)19-29(2,38)22-7-12-27-26(15-22)28(37)36(18-25-11-10-24(32)16-33-25)30(27,39-4)21-5-8-23(31)9-6-21/h5-12,15-16,20,38H,13-14,17-19H2,1-4H3/t20-,29?,30-/m1/s1 XDGXLCFSFAEFAF-DVVOHRMSSA-N 535353 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-6-{1-[(3R)- 3,4-dimethylpiperazin-1-yl]-2- hydroxypropan-2-yl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 272 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535353&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282222 464920594 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135826 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H28Cl2FN5O4/c1-29(42,20-13-37-38(2)15-20)19-11-24-26(25(34)12-19)31(18-3-5-21(32)6-4-18,43-17-30(9-10-30)28(35)41)39(27(24)40)16-23-8-7-22(33)14-36-23/h3-8,11-15,42H,9-10,16-17H2,1-2H3,(H2,35,41)/t29?,31-/m1/s1 XMACNOJSFYZIIC-ZGVDRVBQSA-N 535354 US11236047, Example 178 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.790 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535354&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282386 464920595 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135827 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cn1)[C@@]2(OC)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2N3O4/c1-24(33,23(32)28-2)16-6-11-21-20(12-16)22(31)30(14-19-10-9-18(27)13-29-19)25(21,34-3)15-4-7-17(26)8-5-15/h4-13,33H,14H2,1-3H3,(H,28,32)/t24?,25-/m1/s1 WHDQNEDIIFHEHU-WUBHUQEYSA-N 535355 US11236047, Example 145::US11236047, Example 146 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 210 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535355&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282706 464920596 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135828 CO[C@]1(N(Cc2ccc(cn2)C#N)C(=O)c2cc(cc(F)c12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C25H21ClFN3O3/c1-24(2,32)17-10-20-22(21(27)11-17)25(33-3,16-5-7-18(26)8-6-16)30(23(20)31)14-19-9-4-15(12-28)13-29-19/h4-11,13,32H,14H2,1-3H3/t25-/m1/s1 ZMIMOAHXTNUTOH-RUZDIDTESA-N 535356 6-{[(1R)-1-(4-Chlorophenyl)-7-fluoro- 5-(2-hydroxypropan-2-yl)-1-methoxy- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile.::US11236047, Example 173 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 25.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535356&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283060 464920597 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135829 CNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cn1)[C@@]2(OC)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2N3O4/c1-24(33,23(32)28-2)16-6-11-21-20(12-16)22(31)30(14-19-10-9-18(27)13-29-19)25(21,34-3)15-4-7-17(26)8-5-15/h4-13,33H,14H2,1-3H3,(H,28,32)/t24?,25-/m1/s1 WHDQNEDIIFHEHU-WUBHUQEYSA-N 535355 US11236047, Example 145::US11236047, Example 146 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 81.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535355&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282706 464920596 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135830 CCNC(=O)C(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cn1)[C@@]2(OC)c1ccc(Cl)cc1 InChI=1S/C26H25Cl2N3O4/c1-4-29-24(33)25(2,34)17-7-12-22-21(13-17)23(32)31(15-20-11-10-19(28)14-30-20)26(22,35-3)16-5-8-18(27)9-6-16/h5-14,34H,4,15H2,1-3H3,(H,29,33)/t25?,26-/m1/s1 KYLDDLUOIYASLH-FXDYGKIASA-N 535358 US11236047, Example 148 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 35.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535358&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282453 464920598 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135831 CC(O)C1(CO[C@]2(N(Cc3ccc(cn3)C#N)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H29ClFN3O4/c1-18(36)29(10-11-29)17-39-30(20-5-7-22(31)8-6-20)26-24(12-21(13-25(26)32)28(2,3)38)27(37)35(30)16-23-9-4-19(14-33)15-34-23/h4-9,12-13,15,18,36,38H,10-11,16-17H2,1-3H3/t18?,30-/m1/s1 DUDAOHFBLXUQBQ-ZGPRTBGDSA-N 535359 US11236047, Example 153::US11236047, Example 154 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 15.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535359&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282549 464920599 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135832 CC(O)C1(CO[C@]2(N(Cc3ccc(cn3)C#N)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H29ClFN3O4/c1-18(36)29(10-11-29)17-39-30(20-5-7-22(31)8-6-20)26-24(12-21(13-25(26)32)28(2,3)38)27(37)35(30)16-23-9-4-19(14-33)15-34-23/h4-9,12-13,15,18,36,38H,10-11,16-17H2,1-3H3/t18?,30-/m1/s1 DUDAOHFBLXUQBQ-ZGPRTBGDSA-N 535359 US11236047, Example 153::US11236047, Example 154 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 14.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535359&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282549 464920599 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135833 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36ClFN4O4/c1-32(43,23-9-13-39(2)14-10-23)25-15-28-30(29(36)16-25)34(24-4-6-26(35)7-5-24,44-21-33(20-41)11-12-33)40(31(28)42)19-27-8-3-22(17-37)18-38-27/h3-8,15-16,18,23,41,43H,9-14,19-21H2,1-2H3/t32?,34-/m1/s1 FDQSEIVSQMEFMB-SZFCLFMZSA-N 535361 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methylpiperidin-4- yl)ethyl]-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile Ex. 287 is the faster eluting isomer::US11236047, Example 287::US11236047, Example 288 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535361&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282603 464920600 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135834 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)NC(C)C)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2N3O4/c1-16(2)31-25(34)26(3,35)18-7-12-23-22(13-18)24(33)32(15-21-11-10-20(29)14-30-21)27(23,36-4)17-5-8-19(28)9-6-17/h5-14,16,35H,15H2,1-4H3,(H,31,34)/t26?,27-/m1/s1 SQIISUGGYDTKSQ-SSYAZFEXSA-N 535362 US11236047, Example 152 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 300 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535362&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282152 464920601 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135835 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-29(41,21-13-36-37(2)15-21)20-11-25-27(26(34)12-20)31(19-3-5-22(32)6-4-19,42-18-30(17-39)9-10-30)38(28(25)40)16-24-8-7-23(33)14-35-24/h3-8,11-15,39,41H,9-10,16-18H2,1-2H3/t29?,31-/m1/s1 PTBQGDBOHCKVRI-ZGVDRVBQSA-N 535363 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 345::US11236047, Example 352 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535363&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282087 464920602 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135836 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36ClFN4O4/c1-32(43,23-9-13-39(2)14-10-23)25-15-28-30(29(36)16-25)34(24-4-6-26(35)7-5-24,44-21-33(20-41)11-12-33)40(31(28)42)19-27-8-3-22(17-37)18-38-27/h3-8,15-16,18,23,41,43H,9-14,19-21H2,1-2H3/t32?,34-/m1/s1 FDQSEIVSQMEFMB-SZFCLFMZSA-N 535361 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methylpiperidin-4- yl)ethyl]-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile Ex. 287 is the faster eluting isomer::US11236047, Example 287::US11236047, Example 288 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 46.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535361&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282603 464920600 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135837 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H32ClFN4O5/c1-31(42,21-8-12-43-13-9-21)23-14-26-28(27(35)15-23)33(22-3-5-24(34)6-4-22,44-19-32(10-11-32)30(37)41)39(29(26)40)18-25-7-2-20(16-36)17-38-25/h2-7,14-15,17,21,42H,8-13,18-19H2,1H3,(H2,37,41)/t31?,33-/m1/s1 JEXOJDCVYWEBKG-NFCCVXSLSA-N 535365 1-({[(1R)-1-(4-chlorophenyl)-2-[(5- cyanopyridin-2-yl)methyl]-7-fluoro-5- [1-hydroxy-1-(oxan-4-yl)ethyl]-3-oxo- 2,3-dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 280 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535365&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282624 464920603 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135838 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)C(OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCN(C)CC1 InChI=1S/C33H34Cl2F2N2O5/c1-4-32(43,31(37)13-15-38(2)16-14-31)22-17-25-29(26(36)18-22)33(44-3,21-7-11-24(35)12-8-21)39(30(25)42)27(19-28(40)41)20-5-9-23(34)10-6-20/h5-12,17-18,27,43H,4,13-16,19H2,1-3H3,(H,40,41)/t27-,32?,33?/m0/s1 UASWWYBCWGDNKX-BECFNDGMSA-N 535366 (3S)-3-(4-chlorophenyl)-3-[(1R)-1- (4-chlorophenyl)-7-fluoro-5-[1-(4- fluoro-1-methylpiperidin-4-yl)-1- hydroxypropyl]-1-methoxy-3-oxo- 2,3-dihydro-1H-isoindol-2- yl]propanoic acid::US11236047, Example 131 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 92.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535366&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281559 464920604 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135839 CC[C@](O)(C1CCN(C)CC1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)C(O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H37ClFN3O4/c1-3-34(43,24-12-14-39(2)15-13-24)26-16-30-32(31(37)17-26)35(44-29-18-28(41)19-29,25-8-10-27(36)11-9-25)40(33(30)42)21-23-6-4-22(20-38)5-7-23/h4-11,16-17,24,28-29,41,43H,3,12-15,18-19,21H2,1-2H3/t28-,29+,34-,35?/m0/s1 RVEVEKZOUQPWSR-JOEBACTPSA-N 427189 US10544132, Example 130::US11236047, Example 130 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.70 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427189&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411586 434321502 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135840 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2FN4O5/c1-29(41,18-6-10-42-11-7-18)20-12-23-26(24(34)13-20)31(19-2-4-21(32)5-3-19,43-17-30(8-9-30)28(35)40)38(27(23)39)16-25-36-14-22(33)15-37-25/h2-5,12-15,18,41H,6-11,16-17H2,1H3,(H2,35,40)/t29?,31-/m1/s1 CHZQZTPQTRTMGE-ZGVDRVBQSA-N 535368 US11236047, Example 284 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535368&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282373 464920606 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135841 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H35Cl2FN4O4/c1-31(43,20-9-13-39(2)14-10-20)22-15-26-28(27(36)16-22)33(21-3-5-23(34)6-4-21,44-19-32(11-12-32)30(37)42)40(29(26)41)18-25-8-7-24(35)17-38-25/h3-8,15-17,20,43H,9-14,18-19H2,1-2H3,(H2,37,42)/t31?,33-/m1/s1 KMIRBOKBTSMCMR-NFCCVXSLSA-N 535369 1-({[(1R)-1-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-7-fluoro-5- [1-hydroxy-1-(1-methylpiperidin-4- yl)ethyl]-3-oxo-2,3-dihydro-1H- isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide Ex. 305 is the slower eluting isomer::US11236047, Example 305 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535369&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282857 464920607 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135842 CC(O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-31(41,22-8-12-42-13-9-22)24-14-27-29(28(35)15-24)33(23-3-5-25(34)6-4-23,43-20-32(19-37)10-11-32)39(30(27)40)18-26-7-2-21(16-36)17-38-26/h2-7,14-15,17,22,41H,8-13,18,20H2,1H3/t31?,33-/m1/s1 JPIAYQWVJXBMJC-NFCCVXSLSA-N 535370 US11236047, Example 282 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535370&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282567 464920608 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135843 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2FN3O3/c1-28(37,18-10-12-34(2)13-11-18)20-14-24-26(25(32)15-20)29(38-3,19-4-6-21(30)7-5-19)35(27(24)36)17-23-9-8-22(31)16-33-23/h4-9,14-16,18,37H,10-13,17H2,1-3H3/t28?,29-/m1/s1 YBXWZLZVYYJBMD-YPJJGMIRSA-N 535371 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methylpiperidin-4- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 304 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535371&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282417 464920609 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135844 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cn(C)c(C)n1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2FN4O3/c1-16-33-24(15-34(16)3)27(2,37)18-11-22-25(23(31)12-18)28(38-4,17-5-7-19(29)8-6-17)35(26(22)36)14-21-10-9-20(30)13-32-21/h5-13,15,37H,14H2,1-4H3/t27?,28-/m1/s1 LGLFXSZJTQXTAU-PLYLYKGUSA-N 535372 US11236047, Example 161::US11236047, Example 162 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535372&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283115 464920610 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135845 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cn(C)c(C)n1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2FN4O3/c1-16-33-24(15-34(16)3)27(2,37)18-11-22-25(23(31)12-18)28(38-4,17-5-7-19(29)8-6-17)35(26(22)36)14-21-10-9-20(30)13-32-21/h5-13,15,37H,14H2,1-4H3/t27?,28-/m1/s1 LGLFXSZJTQXTAU-PLYLYKGUSA-N 535372 US11236047, Example 161::US11236047, Example 162 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535372&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283115 464920610 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135846 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CN(C)C1)c1ccc(Cl)cc1 InChI=1S/C27H26Cl2FN3O3/c1-26(35,18-13-32(2)14-18)17-10-22-24(23(30)11-17)27(36-3,16-4-6-19(28)7-5-16)33(25(22)34)15-21-9-8-20(29)12-31-21/h4-12,18,35H,13-15H2,1-3H3/t26?,27-/m1/s1 YKMGWHSTFXEMCZ-SSYAZFEXSA-N 535374 US11236047, Example 308 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 44.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535374&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282602 464920611 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135847 CC[C@](O)(C1CCN(CCC(=O)OC)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H37Cl2FN2O5/c1-4-33(42,23-13-16-38(17-14-23)18-15-30(40)43-2)25-19-28-31(29(37)20-25)34(44-3,24-7-11-27(36)12-8-24)39(32(28)41)21-22-5-9-26(35)10-6-22/h5-12,19-20,23,42H,4,13-18,21H2,1-3H3/t33-,34+/m0/s1 ATEBGPCVCPBSLM-SZAHLOSFSA-N 427195 US10544132, Example 136::US10981898, Example 137::US11236047, Example 136 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 37.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427195&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281761 434321508 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135848 CC[C@](O)(C1CCN(CCC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H35Cl2FN2O5/c1-3-32(42,22-12-15-37(16-13-22)17-14-29(39)40)24-18-27-30(28(36)19-24)33(43-2,23-6-10-26(35)11-7-23)38(31(27)41)20-21-4-8-25(34)9-5-21/h4-11,18-19,22,42H,3,12-17,20H2,1-2H3,(H,39,40)/t32-,33+/m0/s1 ZKUGFHUACFYRES-JHOUSYSJSA-N 535265 3-{4-[(1S)-1-[(1R)-1-(4- chlorophenyl)-2-[(4- chlorophenyl)methyl]-7-fluoro-1- methoxy-3-oxo-2,3-dihydro-1H- isoindol-5-yl]-1- hydroxypropyl]piperidin-1- yl}propanoic acid::US11236047, Example 137 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535265&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281444 464920524 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135849 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-28(39,20-13-35-36(2)15-20)19-11-24-26(25(33)12-19)30(41-17-29(40)9-10-29,18-3-5-21(31)6-4-18)37(27(24)38)16-23-8-7-22(32)14-34-23/h3-8,11-15,39-40H,9-10,16-17H2,1-2H3/t28?,30-/m1/s1 PFXVXXVCBJFYSR-FUJFQHJFSA-N 535375 US11236047, Example 200 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.710 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535375&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282831 464920612 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135850 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1ccn(C)n1)c1ccc(Cl)cc1 InChI=1S/C27H23Cl2FN4O3/c1-26(36,23-10-11-33(2)32-23)17-12-21-24(22(30)13-17)27(37-3,16-4-6-18(28)7-5-16)34(25(21)35)15-20-9-8-19(29)14-31-20/h4-14,36H,15H2,1-3H3/t26?,27-/m1/s1 YOBNVSIBCUFROP-SSYAZFEXSA-N 535376 US11236047, Example 189::US11236047, Example 190 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535376&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283096 464920613 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135851 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1ccn(C)n1)c1ccc(Cl)cc1 InChI=1S/C27H23Cl2FN4O3/c1-26(36,23-10-11-33(2)32-23)17-12-21-24(22(30)13-17)27(37-3,16-4-6-18(28)7-5-16)34(25(21)35)15-20-9-8-19(29)14-31-20/h4-14,36H,15H2,1-3H3/t26?,27-/m1/s1 YOBNVSIBCUFROP-SSYAZFEXSA-N 535376 US11236047, Example 189::US11236047, Example 190 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 37.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535376&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283096 464920613 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135852 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-29(40,19-13-35-36(2)15-19)18-9-25-27(26(33)10-18)30(41-24-11-23(38)12-24,17-3-5-20(31)6-4-17)37(28(25)39)16-22-8-7-21(32)14-34-22/h3-10,13-15,23-24,38,40H,11-12,16H2,1-2H3/t23-,24+,29?,30-/m1/s1 FGIFVIRKAVOOKP-YUNFXOIVSA-N 535378 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[cis-3-hydroxycyclobutoxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 205::US11236047, Example 208 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535378&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283059 464920614 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135853 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-29(40,19-13-35-36(2)15-19)18-9-25-27(26(33)10-18)30(41-24-11-23(38)12-24,17-3-5-20(31)6-4-17)37(28(25)39)16-22-8-7-21(32)14-34-22/h3-10,13-15,23-24,38,40H,11-12,16H2,1-2H3/t23-,24-,29?,30-/m1/s1 FGIFVIRKAVOOKP-UBUFSOAJSA-N 535379 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[trans-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 206 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535379&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283059 464920615 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135854 COc1nc(C)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OC)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C26H26ClFN2O4/c1-15-6-7-16(23(29-15)33-4)14-30-24(31)20-12-18(25(2,3)32)13-21(28)22(20)26(30,34-5)17-8-10-19(27)11-9-17/h6-13,32H,14H2,1-5H3/t26-/m1/s1 MTDAGGJDNAEGRS-AREMUKBSSA-N 535380 (3R)-3-(4-chlorophenyl)-4-fluoro-6-(2- hydroxypropan-2-yl)-3-methoxy-2-[(2- methoxy-6-methylpyridin-3-yl)methyl]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 315 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 460 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535380&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282458 464920616 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135855 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1ncc[nH]1)c1ccc(Cl)cc1 535381 US11236047, Example 163::US11236047, Example 164 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 42.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535381&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282410 464920617 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135856 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1ncc[nH]1)c1ccc(Cl)cc1 535381 US11236047, Example 163::US11236047, Example 164 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 34.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535381&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282410 464920617 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135857 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1nccs1)c1ccc(Cl)cc1 InChI=1S/C26H20Cl2FN3O3S/c1-25(34,24-30-9-10-36-24)16-11-20-22(21(29)12-16)26(35-2,15-3-5-17(27)6-4-15)32(23(20)33)14-19-8-7-18(28)13-31-19/h3-13,34H,14H2,1-2H3/t25?,26-/m1/s1 WJXYQJKFZGKOIF-FXDYGKIASA-N 535383 US11236047, Example 165 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535383&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282667 464920618 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135858 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-29(40,19-13-35-36(2)15-19)18-9-25-27(26(33)10-18)30(41-24-11-23(38)12-24,17-3-5-20(31)6-4-17)37(28(25)39)16-22-8-7-21(32)14-34-22/h3-10,13-15,23-24,38,40H,11-12,16H2,1-2H3/t23-,24+,29?,30-/m1/s1 FGIFVIRKAVOOKP-YUNFXOIVSA-N 535378 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[cis-3-hydroxycyclobutoxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 205::US11236047, Example 208 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 27.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535378&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283059 464920614 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135859 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)C(=O)CN(C)C)c1ccc(Cl)cc1 InChI=1S/C32H35Cl2FN4O4/c1-31(42,20-11-13-38(14-12-20)28(40)19-37(2)3)22-15-26-29(27(35)16-22)32(43-4,21-5-7-23(33)8-6-21)39(30(26)41)18-25-10-9-24(34)17-36-25/h5-10,15-17,20,42H,11-14,18-19H2,1-4H3/t31?,32-/m1/s1 JSDUYCYXQIMWBH-IADGFXSZSA-N 535385 US11236047, Example 298::US11236047, Example 299 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.660 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535385&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282927 464920619 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135860 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)C(=O)CN(C)C)c1ccc(Cl)cc1 InChI=1S/C32H35Cl2FN4O4/c1-31(42,20-11-13-38(14-12-20)28(40)19-37(2)3)22-15-26-29(27(35)16-22)32(43-4,21-5-7-23(33)8-6-21)39(30(26)41)18-25-10-9-24(34)17-36-25/h5-10,15-17,20,42H,11-14,18-19H2,1-4H3/t31?,32-/m1/s1 JSDUYCYXQIMWBH-IADGFXSZSA-N 535385 US11236047, Example 298::US11236047, Example 299 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535385&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282927 464920619 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135861 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(CCN(C)C)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FN5O3/c1-29(40,21-15-35-37(17-21)12-11-36(2)3)20-13-25-27(26(33)14-20)30(41-4,19-5-7-22(31)8-6-19)38(28(25)39)18-24-10-9-23(32)16-34-24/h5-10,13-17,40H,11-12,18H2,1-4H3/t29?,30-/m1/s1 LGDXNVXHJCEZCK-BDCODIICSA-N 535387 US11236047, Example 191::US11236047, Example 192 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 48.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535387&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497966 464920620 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135862 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(CCN(C)C)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FN5O3/c1-29(40,21-15-35-37(17-21)12-11-36(2)3)20-13-25-27(26(33)14-20)30(41-4,19-5-7-22(31)8-6-19)38(28(25)39)18-24-10-9-23(32)16-34-24/h5-10,13-17,40H,11-12,18H2,1-4H3/t29?,30-/m1/s1 LGDXNVXHJCEZCK-BDCODIICSA-N 535387 US11236047, Example 191::US11236047, Example 192 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535387&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497966 464920620 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135863 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)c1ncccn1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN5O3/c1-31(42,20-10-14-39(15-11-20)30-36-12-3-13-37-30)22-16-26-28(27(35)17-22)32(43-2,21-4-6-23(33)7-5-21)40(29(26)41)19-25-9-8-24(34)18-38-25/h3-9,12-13,16-18,20,42H,10-11,14-15,19H2,1-2H3/t31?,32-/m1/s1 LMBZJFUAYACSDA-IADGFXSZSA-N 535389 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- {1-hydroxy-1-[1-(pyrimidin-2- yl)piperidin-4-yl]ethyl}-3-methoxy-2,3- dihydro-1H-isoindol-1-one Ex. 286 is the slower eluting isomer::US11236047, Example 286 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535389&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282487 464920621 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135864 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)C(C)=N)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2FN4O3/c1-18(34)36-12-10-19(11-13-36)29(2,39)21-14-25-27(26(33)15-21)30(40-3,20-4-6-22(31)7-5-20)37(28(25)38)17-24-9-8-23(32)16-35-24/h4-9,14-16,19,34,39H,10-13,17H2,1-3H3/t29?,30-/m1/s1 VGACYBQLPGODGA-BDCODIICSA-N 535390 (3R)-6-[1-(1-acetylpiperidin-4-yl)-1- hydroxyethyl]-3-(4-chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-4-fluoro- 3-methoxy-2,3-dihydro-1H-isoindol-1- one Ex. 293 is the slower eluting isomer::US11236047, Example 293 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535390&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407646 464920622 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135865 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(F)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H28ClF2N5O4/c1-29(42,20-13-37-38(2)15-20)19-11-24-26(25(34)12-19)31(18-3-5-21(32)6-4-18,43-17-30(9-10-30)28(35)41)39(27(24)40)16-23-8-7-22(33)14-36-23/h3-8,11-15,42H,9-10,16-17H2,1-2H3,(H2,35,41)/t29?,31-/m1/s1 KNNAAOMNPYTAMJ-ZGVDRVBQSA-N 535391 1-({[(1R)-1-(4-chlorophenyl)-7-fluoro- 2-[(5-fluoropyridin-2-yl)methyl]-5-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-oxo-2,3-dihydro-1H- isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 209 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535391&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282347 464920623 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135866 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cn(C)nn1)c1ccc(Cl)cc1 InChI=1S/C26H22Cl2FN5O3/c1-25(36,22-14-33(2)32-31-22)16-10-20-23(21(29)11-16)26(37-3,15-4-6-17(27)7-5-15)34(24(20)35)13-19-9-8-18(28)12-30-19/h4-12,14,36H,13H2,1-3H3/t25?,26-/m1/s1 SVSYHJNAJSDECL-FXDYGKIASA-N 535392 US11236047, Example 187 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535392&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282110 464920624 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135867 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)S(C)(=O)=O)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2FN3O5S/c1-28(37,18-10-12-34(13-11-18)41(3,38)39)20-14-24-26(25(32)15-20)29(40-2,19-4-6-21(30)7-5-19)35(27(24)36)17-23-9-8-22(31)16-33-23/h4-9,14-16,18,37H,10-13,17H2,1-3H3/t28?,29-/m1/s1 OCUUERPPLFZCFN-YPJJGMIRSA-N 535393 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1- methanesulfonylpiperidin-4-yl)ethyl]- 3-methoxy-2,3-dihydro-1H-isoindol-1- one::US11236047, Example 294 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.930 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535393&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282530 464920625 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135868 Cc1nc(cn1C)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN5O4/c1-18-38-26(16-39(18)3)30(2,43)20-12-24-27(25(35)13-20)32(19-4-6-21(33)7-5-19,44-17-31(10-11-31)29(36)42)40(28(24)41)15-23-9-8-22(34)14-37-23/h4-9,12-14,16,43H,10-11,15,17H2,1-3H3,(H2,36,42)/t30?,32-/m1/s1 RINWORWTFDLZQT-BDJZEIKTSA-N 535394 US11236047, Example 197::US11236047, Example 198 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.620 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535394&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282960 464920626 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135869 Cc1nc(cn1C)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN5O4/c1-18-38-26(16-39(18)3)30(2,43)20-12-24-27(25(35)13-20)32(19-4-6-21(33)7-5-19,44-17-31(10-11-31)29(36)42)40(28(24)41)15-23-9-8-22(34)14-37-23/h4-9,12-14,16,43H,10-11,15,17H2,1-3H3,(H2,36,42)/t30?,32-/m1/s1 RINWORWTFDLZQT-BDJZEIKTSA-N 535394 US11236047, Example 197::US11236047, Example 198 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535394&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282960 464920626 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135870 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H26ClFN6O3/c1-30(42,23-15-38-39(2)16-23)22-11-26-28(27(34)12-22)32(21-4-6-24(33)7-5-21,43-19-31(18-36)9-10-31)40(29(26)41)17-25-8-3-20(13-35)14-37-25/h3-8,11-12,14-16,42H,9-10,17,19H2,1-2H3/t30?,32-/m1/s1 RKSMIALTWWALNY-BDJZEIKTSA-N 535396 6-{[(1R)-1-(4-chlorophenyl)-1-[(1- cyanocyclopropyl)methoxy]-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-3-oxo-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 211 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.000 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535396&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283189 464920627 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135871 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H26Cl2FN5O3/c1-29(41,21-13-37-38(2)15-21)20-11-25-27(26(34)12-20)31(19-3-5-22(32)6-4-19,42-18-30(17-35)9-10-30)39(28(25)40)16-24-8-7-23(33)14-36-24/h3-8,11-15,41H,9-10,16,18H2,1-2H3/t29?,31-/m1/s1 VDKMMDFDHKJNRA-ZGVDRVBQSA-N 535397 US11236047, Example 201 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535397&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282589 464920628 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135872 CC(O)(c1cscn1)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25Cl2FN4O4S/c1-28(40,24-14-42-16-36-24)18-10-22-25(23(33)11-18)30(17-2-4-19(31)5-3-17,41-15-29(8-9-29)27(34)39)37(26(22)38)13-21-7-6-20(32)12-35-21/h2-7,10-12,14,16,40H,8-9,13,15H2,1H3,(H2,34,39)/t28?,30-/m1/s1 AOSVVLGOJNFRNH-FUJFQHJFSA-N 535398 US11236047, Example 193::US11236047, Example 194 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535398&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282546 464920629 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135873 CC(O)(c1cscn1)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25Cl2FN4O4S/c1-28(40,24-14-42-16-36-24)18-10-22-25(23(33)11-18)30(17-2-4-19(31)5-3-17,41-15-29(8-9-29)27(34)39)37(26(22)38)13-21-7-6-20(32)12-35-21/h2-7,10-12,14,16,40H,8-9,13,15H2,1H3,(H2,34,39)/t28?,30-/m1/s1 AOSVVLGOJNFRNH-FUJFQHJFSA-N 535398 US11236047, Example 193::US11236047, Example 194 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.770 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535398&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282546 464920629 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135874 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(COCC(O)=O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN2O6/c1-28(2,39)19-11-23-26(24(33)12-19)30(18-3-5-20(31)6-4-18,41-17-29(9-10-29)16-40-15-25(36)37)35(27(23)38)14-22-8-7-21(32)13-34-22/h3-8,11-13,39H,9-10,14-17H2,1-2H3,(H,36,37)/t30-/m1/s1 GOUTYWNJSCUIGZ-SSEXGKCCSA-N 535400 2-{[1-({[(1R)-1-(4-Chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-7-fluoro-5- (2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropyl]methoxy} acetic acid::US11236047, Example 144 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535400&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282264 464920630 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135875 CCn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN5O4/c1-3-39-16-21(14-38-39)30(2,43)20-12-25-27(26(35)13-20)32(19-4-6-22(33)7-5-19,44-18-31(10-11-31)29(36)42)40(28(25)41)17-24-9-8-23(34)15-37-24/h4-9,12-16,43H,3,10-11,17-18H2,1-2H3,(H2,36,42)/t30?,32-/m1/s1 DCAVGHLCTQJYEH-BDJZEIKTSA-N 535401 US11236047, Example 180 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.950 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535401&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282574 464920631 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135876 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)C(=O)c1ncco1)c1ccc(Cl)cc1 InChI=1S/C32H29Cl2FN4O5/c1-31(42,19-9-12-38(13-10-19)30(41)28-36-11-14-44-28)21-15-25-27(26(35)16-21)32(43-2,20-3-5-22(33)6-4-20)39(29(25)40)18-24-8-7-23(34)17-37-24/h3-8,11,14-17,19,42H,9-10,12-13,18H2,1-2H3/t31?,32-/m1/s1 RQDLJZPOABRDMA-IADGFXSZSA-N 535402 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- {1-hydroxy-1-[1-(1,3-oxazole-2- carbonyl)piperidin-4-yl]ethyl}-3- methoxy-2,3-dihydro-1H-isoindol-1- one Ex. 295 is the slower eluting isomer::US11236047, Example 295 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.930 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535402&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282892 464920632 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135877 CN(C)CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2FN3O4/c1-28(37,17-34(2)3)19-12-24-26(25(32)13-19)29(39-23-10-11-38-16-23,18-4-6-20(30)7-5-18)35(27(24)36)15-22-9-8-21(31)14-33-22/h4-9,12-14,23,37H,10-11,15-17H2,1-3H3/t23-,28?,29+/m0/s1 DEHGDPBWKNEFGA-SJAHEGMPSA-N 535403 US11236047, Example 138 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535403&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282489 464920633 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135878 CC(=O)NCC1(CO[C@]2(N(Cc3ccc(Cl)cn3)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H30Cl2FN3O4/c1-18(37)35-16-29(10-11-29)17-40-30(19-4-6-21(31)7-5-19)26-24(12-20(13-25(26)33)28(2,3)39)27(38)36(30)15-23-9-8-22(32)14-34-23/h4-9,12-14,39H,10-11,15-17H2,1-3H3,(H,35,37)/t30-/m1/s1 OSEHZDAAYCTXDQ-SSEXGKCCSA-N 535404 N-{[1-({[(1R)-1-(4-Chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-7-fluoro- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropyl]methyl} acetamide::US11236047, Example 156 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535404&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282082 464920634 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135879 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2FN4O4/c1-27(38,19-13-33-34(2)15-19)18-11-23-25(24(31)12-18)28(39-10-9-36,17-3-5-20(29)6-4-17)35(26(23)37)16-22-8-7-21(30)14-32-22/h3-8,11-15,36,38H,9-10,16H2,1-2H3/t27?,28-/m1/s1 JICFZAOJKDDMCA-PLYLYKGUSA-N 535405 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-(2-hydroxyethoxy)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 213 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535405&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282855 464920635 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135880 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2FN5O4/c1-27(39,19-11-35-36(2)14-19)18-9-22-25(23(32)10-18)29(41-16-28(40)7-8-28,17-3-5-20(30)6-4-17)37(26(22)38)15-24-33-12-21(31)13-34-24/h3-6,9-14,39-40H,7-8,15-16H2,1-2H3/t27?,29-/m1/s1 MYMTUGSPJYJBAG-ZBAATNBSSA-N 535406 US11236047, Example 203::US11236047, Example 204 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535406&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497991 464920636 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135881 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2FN5O4/c1-27(39,19-11-35-36(2)14-19)18-9-22-25(23(32)10-18)29(41-16-28(40)7-8-28,17-3-5-20(30)6-4-17)37(26(22)38)15-24-33-12-21(31)13-34-24/h3-6,9-14,39-40H,7-8,15-16H2,1-2H3/t27?,29-/m1/s1 MYMTUGSPJYJBAG-ZBAATNBSSA-N 535406 US11236047, Example 203::US11236047, Example 204 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535406&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497991 464920636 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135882 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN6O4/c1-28(42,19-11-37-38(2)14-19)18-9-22-25(23(33)10-18)30(17-3-5-20(31)6-4-17,43-16-29(7-8-29)27(34)41)39(26(22)40)15-24-35-12-21(32)13-36-24/h3-6,9-14,42H,7-8,15-16H2,1-2H3,(H2,34,41)/t28?,30-/m1/s1 YQQJPSAALPSLDT-FUJFQHJFSA-N 535408 1-({[(1R)-1-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-3-oxo-2,3-dihydro-1H- isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 214 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535408&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282191 464920637 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135883 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCS(=O)(=O)CC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2FN2O5S/c1-27(35,17-9-11-39(36,37)12-10-17)19-13-23-25(24(31)14-19)28(38-2,18-3-5-20(29)6-4-18)33(26(23)34)16-22-8-7-21(30)15-32-22/h3-8,13-15,17,35H,9-12,16H2,1-2H3/t27?,28-/m1/s1 ULHDHSTWWOIQJU-PLYLYKGUSA-N 535409 US11236047, Example 311 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535409&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498011 464920638 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135884 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(CC2)C(N)=O)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)cn1 InChI=1S/C32H31ClFN5O5/c1-30(42,22-15-37-38(2)17-22)21-12-24-27(25(34)13-21)32(20-5-7-23(33)8-6-20,44-18-31(10-11-31)29(35)41)39(28(24)40)16-19-4-9-26(43-3)36-14-19/h4-9,12-15,17,42H,10-11,16,18H2,1-3H3,(H2,35,41)/t30?,32-/m1/s1 QAJDMQMVZQWDGC-BDJZEIKTSA-N 535410 1-({[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-2-[(6-methoxypyridin-3- yl)methyl]-3-oxo-2,3-dihydro-1H- isoindol-1- yl]oxy}methyl)cyclopropane-1- carboxamide::US11236047, Example 216 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535410&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282578 464920639 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135885 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(c1)C1CN(C1)C(C)=O)c1ccc(Cl)cc1 InChI=1S/C31H28Cl2FN5O4/c1-18(40)37-16-25(17-37)39-14-21(12-36-39)30(2,42)20-10-26-28(27(34)11-20)31(43-3,19-4-6-22(32)7-5-19)38(29(26)41)15-24-9-8-23(33)13-35-24/h4-14,25,42H,15-17H2,1-3H3/t30?,31-/m1/s1 LHIMDIZJOXHQDM-NLIBRCFJSA-N 535411 US11236047, Example 182 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535411&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282528 464920640 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135886 CCOCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2FN2O5/c1-3-37-17-28(2,36)19-12-24-26(25(32)13-19)29(39-23-10-11-38-16-23,18-4-6-20(30)7-5-18)34(27(24)35)15-22-9-8-21(31)14-33-22/h4-9,12-14,23,36H,3,10-11,15-17H2,1-2H3/t23-,28?,29+/m0/s1 LWOJSHCDLMMOQI-SJAHEGMPSA-N 535412 US11236047, Example 140::US11236047, Example 141 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.700 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535412&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282474 464920641 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135887 CCOCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2FN2O5/c1-3-37-17-28(2,36)19-12-24-26(25(32)13-19)29(39-23-10-11-38-16-23,18-4-6-20(30)7-5-18)34(27(24)35)15-22-9-8-21(31)14-33-22/h4-9,12-14,23,36H,3,10-11,15-17H2,1-2H3/t23-,28?,29+/m0/s1 LWOJSHCDLMMOQI-SJAHEGMPSA-N 535412 US11236047, Example 140::US11236047, Example 141 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535412&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282474 464920641 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135888 COCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2FN2O5/c1-27(35,16-36-2)18-11-23-25(24(31)12-18)28(38-22-9-10-37-15-22,17-3-5-19(29)6-4-17)33(26(23)34)14-21-8-7-20(30)13-32-21/h3-8,11-13,22,35H,9-10,14-16H2,1-2H3/t22-,27?,28+/m0/s1 JTWNLIFKVVQASM-ITLXXOFFSA-N 535414 US11236047, Example 142::US11236047, Example 143 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.730 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535414&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407647 464920642 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135889 COCC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2FN2O5/c1-27(35,16-36-2)18-11-23-25(24(31)12-18)28(38-22-9-10-37-15-22,17-3-5-19(29)6-4-17)33(26(23)34)14-21-8-7-20(30)13-32-21/h3-8,11-13,22,35H,9-10,14-16H2,1-2H3/t22-,27?,28+/m0/s1 JTWNLIFKVVQASM-ITLXXOFFSA-N 535414 US11236047, Example 142::US11236047, Example 143 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535414&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407647 464920642 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135890 CC(O)(CN1CCCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31ClFN5O3/c1-31(42,20-39-12-2-3-13-39)24-14-27-29(28(35)15-24)33(23-5-7-25(34)8-6-23,43-21-32(19-37)10-11-32)40(30(27)41)18-26-9-4-22(16-36)17-38-26/h4-9,14-15,17,42H,2-3,10-13,18,20-21H2,1H3/t31?,33-/m1/s1 NAJXOWIJGLQLBB-NFCCVXSLSA-N 535416 US11236047, Example 276::US11236047, Example 277 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535416&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282580 464920643 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135891 CC(O)(CN1CCCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31ClFN5O3/c1-31(42,20-39-12-2-3-13-39)24-14-27-29(28(35)15-24)33(23-5-7-25(34)8-6-23,43-21-32(19-37)10-11-32)40(30(27)41)18-26-9-4-22(16-36)17-38-26/h4-9,14-15,17,42H,2-3,10-13,18,20-21H2,1H3/t31?,33-/m1/s1 NAJXOWIJGLQLBB-NFCCVXSLSA-N 535416 US11236047, Example 276::US11236047, Example 277 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535416&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282580 464920643 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135892 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(cn4)C#N)[C@](OCC4(CC4)C#N)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H34ClFN6O3/c1-32(44,21-41-13-11-40(2)12-14-41)25-15-28-30(29(36)16-25)34(24-4-6-26(35)7-5-24,45-22-33(20-38)9-10-33)42(31(28)43)19-27-8-3-23(17-37)18-39-27/h3-8,15-16,18,44H,9-14,19,21-22H2,1-2H3/t32?,34-/m1/s1 OFUBYOJVTHCLBN-SZFCLFMZSA-N 535418 US11236047, Example 278::US11236047, Example 279 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.970 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535418&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283159 464920644 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135893 CN1CCN(CC(C)(O)c2cc3C(=O)N(Cc4ccc(cn4)C#N)[C@](OCC4(CC4)C#N)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H34ClFN6O3/c1-32(44,21-41-13-11-40(2)12-14-41)25-15-28-30(29(36)16-25)34(24-4-6-26(35)7-5-24,45-22-33(20-38)9-10-33)42(31(28)43)19-27-8-3-23(17-37)18-39-27/h3-8,15-16,18,44H,9-14,19,21-22H2,1-2H3/t32?,34-/m1/s1 OFUBYOJVTHCLBN-SZFCLFMZSA-N 535418 US11236047, Example 278::US11236047, Example 279 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535418&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283159 464920644 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135894 Cn1cnc(c1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-28(39,25-15-36(2)17-35-25)19-11-23-26(24(33)12-19)30(41-16-29(40)9-10-29,18-3-5-20(31)6-4-18)37(27(23)38)14-22-8-7-21(32)13-34-22/h3-8,11-13,15,17,39-40H,9-10,14,16H2,1-2H3/t28?,30-/m1/s1 FMSSWQMNRMVPPP-FUJFQHJFSA-N 535420 US11236047, Example 195::US11236047, Example 196 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535420&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282939 464920645 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135895 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-30(40,22-15-36-37(2)16-22)21-11-26-28(27(33)12-21)31(42-25-9-10-41-18-25,20-4-6-23(32)7-5-20)38(29(26)39)17-24-8-3-19(13-34)14-35-24/h3-8,11-12,14-16,25,40H,9-10,17-18H2,1-2H3/t25-,30?,31+/m0/s1 IMGHGKVWJOGDFL-OERQIQHUSA-N 535421 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 218::US11236047, Example 344 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.860 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535421&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282568 464920646 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135896 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)cn1 InChI=1S/C32H32ClFN4O5/c1-30(41,23-15-36-37(2)17-23)22-12-25-28(26(34)13-22)32(21-5-7-24(33)8-6-21,43-19-31(18-39)10-11-31)38(29(25)40)16-20-4-9-27(42-3)35-14-20/h4-9,12-15,17,39,41H,10-11,16,18-19H2,1-3H3/t30?,32-/m1/s1 SRKAMEZCGUXPSS-BDJZEIKTSA-N 535422 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2-[(6-methoxypyridin-3-yl)methyl]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 219::US11236047, Example 220 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.950 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535422&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497980 464920647 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135897 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)cn1 InChI=1S/C32H32ClFN4O5/c1-30(41,23-15-36-37(2)17-23)22-12-25-28(26(34)13-22)32(21-5-7-24(33)8-6-21,43-19-31(18-39)10-11-31)38(29(25)40)16-20-4-9-27(42-3)35-14-20/h4-9,12-15,17,39,41H,10-11,16,18-19H2,1-3H3/t30?,32-/m1/s1 SRKAMEZCGUXPSS-BDJZEIKTSA-N 535422 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2-[(6-methoxypyridin-3-yl)methyl]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 219::US11236047, Example 220 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535422&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497980 464920647 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135898 Cn1cnc(c1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-28(39,25-15-36(2)17-35-25)19-11-23-26(24(33)12-19)30(41-16-29(40)9-10-29,18-3-5-20(31)6-4-18)37(27(23)38)14-22-8-7-21(32)13-34-22/h3-8,11-13,15,17,39-40H,9-10,14,16H2,1-2H3/t28?,30-/m1/s1 FMSSWQMNRMVPPP-FUJFQHJFSA-N 535420 US11236047, Example 195::US11236047, Example 196 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535420&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282939 464920645 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135899 C[C@@H](O)CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(C)c1)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2FN4O4/c1-17(37)16-40-29(18-4-6-21(30)7-5-18)26-24(27(38)36(29)15-23-9-8-22(31)13-33-23)10-19(11-25(26)32)28(2,39)20-12-34-35(3)14-20/h4-14,17,37,39H,15-16H2,1-3H3/t17-,28?,29-/m1/s1 MNQQXUGKGLDIBL-YQNXAQHZSA-N 535425 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(2R)-2-hydroxypropoxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 221::US11236047, Example 354 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 33.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535425&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282239 464920648 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135900 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O4/c1-29(39,20-13-35-36(2)15-20)19-11-25-27(26(33)12-19)30(41-24-9-10-40-17-24,18-3-5-21(31)6-4-18)37(28(25)38)16-23-8-7-22(32)14-34-23/h3-8,11-15,24,39H,9-10,16-17H2,1-2H3/t24-,29?,30+/m0/s1 YSIGKCLZFXUHTB-DHSZNAABSA-N 535426 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(3S)-oxolan-3-yloxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 223 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535426&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282418 464920649 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135901 Cc1nc(cn1C)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-18-36-26(16-37(18)3)29(2,40)20-12-24-27(25(34)13-20)31(42-17-30(41)10-11-30,19-4-6-21(32)7-5-19)38(28(24)39)15-23-9-8-22(33)14-35-23/h4-9,12-14,16,40-41H,10-11,15,17H2,1-3H3/t29?,31-/m1/s1 VZJXEPGTXSZTFT-ZGVDRVBQSA-N 535325 US11236047, Example 324::US11236047, Example 325 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535325&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283141 464920571 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135902 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)nc1 InChI=1S/C32H32ClFN4O5/c1-30(41,22-14-36-37(2)16-22)21-12-26-28(27(34)13-21)32(20-4-6-23(33)7-5-20,43-19-31(18-39)10-11-31)38(29(26)40)17-24-8-9-25(42-3)15-35-24/h4-9,12-16,39,41H,10-11,17-19H2,1-3H3/t30?,32-/m1/s1 FCXTWHDUAWMEGT-BDJZEIKTSA-N 535427 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2-[(5-methoxypyridin-2-yl)methyl]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 224::US11236047, Example 226 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.700 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535427&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498003 464920650 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135903 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)nc1 InChI=1S/C32H32ClFN4O5/c1-30(41,22-14-36-37(2)16-22)21-12-26-28(27(34)13-21)32(20-4-6-23(33)7-5-20,43-19-31(18-39)10-11-31)38(29(26)40)17-24-8-9-25(42-3)15-35-24/h4-9,12-16,39,41H,10-11,17-19H2,1-3H3/t30?,32-/m1/s1 FCXTWHDUAWMEGT-BDJZEIKTSA-N 535427 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2-[(5-methoxypyridin-2-yl)methyl]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 224::US11236047, Example 226 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535427&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498003 464920650 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135904 Cc1nc(cn1C)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-18-36-26(16-37(18)3)29(2,40)20-12-24-27(25(34)13-20)31(42-17-30(41)10-11-30,19-4-6-21(32)7-5-19)38(28(24)39)15-23-9-8-22(33)14-35-23/h4-9,12-14,16,40-41H,10-11,15,17H2,1-3H3/t29?,31-/m1/s1 VZJXEPGTXSZTFT-ZGVDRVBQSA-N 535325 US11236047, Example 324::US11236047, Example 325 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535325&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283141 464920571 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135905 Cc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(O)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)nc1 InChI=1S/C31H30ClFN4O4/c1-19-4-9-24(34-14-19)17-37-28(38)25-12-21(29(2,39)22-15-35-36(3)16-22)13-26(33)27(25)31(37,41-18-30(40)10-11-30)20-5-7-23(32)8-6-20/h4-9,12-16,39-40H,10-11,17-18H2,1-3H3/t29?,31-/m1/s1 DKOKUKMQYMDUPS-ZGVDRVBQSA-N 535430 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2-[(5- methylpyridin-2-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 227 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535430&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282402 464920651 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135906 CC(C)(O)c1cc2C(=O)N([C@@H](C=C)c3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2FN2O4/c1-4-24(23-10-9-20(31)15-33-23)34-26(35)21-13-18(27(2,3)36)14-22(32)25(21)29(34,38-16-28(37)11-12-28)17-5-7-19(30)8-6-17/h4-10,13-15,24,36-37H,1,11-12,16H2,2-3H3/t24-,29+/m0/s1 SJKVIISRJBQDPQ-PWUYWRBVSA-N 535431 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(5- chloropyridin-2-yl)prop-2-en-1-yl]-4- fluoro-3-[(1- hydroxycyclopropyl)methoxy]-6-(2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 174 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535431&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282301 464920652 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135907 CCn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-3-37-16-21(14-36-37)29(2,40)20-12-25-27(26(34)13-20)31(42-18-30(41)10-11-30,19-4-6-22(32)7-5-19)38(28(25)39)17-24-9-8-23(33)15-35-24/h4-9,12-16,40-41H,3,10-11,17-18H2,1-2H3/t29?,31-/m1/s1 QYPLRLGVDBPTMJ-ZGVDRVBQSA-N 535432 US11236047, Example 183::US11236047, Example 184 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535432&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282376 464920653 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135908 CCn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-3-37-16-21(14-36-37)29(2,40)20-12-25-27(26(34)13-20)31(42-18-30(41)10-11-30,19-4-6-22(32)7-5-19)38(28(25)39)17-24-9-8-23(33)15-35-24/h4-9,12-16,40-41H,3,10-11,17-18H2,1-2H3/t29?,31-/m1/s1 QYPLRLGVDBPTMJ-ZGVDRVBQSA-N 535432 US11236047, Example 183::US11236047, Example 184 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.920 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535432&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282376 464920653 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135909 CO[C@]1(N(Cc2ncc(Cl)cc2S(C)(=O)=O)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(C)c1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2FN4O5S/c1-27(37,18-12-33-34(2)14-18)17-9-21-25(22(31)10-17)28(40-3,16-5-7-19(29)8-6-16)35(26(21)36)15-23-24(41(4,38)39)11-20(30)13-32-23/h5-14,37H,15H2,1-4H3/t27?,28-/m1/s1 IXMPETAWBZRMPY-PLYLYKGUSA-N 535434 (3R)-2-[(5-chloro-3- methanesulfonylpyridin-2-yl)methyl]- 3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-methoxy-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 373 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535434&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282963 464920654 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135910 CO[C@]1(N(Cc2ccc(cn2)C#N)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC1)C(C)=O)c1ccc(Cl)cc1 InChI=1S/C31H30ClFN4O4/c1-19(38)36-12-10-21(11-13-36)30(2,40)23-14-26-28(27(33)15-23)31(41-3,22-5-7-24(32)8-6-22)37(29(26)39)18-25-9-4-20(16-34)17-35-25/h4-9,14-15,17,21,40H,10-13,18H2,1-3H3/t30?,31-/m1/s1 UTHIKBCDDXKGAA-NLIBRCFJSA-N 535435 6-{[(1R)-5-[1-(1-acetylpiperidin-4-yl)- 1-hydroxyethyl]-1-(4-chlorophenyl)-7- fluoro-1-methoxy-3-oxo-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyridine-3- carbonitrile Ex. 297 is the slower eluting isomer::US11236047, Example 297 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535435&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282693 464920655 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135911 COc1ccc(CN2C(=O)c3cc(cc(F)c3[C@]2(OCC2(O)CC2)c2ccc(Cl)cc2)C(C)(O)c2cnn(C)c2)cn1 InChI=1S/C31H30ClFN4O5/c1-29(39,22-15-35-36(2)17-22)21-12-24-27(25(33)13-21)31(42-18-30(40)10-11-30,20-5-7-23(32)8-6-20)37(28(24)38)16-19-4-9-26(41-3)34-14-19/h4-9,12-15,17,39-40H,10-11,16,18H2,1-3H3/t29?,31-/m1/s1 YHCHSJVYIURCJK-ZGVDRVBQSA-N 535436 (3R)-3-(4-chlorophenyl)-4-fluoro-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2-[(6- methoxypyridin-3-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 230 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535436&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497974 464920656 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135912 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-30(40,22-15-36-37(2)16-22)21-11-26-28(27(33)12-21)31(42-25-9-10-41-18-25,20-4-6-23(32)7-5-20)38(29(26)39)17-24-8-3-19(13-34)14-35-24/h3-8,11-12,14-16,25,40H,9-10,17-18H2,1-2H3/t25-,30?,31+/m0/s1 IMGHGKVWJOGDFL-OERQIQHUSA-N 535421 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 218::US11236047, Example 344 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535421&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282568 464920646 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135913 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(F)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27ClF2N4O4/c1-28(39,20-13-35-36(2)15-20)19-11-24-26(25(33)12-19)30(41-17-29(40)9-10-29,18-3-5-21(31)6-4-18)37(27(24)38)16-23-8-7-22(32)14-34-23/h3-8,11-15,39-40H,9-10,16-17H2,1-2H3/t28?,30-/m1/s1 CUPHKJSAHLYMSR-FUJFQHJFSA-N 535438 (3R)-3-(4-chlorophenyl)-4-fluoro-2- [(5-fluoropyridin-2-yl)methyl]-6-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 231 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535438&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498010 464920657 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135914 Cc1nnc(o1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H25Cl2FN4O5/c1-16-34-35-26(41-16)27(2,38)18-11-22-24(23(32)12-18)29(40-15-28(39)9-10-28,17-3-5-19(30)6-4-17)36(25(22)37)14-21-8-7-20(31)13-33-21/h3-8,11-13,38-39H,9-10,14-15H2,1-2H3/t27?,29-/m1/s1 YLSBIZWHGKMZFC-ZBAATNBSSA-N 535439 US11236047, Example 186 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535439&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282684 464920658 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135915 CC(O)(C1CCS(=O)(=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2FN2O6S/c1-28(37,18-8-12-41(38,39)13-9-18)20-14-24-26(25(32)15-20)29(40-11-10-35,19-2-4-21(30)5-3-19)34(27(24)36)17-23-7-6-22(31)16-33-23/h2-7,14-16,18,35,37H,8-13,17H2,1H3/t28?,29-/m1/s1 LNHWDLFOWCRHJS-YPJJGMIRSA-N 535440 US11236047, Example 313 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535440&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497990 464920659 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135916 CNC(=O)CNCC1(CO[C@]2(N(Cc3ccc(Cl)cn3)C(=O)c3cc(cc(F)c23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C31H33Cl2FN4O4/c1-29(2,41)20-12-24-27(25(34)13-20)31(19-4-6-21(32)7-5-19,38(28(24)40)16-23-9-8-22(33)14-37-23)42-18-30(10-11-30)17-36-15-26(39)35-3/h4-9,12-14,36,41H,10-11,15-18H2,1-3H3,(H,35,39)/t31-/m1/s1 QYDCIWZUSXZNGK-WJOKGBTCSA-N 535441 2-({[1-({[(1R)-1-(4-chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-7-fluoro- 5-(2-hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropyl]methyl}amino)- N-methylacetamide::US11236047, Example 155 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535441&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282779 464920660 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135917 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2FN4O4/c1-29(41,21-13-36-37(2)15-21)20-11-25-27(26(34)12-20)31(19-3-5-22(32)6-4-19,42-18-30(17-39)9-10-30)38(28(25)40)16-24-8-7-23(33)14-35-24/h3-8,11-15,39,41H,9-10,16-18H2,1-2H3/t29?,31-/m1/s1 PTBQGDBOHCKVRI-ZGVDRVBQSA-N 535363 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 345::US11236047, Example 352 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535363&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282087 464920602 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135918 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29Cl2F2N3O5/c1-27(39,29(34)8-10-41-11-9-29)19-12-22-25(23(33)13-19)30(42-17-28(40)6-7-28,18-2-4-20(31)5-3-18)37(26(22)38)16-24-35-14-21(32)15-36-24/h2-5,12-15,39-40H,6-11,16-17H2,1H3/t27?,30-/m1/s1 NKWFYVHKVVJQBQ-DINWUYGQSA-N 535443 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 385::US11236047, Example 386 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535443&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497986 464920661 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135919 C[C@@H](O)CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)c1cnn(C)c1)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2FN4O4/c1-17(37)16-40-29(18-4-6-21(30)7-5-18)26-24(27(38)36(29)15-23-9-8-22(31)13-33-23)10-19(11-25(26)32)28(2,39)20-12-34-35(3)14-20/h4-14,17,37,39H,15-16H2,1-3H3/t17-,28?,29-/m1/s1 MNQQXUGKGLDIBL-YQNXAQHZSA-N 535425 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-[(2R)-2-hydroxypropoxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 221::US11236047, Example 354 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535425&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282239 464920648 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135920 CC(=O)N1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FN3O5/c1-19(39)36-11-9-20(10-12-36)30(2,41)22-15-26-28(27(34)16-22)31(42-14-13-38,21-3-5-23(32)6-4-21)37(29(26)40)18-25-8-7-24(33)17-35-25/h3-8,15-17,20,38,41H,9-14,18H2,1-2H3/t30?,31-/m1/s1 CXOYTFMILJYYKW-NLIBRCFJSA-N 535445 (3R)-6-[1-(1-acetylpiperidin-4-yl)-1- hydroxyethyl]-3-(4-chlorophenyl)-2- [(5-chloropyridin-2-yl)methyl]-4-fluoro- 3-(2-hydroxyethoxy)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 421 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.840 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535445&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282639 464920662 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135921 Cn1cc(cn1)C(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25ClFN5O4/c1-36-15-20(14-35-36)28(38)19-10-25-27(26(32)11-19)30(41-24-8-9-40-17-24,21-3-5-22(31)6-4-21)37(29(25)39)16-23-7-2-18(12-33)13-34-23/h2-7,10-11,13-15,24,28,38H,8-9,16-17H2,1H3/t24-,28?,30+/m0/s1 RRUBGLIKOBFXDA-FDTSKNAKSA-N 535446 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[hydroxy(1-methyl-1H-pyrazol-4- yl)methyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile Ex. 357 is the slower eluting isomer::US11236047, Example 357::US11236047, Example 360 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535446&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283067 464920663 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135922 Cn1cc(cn1)C(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25ClFN5O4/c1-36-15-20(14-35-36)28(38)19-10-25-27(26(32)11-19)30(41-24-8-9-40-17-24,21-3-5-22(31)6-4-21)37(29(25)39)16-23-7-2-18(12-33)13-34-23/h2-7,10-11,13-15,24,28,38H,8-9,16-17H2,1H3/t24-,28?,30+/m0/s1 RRUBGLIKOBFXDA-FDTSKNAKSA-N 535446 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[hydroxy(1-methyl-1H-pyrazol-4- yl)methyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile Ex. 357 is the slower eluting isomer::US11236047, Example 357::US11236047, Example 360 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535446&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283067 464920663 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135923 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CN(C1)C(C)=O)c1ccc(Cl)cc1 InChI=1S/C28H26Cl2FN3O4/c1-16(35)33-13-19(14-33)27(2,37)18-10-23-25(24(31)11-18)28(38-3,17-4-6-20(29)7-5-17)34(26(23)36)15-22-9-8-21(30)12-32-22/h4-12,19,37H,13-15H2,1-3H3/t27?,28-/m1/s1 NGYNMONWMIFMBU-PLYLYKGUSA-N 535448 US11236047, Example 390 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535448&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282612 464920664 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135924 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CN(C1)C(=O)CO)c1ccc(Cl)cc1 InChI=1S/C28H26Cl2FN3O5/c1-27(38,18-12-33(13-18)24(36)15-35)17-9-22-25(23(31)10-17)28(39-2,16-3-5-19(29)6-4-16)34(26(22)37)14-21-8-7-20(30)11-32-21/h3-11,18,35,38H,12-15H2,1-2H3/t27?,28-/m1/s1 GIKVEWGVNKXMRA-PLYLYKGUSA-N 535449 US11236047, Example 391 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535449&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282679 464920665 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135925 CC(O)(C1CCC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H27ClFN3O4/c1-28(37,19-3-2-4-19)21-13-24-26(25(31)14-21)29(38-12-11-35,20-6-8-22(30)9-7-20)34(27(24)36)17-23-10-5-18(15-32)16-33-23/h5-10,13-14,16,19,35,37H,2-4,11-12,17H2,1H3/t28?,29-/m1/s1 ZDFDJHLMOSFIGS-YPJJGMIRSA-N 535450 US11236047, Example 405 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535450&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282605 464920666 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135926 CC(C)(O)c1cc2C(=O)N([C@@H](CO)c3ccc(Cl)cn3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2FN2O5/c1-27(2,38)18-11-21-25(22(32)12-18)29(17-3-5-19(30)6-4-17,39-16-28(15-36)9-10-28)34(26(21)37)24(14-35)23-8-7-20(31)13-33-23/h3-8,11-13,24,35-36,38H,9-10,14-16H2,1-2H3/t24-,29+/m0/s1 OUIQFUHIJYJICV-PWUYWRBVSA-N 535451 (3R)-3-(4-Chlorophenyl)-2-[(1R)-1-(5- chloropyridin-2-yl)-2-hydroxyethyl]-4- fluoro-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 418 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.810 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535451&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283138 464920667 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135927 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3=O)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H26Cl2FN5O4/c1-29(41,21-13-36-37(2)14-21)20-11-25-27(26(34)12-20)31(19-3-5-22(32)6-4-19,43-18-30(17-35)9-10-30)38(28(25)40)16-24-8-7-23(33)15-39(24)42/h3-8,11-15,41H,9-10,16,18H2,1-2H3/t29?,31-/m1/s1 PPRQBTGGPVRJIV-ZGVDRVBQSA-N 535452 1-({[(1R)-2-[(5-chloro-1-oxo-1lambda5- pyridin-2-yl)methyl]-1-(4- chlorophenyl)-7-fluoro-5-[1-hydroxy- 1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3- oxo-2,3-dihydro-1H-isoindol-1- yl]oxy}methyl)cyclopropane-1- carbonitrile::US11236047, Example 408 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535452&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282625 464920668 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135928 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cn3=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN4O5/c1-28(39,20-13-34-35(2)14-20)19-11-24-26(25(33)12-19)30(42-17-29(40)9-10-29,18-3-5-21(31)6-4-18)36(27(24)38)16-23-8-7-22(32)15-37(23)41/h3-8,11-15,39-40H,9-10,16-17H2,1-2H3/t28?,30-/m1/s1 XFMUFTRUWONRPH-FUJFQHJFSA-N 535453 (3R)-2-[(5-chloro-1-oxo-1lambda5-pyridin-2- yl)methyl]-3-(4-chlorophenyl)-4- fluoro-6-[1-hydroxy-1-(1-methyl-1H- pyrazol-4-yl)ethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 409 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535453&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497969 464920669 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135929 CC(O)(c1cc2C(=O)N(Cc3ccc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1)c1ncccn1 InChI=1S/C30H25Cl2FN4O4/c1-28(39,27-34-11-2-12-35-27)19-13-23-25(24(33)14-19)30(41-17-29(40)9-10-29,18-3-5-20(31)6-4-18)37(26(23)38)16-22-8-7-21(32)15-36-22/h2-8,11-15,39-40H,9-10,16-17H2,1H3/t28?,30-/m1/s1 ZDTDRSMIUYSHRA-FUJFQHJFSA-N 535454 US11236047, Example 396 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535454&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282714 464920670 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135930 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FN5O4/c1-28(41,20-11-36-37(2)14-20)19-9-23-26(24(33)10-19)30(18-3-5-21(31)6-4-18,42-17-29(16-39)7-8-29)38(27(23)40)15-25-34-12-22(32)13-35-25/h3-6,9-14,39,41H,7-8,15-17H2,1-2H3/t28?,30-/m1/s1 AUSFXZCNGFOETO-FUJFQHJFSA-N 535455 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 2,3-dihydro-1H-isoindol-1-one Ex. 348 is the slower eluting isomer::US11236047, Example 348 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535455&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282623 464920671 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135931 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-29(40,22-15-36-37(2)16-22)21-11-25-27(26(33)12-21)31(42-18-30(41)9-10-30,20-4-6-23(32)7-5-20)38(28(25)39)17-24-8-3-19(13-34)14-35-24/h3-8,11-12,14-16,40-41H,9-10,17-18H2,1-2H3/t29?,31-/m1/s1 DOGJTGROPSWBRY-ZGVDRVBQSA-N 535456 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)ethyl]-1-[(1- hydroxycyclopropyl)methoxy]-3-oxo- 2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 341 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535456&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282545 464920672 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135932 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29Cl2F2N3O5/c1-27(39,29(34)8-10-41-11-9-29)19-12-22-25(23(33)13-19)30(42-17-28(40)6-7-28,18-2-4-20(31)5-3-18)37(26(22)38)16-24-35-14-21(32)15-36-24/h2-5,12-15,39-40H,6-11,16-17H2,1H3/t27?,30-/m1/s1 NKWFYVHKVVJQBQ-DINWUYGQSA-N 535443 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-[(1- hydroxycyclopropyl)methoxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 385::US11236047, Example 386 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.650 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535443&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497986 464920661 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135933 CC(=O)N1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2FN4O5/c1-18(39)36-9-7-19(8-10-36)29(2,41)21-13-24-27(25(33)14-21)30(42-12-11-38,20-3-5-22(31)6-4-20)37(28(24)40)17-26-34-15-23(32)16-35-26/h3-6,13-16,19,38,41H,7-12,17H2,1-2H3/t29?,30-/m1/s1 OEMUXZKPZLMBBQ-BDCODIICSA-N 535458 (3R)-6-[1-(1-acetylpiperidin-4-yl)-1- hydroxyethyl]-3-(4-chlorophenyl)-2- [(5-chloropyrimidin-2-yl)methyl]-4- fluoro-3-(2-hydroxyethoxy)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 422 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535458&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283065 464920673 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135934 CC(O)(C1CCC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN4O4/c1-28(40,17-3-2-4-17)19-11-22-25(23(33)12-19)30(18-5-7-20(31)8-6-18,41-16-29(9-10-29)27(34)39)37(26(22)38)15-24-35-13-21(32)14-36-24/h5-8,11-14,17,40H,2-4,9-10,15-16H2,1H3,(H2,34,39)/t28?,30-/m1/s1 BYBQBCBTNQMUTJ-FUJFQHJFSA-N 535459 US11236047, Example 404 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535459&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282813 464920674 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135935 Cn1cc(cn1)C(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-30(41,21-15-36-37(2)16-21)20-9-26-28(27(33)10-20)31(42-25-11-24(39)12-25,19-4-6-22(32)7-5-19)38(29(26)40)17-23-8-3-18(13-34)14-35-23/h3-10,14-16,24-25,39,41H,11-12,17H2,1-2H3/t24-,25+,30?,31-/m1/s1 PLLUZPZNYWOMRY-MRRBAKFHSA-N 535460 6-{[1-(4-chlorophenyl)-7-fluoro-5-[1- hydroxy-1-(1-methyl-1H-pyrazol-4- yl)ethyl]-3-oxo-1-[cis-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile Ex. 356 is the slower eluting isomer::US11236047, Example 356 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535460&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137512908 464920675 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135936 CCC(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29ClFN3O4/c1-3-28(2,38)21-12-24-26(25(32)13-21)30(20-5-7-22(31)8-6-20,39-18-29(17-36)10-11-29)35(27(24)37)16-23-9-4-19(14-33)15-34-23/h4-9,12-13,15,36,38H,3,10-11,16-18H2,1-2H3/t28?,30-/m1/s1 LCMLWYJDMGQUES-FUJFQHJFSA-N 535461 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-(2-hydroxybutan-2-yl)-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 410::US11236047, Example 411 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535461&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282513 464920676 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135937 CCC(C)(O)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29ClFN3O4/c1-3-28(2,38)21-12-24-26(25(32)13-21)30(20-5-7-22(31)8-6-20,39-18-29(17-36)10-11-29)35(27(24)37)16-23-9-4-19(14-33)15-34-23/h4-9,12-13,15,36,38H,3,10-11,16-18H2,1-2H3/t28?,30-/m1/s1 LCMLWYJDMGQUES-FUJFQHJFSA-N 535461 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-(2-hydroxybutan-2-yl)-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 410::US11236047, Example 411 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.930 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535461&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282513 464920676 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135938 CC(O)(C=C)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27ClFN3O4/c1-3-28(2,38)21-12-24-26(25(32)13-21)30(20-5-7-22(31)8-6-20,39-18-29(17-36)10-11-29)35(27(24)37)16-23-9-4-19(14-33)15-34-23/h3-9,12-13,15,36,38H,1,10-11,16-18H2,2H3/t28?,30-/m1/s1 ZUYUPGSFWPOBQN-FUJFQHJFSA-N 535722 6-{[(1R)-1-(4-Chlorophenyl)-7-fluoro- 5-(2-hydroxybut-3-en-2-yl)-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 412::US11236047, Example 413 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535722&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282590 464920922 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135939 CC(O)(C=C)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27ClFN3O4/c1-3-28(2,38)21-12-24-26(25(32)13-21)30(20-5-7-22(31)8-6-20,39-18-29(17-36)10-11-29)35(27(24)37)16-23-9-4-19(14-33)15-34-23/h3-9,12-13,15,36,38H,1,10-11,16-18H2,2H3/t28?,30-/m1/s1 ZUYUPGSFWPOBQN-FUJFQHJFSA-N 535722 6-{[(1R)-1-(4-Chlorophenyl)-7-fluoro- 5-(2-hydroxybut-3-en-2-yl)-1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 412::US11236047, Example 413 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535722&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282590 464920922 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135940 CC(O)(C1CCS(=O)(=O)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FN3O6S/c1-28(38,18-6-10-43(40,41)11-7-18)20-12-23-26(24(33)13-20)30(42-17-29(39)8-9-29,19-2-4-21(31)5-3-19)36(27(23)37)16-25-34-14-22(32)15-35-25/h2-5,12-15,18,38-39H,6-11,16-17H2,1H3/t28?,30-/m1/s1 UQSZGPZMUWVMKS-FUJFQHJFSA-N 535724 US11236047, Example 398 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535724&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497992 464920923 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135941 CN1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FN4O4/c1-30(40,19-7-10-37(2)11-8-19)21-13-25-28(26(34)14-21)31(42-24-9-12-41-18-24,20-3-5-22(32)6-4-20)38(29(25)39)17-27-35-15-23(33)16-36-27/h3-6,13-16,19,24,40H,7-12,17-18H2,1-2H3/t24-,30?,31+/m0/s1 CXQPNLBJOBIXBV-JOINGXBXSA-N 535725 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-hydroxy-1-(1-methylpiperidin-4- yl)ethyl]-3-[(3S)-oxolan-3-yloxy]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 423 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535725&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282519 464920924 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135942 CC(O)(c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H24ClF4N3O4/c1-26(40,29(32,33)34)19-10-22-24(23(31)11-19)28(18-3-5-20(30)6-4-18,41-16-27(15-38)8-9-27)37(25(22)39)14-21-7-2-17(12-35)13-36-21/h2-7,10-11,13,38,40H,8-9,14-16H2,1H3/t26?,28-/m1/s1 FNRDUUKOZHITMC-SVNIRARHSA-N 535732 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-5-(1,1,1-trifluoro-2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 416::US11236047, Example 417 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535732&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497995 464920931 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135943 CC(O)(c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1)C(F)(F)F InChI=1S/C29H24ClF4N3O4/c1-26(40,29(32,33)34)19-10-22-24(23(31)11-19)28(18-3-5-20(30)6-4-18,41-16-27(15-38)8-9-27)37(25(22)39)14-21-7-2-17(12-35)13-36-21/h2-7,10-11,13,38,40H,8-9,14-16H2,1H3/t26?,28-/m1/s1 FNRDUUKOZHITMC-SVNIRARHSA-N 535732 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-5-(1,1,1-trifluoro-2- hydroxypropan-2-yl)-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 416::US11236047, Example 417 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535732&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497995 464920931 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135944 CC(O)(C1CC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFN3O4/c1-29(39,20-3-4-20)22-12-25-27(26(33)13-22)31(21-5-7-23(32)8-6-21,40-18-30(17-37)10-11-30)36(28(25)38)16-24-9-2-19(14-34)15-35-24/h2,5-9,12-13,15,20,37,39H,3-4,10-11,16-18H2,1H3/t29?,31-/m1/s1 KFTDOSOUWLTHRI-ZGVDRVBQSA-N 535734 6-{[(1R)-1-(4-Chlorophenyl)-5-(1- cyclopropyl-1-hydroxyethyl)-7-fluoro- 1-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 415 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.840 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535734&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282517 464920932 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135945 CO[C@]1(N(Cc2ccc(cn2)C#N)C(=O)c2cc(cc(F)c12)C(C)(O)C1CN(C1)C(=O)N(C)C)c1ccc(Cl)cc1 InChI=1S/C30H29ClFN5O4/c1-29(40,21-15-36(16-21)28(39)35(2)3)20-11-24-26(25(32)12-20)30(41-4,19-6-8-22(31)9-7-19)37(27(24)38)17-23-10-5-18(13-33)14-34-23/h5-12,14,21,40H,15-17H2,1-4H3/t29?,30-/m1/s1 YXJHOYZUTJDSKB-BDCODIICSA-N 535735 US11236047, Example 393 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535735&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282936 464920933 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135946 Cn1cc(cn1)C(O)(C=C)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H27ClFN5O4/c1-3-31(42,22-16-37-38(2)17-22)21-10-27-29(28(34)11-21)32(43-26-12-25(40)13-26,20-5-7-23(33)8-6-20)39(30(27)41)18-24-9-4-19(14-35)15-36-24/h3-11,15-17,25-26,40,42H,1,12-13,18H2,2H3/t25-,26+,31?,32-/m1/s1 CBSMDIHLXRBTIK-UGDYSZKESA-N 535737 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)prop-2-en-1-yl]-3-oxo-1-[cis-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile Ex. 361 is the slower eluting isomer::US11236047, Example 361 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535737&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498016 464920935 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135947 CC(=O)N1CCC(CC1)C(C)(O)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN4O5/c1-18(40)38-9-7-19(8-10-38)31(2,43)21-11-26-29(27(35)12-21)32(44-25-13-24(41)14-25,20-3-5-22(33)6-4-20)39(30(26)42)17-28-36-15-23(34)16-37-28/h3-6,11-12,15-16,19,24-25,41,43H,7-10,13-14,17H2,1-2H3/t24-,25+,31?,32-/m1/s1 NQWJDULBVXLQNH-GYUPVUOFSA-N 535739 (3R)-6-[1-(1-acetylpiperidin-4-yl)-1- hydroxyethyl]-3-(4-chlorophenyl)-2- [(5-chloropyrimidin-2-yl)methyl]-4- fluoro-3-[cis-3-hydroxycyclobutoxy]- 2,3-dihydro-1H-isoindol-1-one Ex. 425 is the slower eluting isomer::US11236047, Example 425 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535739&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283154 464920937 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135948 OC(C1CCS(=O)(=O)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2FN3O6S/c30-20-3-1-19(2-4-20)29(41-16-28(38)7-8-28)25-22(27(37)35(29)15-24-33-13-21(31)14-34-24)11-18(12-23(25)32)26(36)17-5-9-42(39,40)10-6-17/h1-4,11-14,17,26,36,38H,5-10,15-16H2/t26?,29-/m1/s1 ONJSKBXTOJKOHB-BNGNXUGRSA-N 535740 US11236047, Example 400 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535740&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497957 464920938 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135949 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27ClFN5O4/c1-3-29(40,26-17-36(2)18-35-26)21-12-24-27(25(32)13-21)30(41-11-10-38,20-5-7-22(31)8-6-20)37(28(24)39)16-23-9-4-19(14-33)15-34-23/h4-9,12-13,15,17-18,38,40H,3,10-11,16H2,1-2H3/t29?,30-/m1/s1 NDQMLIDFCBBJEJ-BDCODIICSA-N 535741 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-1-(2- hydroxyethoxy)-3-oxo-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 364 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535741&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282564 464920939 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135950 CCC(O)(c1cscn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H24ClFN4O4S/c1-2-28(38,25-16-40-17-34-25)20-11-23-26(24(31)12-20)29(39-10-9-36,19-4-6-21(30)7-5-19)35(27(23)37)15-22-8-3-18(13-32)14-33-22/h3-8,11-12,14,16-17,36,38H,2,9-10,15H2,1H3/t28?,29-/m1/s1 XIIWYJNBDQFHIK-YPJJGMIRSA-N 535743 US11236047, Example 333 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535743&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282999 464920941 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135951 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-3-31(41,28-17-38(2)19-37-28)22-12-26-29(27(34)13-22)32(43-25-10-11-42-18-25,21-5-7-23(33)8-6-21)39(30(26)40)16-24-9-4-20(14-35)15-36-24/h4-9,12-13,15,17,19,25,41H,3,10-11,16,18H2,1-2H3/t25-,31?,32+/m0/s1 XHCNIWPQGUYHCF-LOKXLOOWSA-N 535744 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-oxo-1-[(3S)- oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 365::US11236047, Example 366 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535744&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498006 464920942 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135952 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-3-31(41,28-17-38(2)19-37-28)22-12-26-29(27(34)13-22)32(43-25-10-11-42-18-25,21-5-7-23(33)8-6-21)39(30(26)40)16-24-9-4-20(14-35)15-36-24/h4-9,12-13,15,17,19,25,41H,3,10-11,16,18H2,1-2H3/t25-,31?,32+/m0/s1 XHCNIWPQGUYHCF-LOKXLOOWSA-N 535744 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-oxo-1-[(3S)- oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 365::US11236047, Example 366 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 190 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535744&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498006 464920942 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135953 CC(O)([C@H]1CC[C@H](O)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H34Cl2FN3O5/c1-30(42,19-4-8-24(40)9-5-19)21-12-25-28(26(35)13-21)32(20-2-6-22(33)7-3-20,43-18-31(17-39)10-11-31)38(29(25)41)16-27-36-14-23(34)15-37-27/h2-3,6-7,12-15,19,24,39-40,42H,4-5,8-11,16-18H2,1H3/t19-,24-,30?,32-/m1/s1 FFCUBEPVLPUEKV-TXICZZBISA-N 535746 US11236047, Example 402 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535746&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282829 464920943 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135954 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(Cl)nc3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2FN4O4/c1-3-28(39,24-16-35(2)17-34-24)20-12-22-26(23(32)13-20)29(40-11-10-37,19-5-7-21(30)8-6-19)36(27(22)38)15-18-4-9-25(31)33-14-18/h4-9,12-14,16-17,37,39H,3,10-11,15H2,1-2H3/t28?,29-/m1/s1 WRBVILCYNJXAHL-YPJJGMIRSA-N 535747 (3R)-3-(4-chlorophenyl)-2-[(6- chloropyridin-3-yl)methyl]-4-fluoro-6- [1-hydroxy-1-(1-methyl-1H-imidazol- 4-yl)propyl]-3-(2-hydroxyethoxy)-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 367 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535747&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282741 464920944 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135955 CCC(O)(c1ccn(C)c(=O)c1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H30ClFN4O5/c1-3-33(43,23-10-12-39(2)30(41)16-23)24-14-28-31(29(36)15-24)34(45-27-11-13-44-20-27,22-5-7-25(35)8-6-22)40(32(28)42)19-26-9-4-21(17-37)18-38-26/h4-10,12,14-16,18,27,43H,3,11,13,19-20H2,1-2H3/t27-,33?,34+/m0/s1 BBYFUSWKYJIKDG-FNHRJEOVSA-N 535748 US11236047, Example 374 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.900 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535748&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282488 464920945 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135956 CC(O)(c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H30ClF2N3O5/c1-30(40,31(35)9-12-41-13-10-31)22-14-26-28(27(34)15-22)32(43-25-8-11-42-19-25,21-3-5-23(33)6-4-21)38(29(26)39)18-24-7-2-20(16-36)17-37-24/h2-7,14-15,17,25,40H,8-13,18-19H2,1H3/t25-,30?,32+/m0/s1 GGKZSFCTBQWUHO-HZGBORAXSA-N 535749 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 388 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535749&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282626 464920946 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135957 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H28ClFN6O4/c1-3-30(41,26-15-38(2)18-37-26)21-10-24-28(25(33)11-21)31(43-23-8-9-42-17-23,20-4-6-22(32)7-5-20)39(29(24)40)16-27-35-13-19(12-34)14-36-27/h4-7,10-11,13-15,18,23,41H,3,8-9,16-17H2,1-2H3/t23-,30?,31+/m0/s1 XUQLKCXDANADHI-GMMQIRHLSA-N 535751 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-oxo-1-[(3S)- oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyrimidine-5- carbonitrile Ex. 369 is the slower eluting isomer::US11236047, Example 369 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.610 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535751&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282956 464920948 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135958 CCC(O)(c1cnn(C)c1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-3-31(42,22-16-37-38(2)17-22)21-10-27-29(28(34)11-21)32(43-26-12-25(40)13-26,20-5-7-23(33)8-6-20)39(30(27)41)18-24-9-4-19(14-35)15-36-24/h4-11,15-17,25-26,40,42H,3,12-13,18H2,1-2H3/t25-,26+,31?,32-/m1/s1 RFTMWICFZAQJMI-UGDYSZKESA-N 535752 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 4-yl)propyl]-3-oxo-1-[cis-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 339 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.510 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535752&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497968 464920949 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135959 Cn1cnc(c1)C(O)(C1CC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H29ClFN5O4/c1-39-17-29(38-19-39)32(42,21-3-4-21)23-12-27-30(28(35)13-23)33(44-26-10-11-43-18-26,22-5-7-24(34)8-6-22)40(31(27)41)16-25-9-2-20(14-36)15-37-25/h2,5-9,12-13,15,17,19,21,26,42H,3-4,10-11,16,18H2,1H3/t26-,32?,33+/m0/s1 DQSUJJZOQXTIMY-UBORAUAPSA-N 535753 6-{[(1R)-1-(4-chlorophenyl)-5- [cyclopropyl(hydroxy)(1-methyl-1H- imidazol-4-yl)methyl]-7-fluoro-3-oxo- 1-[(3S)-oxolan-3-yloxy]-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 433::US11236047, Example 434 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535753&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282888 464920950 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135960 Cn1cnc(c1)C(O)(C1CC1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H29ClFN5O4/c1-39-17-29(38-19-39)32(42,21-3-4-21)23-12-27-30(28(35)13-23)33(44-26-10-11-43-18-26,22-5-7-24(34)8-6-22)40(31(27)41)16-25-9-2-20(14-36)15-37-25/h2,5-9,12-13,15,17,19,21,26,42H,3-4,10-11,16,18H2,1H3/t26-,32?,33+/m0/s1 DQSUJJZOQXTIMY-UBORAUAPSA-N 535753 6-{[(1R)-1-(4-chlorophenyl)-5- [cyclopropyl(hydroxy)(1-methyl-1H- imidazol-4-yl)methyl]-7-fluoro-3-oxo- 1-[(3S)-oxolan-3-yloxy]-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 433::US11236047, Example 434 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535753&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282888 464920950 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135961 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](O[C@@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-3-31(41,28-17-38(2)19-37-28)22-12-26-29(27(34)13-22)32(43-25-10-11-42-18-25,21-5-7-23(33)8-6-21)39(30(26)40)16-24-9-4-20(14-35)15-36-24/h4-9,12-13,15,17,19,25,41H,3,10-11,16,18H2,1-2H3/t25-,31?,32-/m1/s1 XHCNIWPQGUYHCF-CYMJYBMMSA-N 535756 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-oxo-1-[(3R)- oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 426 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.720 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535756&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497987 464920952 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135962 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OC[C@@H](C)O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFN5O4/c1-4-30(41,27-16-37(3)18-36-27)22-11-25-28(26(33)12-22)31(42-17-19(2)39,21-6-8-23(32)9-7-21)38(29(25)40)15-24-10-5-20(13-34)14-35-24/h5-12,14,16,18-19,39,41H,4,15,17H2,1-3H3/t19-,30?,31-/m1/s1 YDFBJRFMXYRLJM-VSVGVIERSA-N 535757 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-1-[(2R)-2- hydroxypropoxy]-3-oxo-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyridine-3- carbonitrile::US11236047, Example 438 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535757&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282353 464920953 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135963 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31ClFN5O4/c1-3-32(43,28-17-39(2)20-38-28)23-12-26-29(27(35)13-23)33(22-5-7-24(34)8-6-22,44-19-31(18-41)10-11-31)40(30(26)42)16-25-9-4-21(14-36)15-37-25/h4-9,12-13,15,17,20,41,43H,3,10-11,16,18-19H2,1-2H3/t32?,33-/m1/s1 WNVLDRQSRWIKSR-ZHZZGXISSA-N 535759 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-({1- [hydroxy(2H2)methyl]cyclopropyl}(2H2) methoxy)-5-[1-hydroxy-1-(1-methyl- 1H-imidazol-4-yl)propyl]-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 440 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535759&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282541 464920955 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135964 Cn1cc(cn1)C(O)(CF)c1ccc2c(c1)C(=O)N(Cc1ccc(cn1)C#N)[C@@]2(O[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-37-16-23(15-36-37)30(40,19-33)22-5-9-28-27(12-22)29(39)38(17-25-8-2-20(13-34)14-35-25)31(28,42-26-10-11-41-18-26)21-3-6-24(32)7-4-21/h2-9,12,14-16,26,40H,10-11,17-19H2,1H3/t26-,30?,31+/m0/s1 YVIAFQAKHVRQOG-JCHZNZEOSA-N 535760 US11236047, Example 441::US11236047, Example 442 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535760&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137513400 464920956 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135965 Cn1cc(cn1)C(O)(CF)c1ccc2c(c1)C(=O)N(Cc1ccc(cn1)C#N)[C@@]2(O[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C31H27ClFN5O4/c1-37-16-23(15-36-37)30(40,19-33)22-5-9-28-27(12-22)29(39)38(17-25-8-2-20(13-34)14-35-25)31(28,42-26-10-11-41-18-26)21-3-6-24(32)7-4-21/h2-9,12,14-16,26,40H,10-11,17-19H2,1H3/t26-,30?,31+/m0/s1 YVIAFQAKHVRQOG-JCHZNZEOSA-N 535760 US11236047, Example 441::US11236047, Example 442 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535760&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137513400 464920956 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135966 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)NC1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C30H32Cl2N4O4/c1-29(39,28(38)34-23-12-14-35(2)15-13-23)20-6-11-26-25(16-20)27(37)36(18-24-10-9-22(32)17-33-24)30(26,40-3)19-4-7-21(31)8-5-19/h4-11,16-17,23,39H,12-15,18H2,1-3H3,(H,34,38)/t29?,30-/m1/s1 WCTSDTWABMUYDH-BDCODIICSA-N 535762 US11236047, Example 451::US11236047, Example 452 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 78.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535762&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282606 464920957 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135967 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)NC1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C30H32Cl2N4O4/c1-29(39,28(38)34-23-12-14-35(2)15-13-23)20-6-11-26-25(16-20)27(37)36(18-24-10-9-22(32)17-33-24)30(26,40-3)19-4-7-21(31)8-5-19/h4-11,16-17,23,39H,12-15,18H2,1-3H3,(H,34,38)/t29?,30-/m1/s1 WCTSDTWABMUYDH-BDCODIICSA-N 535762 US11236047, Example 451::US11236047, Example 452 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535762&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282606 464920957 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135968 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)Nc1cnn(C)c1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2N5O4/c1-27(38,26(37)33-22-14-32-34(2)15-22)18-6-11-24-23(12-18)25(36)35(16-21-10-9-20(30)13-31-21)28(24,39-3)17-4-7-19(29)8-5-17/h4-15,38H,16H2,1-3H3,(H,33,37)/t27?,28-/m1/s1 LDOZVXKNXVTXJP-PLYLYKGUSA-N 535765 US11236047, Example 453::US11236047, Example 454 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 94.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535765&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282732 464920959 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135969 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)Nc1cnn(C)c1)c1ccc(Cl)cc1 InChI=1S/C28H25Cl2N5O4/c1-27(38,26(37)33-22-14-32-34(2)15-22)18-6-11-24-23(12-18)25(36)35(16-21-10-9-20(30)13-31-21)28(24,39-3)17-4-7-19(29)8-5-17/h4-15,38H,16H2,1-3H3,(H,33,37)/t27?,28-/m1/s1 LDOZVXKNXVTXJP-PLYLYKGUSA-N 535765 US11236047, Example 453::US11236047, Example 454 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 35.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535765&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282732 464920959 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135970 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(ccc12)C(C)(O)C(=O)NC1CN(C)C1)c1ccc(Cl)cc1 InChI=1S/C28H28Cl2N4O4/c1-27(37,26(36)32-22-14-33(2)15-22)18-6-11-24-23(12-18)25(35)34(16-21-10-9-20(30)13-31-21)28(24,38-3)17-4-7-19(29)8-5-17/h4-13,22,37H,14-16H2,1-3H3,(H,32,36)/t27?,28-/m1/s1 KCMILRVZTKUFMT-PLYLYKGUSA-N 535767 US11236047, Example 456 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 210 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535767&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282944 464920960 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135971 CO[C@]1(N(Cc2ccc(Cl)cn2)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(CC(O)=O)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FN3O5/c1-29(40,18-9-11-35(12-10-18)17-26(37)38)20-13-24-27(25(33)14-20)30(41-2,19-3-5-21(31)6-4-19)36(28(24)39)16-23-8-7-22(32)15-34-23/h3-8,13-15,18,40H,9-12,16-17H2,1-2H3,(H,37,38)/t29?,30-/m1/s1 LEBZOJICUSODDT-BDCODIICSA-N 535768 2-(4-{1-[(1R)-1-(4-chlorophenyl)-2-[(5- chloropyridin-2-yl)methyl]-7-fluoro-1- methoxy-3-oxo-2,3-dihydro-1H- isoindol-5-yl]-1- hydroxyethyl}piperidin-1-yl)acetic acid Ex. 459 is the slower eluting isomer::US11236047, Example 459 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535768&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283062 464920961 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135972 Cc1cnc(CN2C(=O)c3cc(ccc3[C@]2(OCC2(CO)CC2)c2ccc(Cl)cc2)C(C)(C)O)cn1 InChI=1S/C28H30ClN3O4/c1-18-13-31-22(14-30-18)15-32-25(34)23-12-20(26(2,3)35)6-9-24(23)28(32,19-4-7-21(29)8-5-19)36-17-27(16-33)10-11-27/h4-9,12-14,33,35H,10-11,15-17H2,1-3H3/t28-/m1/s1 ZWMXXGFGENSWSG-MUUNZHRXSA-N 535769 (3R)-3-(4-Chlorophenyl)-3-{[1- (hydroxymethyl)cyclopropyl]methoxy}- 6-(2-hydroxypropan-2-yl)-2-[(5- methylpyrazin-2-yl)methyl]-2,3- dihydro-1H-isoindol-1-one::US11236047, Example 460 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 480 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535769&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282582 464920962 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135973 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OC3CCC(O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30ClFN6O4/c1-3-31(43,27-16-39(2)18-38-27)21-10-25-29(26(34)11-21)32(20-4-6-22(33)7-5-20,44-24-9-8-23(41)12-24)40(30(25)42)17-28-36-14-19(13-35)15-37-28/h4-7,10-11,14-16,18,23-24,41,43H,3,8-9,12,17H2,1-2H3/t23?,24?,31?,32-/m1/s1 SIFDSZDGKUGJTO-NQSPBDJXSA-N 535770 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-1-[(trans-3- hydroxycyclopentyl)oxy]-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 461::US11236047, Example 479 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.530 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535770&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137512742 464920963 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135974 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FN5O4/c1-3-29(41,25-14-37(2)16-36-25)18-8-23-27(24(33)9-18)30(42-22-10-21(39)11-22,17-4-6-19(31)7-5-17)38(28(23)40)15-26-34-12-20(32)13-35-26/h4-9,12-14,16,21-22,39,41H,3,10-11,15H2,1-2H3/t21-,22+,29?,30-/m1/s1 PUEPUEVWUMLLPQ-VELDXABHSA-N 535771 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-[cis-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 464 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535771&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282845 464920964 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135975 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cn3)C#N)[C@](OCC(=C)CO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H29ClFN5O4/c1-4-31(42,28-16-38(3)19-37-28)23-11-26-29(27(34)12-23)32(43-18-20(2)17-40,22-6-8-24(33)9-7-22)39(30(26)41)15-25-10-5-21(13-35)14-36-25/h5-12,14,16,19,40,42H,2,4,15,17-18H2,1,3H3/t31?,32-/m1/s1 OPDQOJKZFYMCJQ-IADGFXSZSA-N 535772 6-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-1-(3-hydroxy-2- methylidenepropoxy)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyridine-3-carbonitrile::US11236047, Example 466 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.860 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535772&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282656 464920965 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135976 Cn1cnc(c1)C(C)(O)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25ClF2N6O4/c1-28(41,24-12-38(2)17-37-24)20-7-22-26(23(32)8-20)30(19-3-5-21(31)6-4-19,43-16-29(33)14-42-15-29)39(27(22)40)13-25-35-10-18(9-34)11-36-25/h3-8,10-12,17,41H,13-16H2,1-2H3/t28?,30-/m1/s1 CCIHRCXDXNUEJC-FUJFQHJFSA-N 535773 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-[(3-fluorooxetan-3-yl)methoxy]-5-[1- hydroxy-1-(1-methyl-1H-imidazol-4- yl)ethyl]-3-oxo-2,3-dihydro-1H- isoindol-2-yl]methyl}pyrimidine-5- carbonitrile::US11236047, Example 468 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.50 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535773&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282979 464920966 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135977 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H27ClF2N6O4/c1-3-30(42,25-13-39(2)18-38-25)21-8-23-27(24(33)9-21)31(20-4-6-22(32)7-5-20,44-17-29(34)15-43-16-29)40(28(23)41)14-26-36-11-19(10-35)12-37-26/h4-9,11-13,18,42H,3,14-17H2,1-2H3/t30?,31-/m1/s1 DGWQHGBOIMCQFW-NLIBRCFJSA-N 535774 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-[(3-fluorooxetan-3-yl)methoxy]-5-[1- hydroxy-1-(1-methyl-1H-imidazol-4- yl)propyl]-3-oxo-2,3-dihydro-1H- isoindol-2-yl]methyl}pyrimidine-5- carbonitrile::US11236047, Example 470 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.000 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535774&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282631 464920967 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135978 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OC3CCC(O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30ClFN6O4/c1-3-31(43,27-16-39(2)18-38-27)21-10-25-29(26(34)11-21)32(20-4-6-22(33)7-5-20,44-24-9-8-23(41)12-24)40(30(25)42)17-28-36-14-19(13-35)15-37-28/h4-7,10-11,14-16,18,23-24,41,43H,3,8-9,12,17H2,1-2H3/t23?,24?,31?,32-/m1/s1 SIFDSZDGKUGJTO-NQSPBDJXSA-N 535770 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-1-[(trans-3- hydroxycyclopentyl)oxy]-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 461::US11236047, Example 479 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.600 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535770&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137512742 464920963 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135979 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](O[C@H]3C[C@H](CO)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30ClFN6O4/c1-3-31(43,27-15-39(2)18-38-27)22-10-25-29(26(34)11-22)32(21-4-6-23(33)7-5-21,44-24-8-19(9-24)17-41)40(30(25)42)16-28-36-13-20(12-35)14-37-28/h4-7,10-11,13-15,18-19,24,41,43H,3,8-9,16-17H2,1-2H3/t19-,24-,31?,32-/m1/s1 LWGPMDOLLXQRCR-QFNVXXLUSA-N 535776 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-oxo-1-[trans-3- (hydroxymethyl)cyclobutoxy]-2,3- dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 481 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535776&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497997 464920968 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135980 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29Cl2F2N3O5/c1-28(39,29(34)7-10-40-11-8-29)19-12-23-26(24(33)13-19)30(42-22-6-9-41-17-22,18-2-4-20(31)5-3-18)37(27(23)38)16-25-35-14-21(32)15-36-25/h2-5,12-15,22,39H,6-11,16-17H2,1H3/t22-,28?,30+/m0/s1 YHOMQLQCVYYRQC-GQMPWXHXSA-N 535777 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-[(3S)-oxolan-3-yloxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 493::US11236047, Example 494::US11236047, Example 516 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.540 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535777&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282598 464920969 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135981 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29Cl2F2N3O5/c1-28(39,29(34)7-10-40-11-8-29)19-12-23-26(24(33)13-19)30(42-22-6-9-41-17-22,18-2-4-20(31)5-3-18)37(27(23)38)16-25-35-14-21(32)15-36-25/h2-5,12-15,22,39H,6-11,16-17H2,1H3/t22-,28?,30+/m0/s1 YHOMQLQCVYYRQC-GQMPWXHXSA-N 535777 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-[(3S)-oxolan-3-yloxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 493::US11236047, Example 494::US11236047, Example 516 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 13.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535777&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282598 464920969 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135982 CC(O)([C@H]1CC[C@H](O)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FN3O5/c1-30(41,17-4-8-22(38)9-5-17)19-10-25-28(26(34)11-19)31(42-24-12-23(39)13-24,18-2-6-20(32)7-3-18)37(29(25)40)16-27-35-14-21(33)15-36-27/h2-3,6-7,10-11,14-15,17,22-24,38-39,41H,4-5,8-9,12-13,16H2,1H3/t17-,22-,23-,24+,30?,31-/m1/s1 IASXKSYUAIXXDE-NWFWUAPVSA-N 535780 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-{1-hydroxy-1-[trans-4- hydroxycyclohexyl}-3-[cis-3- hydroxycyclobutoxy]-2,3-dihydro-1H- isoindol-1-one *slow eluting isomer::US11236047, Example 495 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535780&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137512892 464920971 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135983 CC[C@@](O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C29H29Cl2F2N3O5/c1-2-28(39,27(33)7-10-40-11-8-27)19-13-22-25(23(32)14-19)29(41-12-9-37,18-3-5-20(30)6-4-18)36(26(22)38)17-24-34-15-21(31)16-35-24/h3-6,13-16,37,39H,2,7-12,17H2,1H3/t28-,29-/m1/s1 CPLOBKSITDKJJL-FQLXRVMXSA-N 535781 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[(1R)-1-(4-fluorooxan-4-yl)-1- hydroxypropyl]-3-(2-hydroxyethoxy)- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 501 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535781&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497958 464920972 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135984 CC[C@@](O)(c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29ClF2N4O5/c1-2-29(40,28(33)7-10-41-11-8-28)21-13-23-26(24(32)14-21)30(42-12-9-38,20-3-5-22(31)6-4-20)37(27(23)39)18-25-35-16-19(15-34)17-36-25/h3-6,13-14,16-17,38,40H,2,7-12,18H2,1H3/t29-,30-/m1/s1 FRAVIXIBGFVNQU-LOYHVIPDSA-N 535782 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[(1R)-1-(4-fluorooxan-4-yl)-1- hydroxypropyl]-1-(2-hydroxyethoxy)- 3-oxo-2,3-dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 509 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.940 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535782&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282723 464920973 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135985 CCC(O)([C@H]1CC[C@H](O)CC1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OC[C@@H](C)O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H34ClFN4O5/c1-3-31(42,21-6-10-25(40)11-7-21)23-12-26-29(27(34)13-23)32(43-18-19(2)39,22-4-8-24(33)9-5-22)38(30(26)41)17-28-36-15-20(14-35)16-37-28/h4-5,8-9,12-13,15-16,19,21,25,39-40,42H,3,6-7,10-11,17-18H2,1-2H3/t19-,21-,25-,31?,32-/m1/s1 MFJXVQCJOJBJSN-ZDDMJVHESA-N 535783 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-{1-hydroxy-1-[trans-4- hydroxycyclohexyl]propyl}-1-[(2R)-2- hydroxypropoxy]-3-oxo-2,3-dihydro- 1H-isoindol-2-yl]methyl}pyrimidine-5- carbonitrile::US11236047, Example 512 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.480 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535783&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137497976 464920974 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135986 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C30H29Cl2F2N3O5/c1-28(39,29(34)7-10-40-11-8-29)19-12-23-26(24(33)13-19)30(42-22-6-9-41-17-22,18-2-4-20(31)5-3-18)37(27(23)38)16-25-35-14-21(32)15-36-25/h2-5,12-15,22,39H,6-11,16-17H2,1H3/t22-,28?,30+/m0/s1 YHOMQLQCVYYRQC-GQMPWXHXSA-N 535777 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-[(3S)-oxolan-3-yloxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 493::US11236047, Example 494::US11236047, Example 516 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.20 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535777&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282598 464920969 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135987 CCC(O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2FN5O4/c1-2-30(41,19-38-10-8-35-9-11-38)21-13-25-28(26(34)14-21)31(43-24-7-12-42-18-24,20-3-5-22(32)6-4-20)39(29(25)40)17-27-36-15-23(33)16-37-27/h3-6,13-16,24,35,41H,2,7-12,17-19H2,1H3/t24-,30?,31+/m0/s1 DOOLEYVFQATQEL-JOINGXBXSA-N 535785 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[2-hydroxy-1-(piperazin-1-yl)butan- 2-yl]-3-[(3S)-oxolan-3-yloxy]-2,3- dihydro-1H-isoindol-1-one Ex. 524 is the faster eluting isomer::US11236047, Example 524 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 21.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535785&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282089 464920975 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135988 CCC(O)(CN1CC[C@@H](O)C1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FN4O5/c1-2-30(41,18-37-9-7-23(39)15-37)20-11-25-28(26(34)12-20)31(43-24-8-10-42-17-24,19-3-5-21(32)6-4-19)38(29(25)40)16-27-35-13-22(33)14-36-27/h3-6,11-14,23-24,39,41H,2,7-10,15-18H2,1H3/t23-,24+,30?,31-/m1/s1 KKQVYJKFFYTVGQ-VPAANPLTSA-N 535786 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-{2-hydroxy-1-[(3R)-3- hydroxypyrrolidin-1-yl]butan-2-yl}-3- [(3S)-oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-1-one Ex. 526 is the faster eluting isomer::US11236047, Example 526::US11236047, Example 527 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535786&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498040 464920976 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135989 CCC(O)(CN1CC[C@@H](O)C1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FN4O5/c1-2-30(41,18-37-9-7-23(39)15-37)20-11-25-28(26(34)12-20)31(43-24-8-10-42-17-24,19-3-5-21(32)6-4-19)38(29(25)40)16-27-35-13-22(33)14-36-27/h3-6,11-14,23-24,39,41H,2,7-10,15-18H2,1H3/t23-,24+,30?,31-/m1/s1 KKQVYJKFFYTVGQ-VPAANPLTSA-N 535786 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-{2-hydroxy-1-[(3R)-3- hydroxypyrrolidin-1-yl]butan-2-yl}-3- [(3S)-oxolan-3-yloxy]-2,3-dihydro-1H- isoindol-1-one Ex. 526 is the faster eluting isomer::US11236047, Example 526::US11236047, Example 527 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535786&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498040 464920976 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135990 CCC(O)(CN(C)C)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2FN4O4/c1-4-28(38,17-35(2)3)19-11-23-26(24(32)12-19)29(40-22-9-10-39-16-22,18-5-7-20(30)8-6-18)36(27(23)37)15-25-33-13-21(31)14-34-25/h5-8,11-14,22,38H,4,9-10,15-17H2,1-3H3/t22-,28?,29+/m0/s1 IMWIKKNQOUEPQC-MVAUJPHFSA-N 535788 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-6-[1- (dimethylamino)-2-hydroxybutan-2- yl]-4-fluoro-3-[(3S)-oxolan-3-yloxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 528::US11236047, Example 529 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535788&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282169 464920977 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135991 CCC(O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H32Cl2FN5O4/c1-2-28(40,18-36-9-7-33-8-10-36)20-13-23-26(24(32)14-20)29(41-12-11-38,19-3-5-21(30)6-4-19)37(27(23)39)17-25-34-15-22(31)16-35-25/h3-6,13-16,33,38,40H,2,7-12,17-18H2,1H3/t28?,29-/m1/s1 ISTMKLDBKUEYGB-YPJJGMIRSA-N 535789 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[2-hydroxy-1-(piperazin-1-yl)butan- 2-yl]-3-(2-hydroxyethoxy)-2,3- dihydro-1H-isoindol-1-one Ex. 530 is the faster eluting isomer::US11236047, Example 530 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535789&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282086 464920978 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135992 CCC(O)(CN1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H34Cl2FN5O4/c1-3-29(41,19-37-10-8-36(2)9-11-37)21-14-24-27(25(33)15-21)30(42-13-12-39,20-4-6-22(31)7-5-20)38(28(24)40)18-26-34-16-23(32)17-35-26/h4-7,14-17,39,41H,3,8-13,18-19H2,1-2H3/t29?,30-/m1/s1 OVXCRCRSYWAUFQ-BDCODIICSA-N 535790 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[2-hydroxy-1-(4-methylpiperazin-1- yl)butan-2-yl]-3-(2-hydroxyethoxy)- 2,3-dihydro-1H-isoindol-1-one Ex. 532 is the faster eluting isomer::US11236047, Example 532 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535790&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282348 464920979 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135993 CCC(O)(CN1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H35Cl2FN6O3/c1-3-32(44,20-41-12-10-40(2)11-13-41)23-14-26-29(27(36)15-23)33(22-4-6-24(34)7-5-22,45-21-31(19-37)8-9-31)42(30(26)43)18-28-38-16-25(35)17-39-28/h4-7,14-17,44H,3,8-13,18,20-21H2,1-2H3/t32?,33-/m1/s1 GJZOHGAQYXUXCM-ZHZZGXISSA-N 535791 1-({[(1R)-1-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-7-fluoro- 5-[2-hydroxy-1-(4-methylpiperazin-1- yl)butan-2-yl]-3-oxo-2,3-dihydro-1H- isoindol-1- yl]oxy}methyl)cyclopropane-1- carbonitrile Ex. 534 is the faster eluting isomer::US11236047, Example 534 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.80 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535791&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282707 464920980 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135994 CCC(O)(CN1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H36Cl2FN5O4/c1-3-31(42,20-39-11-9-38(2)10-12-39)22-14-26-29(27(35)15-22)32(44-25-8-13-43-19-25,21-4-6-23(33)7-5-21)40(30(26)41)18-28-36-16-24(34)17-37-28/h4-7,14-17,25,42H,3,8-13,18-20H2,1-2H3/t25-,31?,32+/m0/s1 UWEXKSFZEKXFGI-LOKXLOOWSA-N 535792 US11236047, Example 522 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.700 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535792&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282597 464920981 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135995 CC[C@](O)(C1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2FN4O3/c1-4-28(38,18-9-11-35(2)12-10-18)20-13-23-26(24(32)14-20)29(39-3,19-5-7-21(30)8-6-19)36(27(23)37)17-25-33-15-22(31)16-34-25/h5-8,13-16,18,38H,4,9-12,17H2,1-3H3/t28-,29+/m0/s1 RXWFSQUACIFPTB-URLMMPGGSA-N 535793 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[(1S)-1-hydroxy-1-(1- methylpiperidin-4-yl)propyl]-3- methoxy-2,3-dihydro-1H-isoindol-1- one::US11236047, Example 553 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.600 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535793&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283031 464920982 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135996 CC[C@](O)(C1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H33Cl2FN4O4/c1-3-29(40,19-8-10-36(2)11-9-19)21-14-24-27(25(33)15-21)30(41-13-12-38,20-4-6-22(31)7-5-20)37(28(24)39)18-26-34-16-23(32)17-35-26/h4-7,14-17,19,38,40H,3,8-13,18H2,1-2H3/t29-,30+/m0/s1 MTVISPOCUBWYQU-XZWHSSHBSA-N 535794 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[(1S)-1-hydroxy-1-(1- methylpiperidin-4-yl)propyl]-3-(2- hydroxyethoxy)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 559 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.620 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535794&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282534 464920983 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135997 CC[C@](O)(C1CCN(C)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OC[C@@H](C)O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H35Cl2FN4O4/c1-4-30(41,20-9-11-37(3)12-10-20)22-13-25-28(26(34)14-22)31(42-18-19(2)39,21-5-7-23(32)8-6-21)38(29(25)40)17-27-35-15-24(33)16-36-27/h5-8,13-16,19-20,39,41H,4,9-12,17-18H2,1-3H3/t19-,30+,31-/m1/s1 VBOLIJYMGSQRFX-MUMCFHHVSA-N 535795 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[(1S)-1-hydroxy-1-(1- methylpiperidin-4-yl)propyl]-3-[(2R)-2- hydroxypropoxy]-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 562 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535795&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282478 464920984 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135998 CC[C@](O)(C1CCN(CCO)CC1)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H33Cl2FN4O4/c1-3-29(40,19-8-10-36(11-9-19)12-13-38)21-14-24-27(25(33)15-21)30(41-2,20-4-6-22(31)7-5-20)37(28(24)39)18-26-34-16-23(32)17-35-26/h4-7,14-17,19,38,40H,3,8-13,18H2,1-2H3/t29-,30+/m0/s1 JRFKQIQQIAJEPR-XZWHSSHBSA-N 535796 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[(1S)-1-hydroxy-1-[1-(2- hydroxyethyl)piperidin-4-yl]propyl]-3- methoxy-2,3-dihydro-1H-isoindol-1- one Ex. 550 is the faster eluting isomer::US11236047, Example 550 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.980 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535796&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282931 464920985 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1135999 CC(C)(O)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C28H26ClFN4O4/c1-26(2,37)19-9-21-24(22(30)10-19)28(18-3-5-20(29)6-4-18,38-16-27(15-35)7-8-27)34(25(21)36)14-23-32-12-17(11-31)13-33-23/h3-6,9-10,12-13,35,37H,7-8,14-16H2,1-2H3/t28-/m1/s1 XJGKRRJKFHLFEF-MUUNZHRXSA-N 535797 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-({1- [hydroxydideuteromethyl]cyclopropyl} dideuteromethoxy)-5-(2- hydroxypropan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 513 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.10 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535797&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407656 464920986 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136000 CCC(C)(O)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28ClFN4O4/c1-3-27(2,38)20-10-22-25(23(31)11-20)29(19-4-6-21(30)7-5-19,39-17-28(16-36)8-9-28)35(26(22)37)15-24-33-13-18(12-32)14-34-24/h4-7,10-11,13-14,36,38H,3,8-9,15-17H2,1-2H3/t27?,29-/m1/s1 XFDBIZMVEPJQIF-ZBAATNBSSA-N 535798 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 1-({1- [hydroxydideuteromethyl]cyclopropyl} dideuteromethoxy)-5-(2- hydroxybutan-2-yl)-3-oxo-2,3- dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile Ex. 577 is the faster eluting isomer::US11236047, Example 577 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.930 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535798&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 163407657 464920987 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136001 CCC(O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ncc(Cl)cc3OC)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN4O5/c1-4-29(40,26-16-36(2)17-35-26)19-11-22-27(23(33)12-19)30(42-10-9-38,18-5-7-20(31)8-6-18)37(28(22)39)15-24-25(41-3)13-21(32)14-34-24/h5-8,11-14,16-17,38,40H,4,9-10,15H2,1-3H3/t29?,30-/m1/s1 QTAAEQKGSBEGOC-BDCODIICSA-N 535799 (3R)-2-[(5-chloro-3-methoxypyridin-2- yl)methyl]-3-(4-chlorophenyl)-4- fluoro-6-[1-hydroxy-1-(1-methyl-1H- imidazol-4-yl)propyl]-3-(2- hydroxyethoxy)-2,3-dihydro-1H- isoindol-1-one::US11236047, Example 491 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 8.90 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535799&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137498015 464920988 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136002 CC(O)(c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](OCCO)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C28H27Cl2F2N3O5/c1-26(38,27(32)6-9-39-10-7-27)18-12-21-24(22(31)13-18)28(40-11-8-36,17-2-4-19(29)5-3-17)35(25(21)37)16-23-33-14-20(30)15-34-23/h2-5,12-15,36,38H,6-11,16H2,1H3/t26?,28-/m1/s1 WCODONRZQFMBLE-SVNIRARHSA-N 535800 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-4-fluoro- 6-[1-(4-fluorooxan-4-yl)-1- hydroxyethyl]-3-(2-hydroxyethoxy)- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 578 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535800&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283143 464920989 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136003 CCC(O)(CN(C)C)c1cc2C(=O)N(Cc3ncc(Cl)cn3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2FN4O4/c1-4-28(38,17-35(2)3)19-11-23-26(24(32)12-19)29(40-22-9-10-39-16-22,18-5-7-20(30)8-6-18)36(27(23)37)15-25-33-13-21(31)14-34-25/h5-8,11-14,22,38H,4,9-10,15-17H2,1-3H3/t22-,28?,29+/m0/s1 IMWIKKNQOUEPQC-MVAUJPHFSA-N 535788 (3R)-3-(4-chlorophenyl)-2-[(5- chloropyrimidin-2-yl)methyl]-6-[1- (dimethylamino)-2-hydroxybutan-2- yl]-4-fluoro-3-[(3S)-oxolan-3-yloxy]- 2,3-dihydro-1H-isoindol-1-one::US11236047, Example 528::US11236047, Example 529 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 28.0 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535788&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282169 464920977 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136004 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(C)nc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C31H31ClF2N2O6/c1-4-30(40,29(34)11-13-42-14-12-29)21-15-23-25(24(33)16-21)31(41-3,20-7-9-22(32)10-8-20)36(27(23)37)17-19-6-5-18(2)35-26(19)28(38)39/h5-10,15-16,40H,4,11-14,17H2,1-3H3,(H,38,39)/t30-,31-/m1/s1 XSHRXYPCIVWDNP-FIRIVFDPSA-N 535805 3-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[(1R)-1-(4-fluorooxan-4-yl)-1- hydroxypropyl]-1-methoxy-3-oxo-2,3- dihydro-1H-isoindol-2-yl]methyl}-6- methylpyridine-2-carboxylic acid::US11236047, Example 515 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.40 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535805&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135282501 464920993 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 1136005 CCC(O)(c1ccn(C)n1)c1cc2C(=O)N(Cc3ncc(cn3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H28ClFN6O4/c1-3-30(41,26-8-10-38(2)37-26)21-12-24-28(25(33)13-21)31(43-23-9-11-42-18-23,20-4-6-22(32)7-5-20)39(29(24)40)17-27-35-15-19(14-34)16-36-27/h4-8,10,12-13,15-16,23,41H,3,9,11,17-18H2,1-2H3/t23-,30?,31+/m0/s1 HYWAMQVGJDJCMR-GMMQIRHLSA-N 535806 2-{[(1R)-1-(4-chlorophenyl)-7-fluoro- 5-[1-hydroxy-1-(1-methyl-1H-pyrazol- 3-yl)propyl]-3-oxo-1-[(3S)-oxolan-3- yloxy]-2,3-dihydro-1H-isoindol-2- yl]methyl}pyrimidine-5-carbonitrile::US11236047, Example 490 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q2XD14WT aid1806302 US11236047 Chessari, G; Lyons, JF 2/1/2022 6/6/2022 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=535806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=535806&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135283147 464920994 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8